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ABSTRACT 
Chapter 1 
A comprehensive review of diiron modeling in the Lippard group over the past thirty years is 
presented. This account describes the different strategies employed to prepare biomimetic 
complexes of non-heme diiron protein active sites, highlighting the accomplishments of the past 
as well as the challenges for the future. Studies of various model systems have led to a more 
profound understanding of the fundamental properties of carboxylate-bridged diiron units and 
their reactivity toward molecular oxygen and organic substrates. The key principles and lessons 
that have emerged from these studies have been an inspiration for the original work presented in 
this thesis. 
Chapter 2 
A series of phenoxylpyridyl and phenoxylimine ligands, H2LR,R’ (compounds derived from 
bis(phenoxylpyridyl)diethynylbenzene, where R = H, Me, or t-Bu, and R’ = H, or Ph) and 
H2BIPSMe,Ph (bis((phenylphenoxyl)iminephenyl)sulfone) were synthesized as platforms for non-
	   4	  
heme diiron(II) protein model complexes. UV-vis spectrophotometric studies and preparative-
scale reactions of [LR,R’]2– or [BIPSMe,Ph]2–, where [LR,R’]2– and [BIPSMe,Ph]2–are the deprotonated 
forms of H2LR,R’ and H2BIPSMe,Ph, respectively, with Fe(II) revealed that the presence of 
sterically protective ortho phenol substituents is necessary to obtain discrete dinuclear species. 
Reaction of [LMe,Ph]2– with Fe(II) in THF afforded the doubly-bridged compound 
[Fe2(LMe,Ph)2(THF)3] (1), which was characterized in the solid state by X-ray crystallography. A 
large internal cavity in this complex facilitates its rapid reaction with dioxygen, even at –50 ºC, 
to produce the thermodynamically stable [Fe2(µ-O)(LMe,Ph)2] (2) species. Reaction of 18O2 instead 
of 16O2 with 1 led to a shift in the Fe–O–Fe vibrational frequency from 833 cm-1 to 798 cm-1, 
confirming the presence of the µ-oxodiiron(III) core and molecular oxygen as the source of the 
bridging oxo group. The [LMe,Ph]2– ligand is robust toward oxidative decomposition and does not 
display any reversible redox activity.   
Chapter 3 
A dinucleating macrocycle, H2PIM, containing phenoxylimine metal-binding units has been 
prepared. Reaction of H2PIM with [Fe2(Mes)4] (Mes = 2,4,6-trimethylphenyl) and sterically 
hindered carboxylic acids, Ph3CCO2H or ArTolCO2H (2,6-bis(p-tolyl)benzoic acid), afforded 
complexes [Fe2(PIM)(Ph3CCO2)2] (1) and [Fe2(PIM)(ArTolCO2)2] (2), respectively. X-ray 
diffraction studies revealed that these diiron(II) complexes closely mimic the active site 
structures of the hydroxylase components of bacterial multi-component monooxygenases 
(BMMs), particularly the syn disposition of the nitrogen donor atoms and the bridging μ-η1η2 
and μ-η1η1 modes of the carboxylate ligands at the diiron(II) centers. Cyclic voltammograms of 1 
and 2 displayed quasi-reversible redox couples at +16 and +108 mV vs. ferrocene/ferrocenium, 
respectively, assigned to metal-centered oxidations. Treatment of 2 with silver perchlorate 
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afforded a silver(I)/diiron(III) heterotrimetallic complex, [Fe2(μ-OH)2(ClO4)2(PIM)(ArTolCO2)Ag] 
(3), which was structurally and spectroscopically characterized. Complexes 1 and 2 both react 
rapidly with dioxygen. Oxygenation of 1 afforded a (μ-hydroxo)diiron(III) complex [Fe2(μ-
OH)(PIM)(Ph3CCO2)3] (4), a hexa(μ-hydroxo)tetrairon(III) complex [Fe4(μ-
OH)6(PIM)2(Ph3CCO2)2] (5), and an unidentified iron(III) species. Oxygenation of 2 exclusively 
formed di(carboxylato)diiron(III) products. X-ray crystallographic and 57Fe Mössbauer 
spectroscopic investigations indicated that 2 reacts with dioxygen to give a mixture of (μ-
oxo)diiron(III) [Fe2(μ-O)(PIM)(ArTolCO2)2] (6) and di(μ-hydroxo)diiron(III) [Fe2(μ-
OH)2(PIM)(ArTolCO2)2] (7) complexes in the same crystal lattice. Compounds 6 and 7 
spontaneously convert to a tetrairon(III) complex, [Fe4(μ-OH)6(PIM)2(ArTolCO2)2] (8), when 
treated with excess H2O. The possible biological implications of these findings are discussed. 
Chapter 4 
To investigate how protons may be involved in the dioxygen activation pathway of non-heme 
diiron enzymes, the reaction of H+ with a synthetic (µ-1,2-peroxo)(carboxylato)diiron(III) 
complex was explored. Addition of an H+ donor to [Fe2(O2)(N-EtHPTB)(PhCO2)]2+ (1·O2, where 
N-EtHPTB = anion of N,N,Nʹ ,Nʹ -tetrakis(2-benzimidazolylmethyl)-2-hydroxy-1,3-diamino-
propane) resulted in protonation of the carboxylate rather than the peroxo ligand. Mössbauer and 
resonance Raman spectroscopic measurements indicate that the Fe2(O2) core of the protonated 
complex [1·O2]H+ is identical to that of 1·O2. In contrast, the benzoate ligand of [1·O2]H+ 
displays significantly different IR and NMR spectral features relative to those of the starting 
complex. The [1·O2]H+ species can be converted back to 1·O2 upon treatment with base, 
indicating that protonation of the carboxylate is reversible. These findings suggest that in the 
reaction cycle of soluble methane monooxygenases and related diiron proteins, protons may 
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induce a carboxylate shift to enable substrate access to the diiron core and/or increase the 
electrophilicity of the oxygenated complex. 
Chapter 5 
To explore additional methods to interrogate the properties of diiron protein intermediates, 
studies of the vibrational profiles of (µ-1,2-peroxo)diiron(III) species were pursued using nuclear 
resonance vibrational spectroscopy (NRVS). Comparison of the NRVS of [Fe2(O2)(N-
EtHPTB)(PhCO2)]2+ (1·O2) to that of the diiron(II) starting material [Fe2(N-EtHPTB)(PhCO2)]2+ 
(1) revealed  that the oxygenated complex displays new frequencies above 350 cm-1, which are 
attributed to the Fe–O–O–Fe core vibrations based on 18O2/16O2 isotopic labeling studies. The 
peak at 338 cm–1 has not been previously observed by resonance Raman spectroscopy. Empirical 
normal mode analysis provides a qualitative description of these isotopic sensitive modes. The 
NRVS of [Fe2(µ-O2)(HB(iPrpz)3)2(PhCH2CO2)2] (4·O2, where HB(iPrpz)3 = tris(3,5-diisopropyl-
pyrazoyl)hydroborate) was also measured and shows several Fe2(O2) modes between 350–500 
cm–1. 
Appendix A 
Attempts to prepare a diiron(IV) complex described in the literature led to several unexpected 
discoveries. Reaction of tris((3,5-dimethyl-4-methoxy)pyridyl-2-methyl)amine (R3TPA) with 
iron(III) perchlorate decahydrate and sodium hydroxide afforded a (µ-oxo)(µ-hydroxo)diiron(III) 
[Fe2(µ-O)(µ-OH)(R3TPA)2](ClO4)3 complex (1), rather than [Fe2(µ-O)(OH)(H2O)-
(R3TPA)2](ClO4)3 (B) as previously reported. The putative diiron(III) starting material B is 
formed only at low temperature when excess water is present. Compound 1 hydrolyzes 
acetonitrile to acetate under ambient conditions. The acetate-bridged diiron compound, [Fe2(µ-
O)(µ-CH3CO2)(R3TPA)2](ClO4)3 (4A), was characterized by X-ray crystallography as well as 
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various spectroscopic methods and elemental analysis. The identity of the acetate bridged 
complex was confirmed by comparing the structural and spectroscopic characteristics of 4A to 
those of an independently prepared sample of [Fe2(µ-O)(µ-CH3CO2)(R3TPA)2](ClO4)3.  
 
 
Thesis Supervisor: Stephen J. Lippard 
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Preface 
 
  The goal of synthetic modeling is to illuminate the underlying inorganic chemistry 
adopted by nature to achieve specific and complex transformations. A family of metalloenzymes 
that catalyzes the regio- and stereoselective oxidation of hydrocarbons using the earth abundant 
molecule O2 is the bacterial multi-component monooxygenases (BMMs). The BMMs are 
sophisticated biological machineries that require several protein components to function, 
including a hydroxylase that contains a diiron active site, a reductase that shuttles electrons from 
nicotinamide adenine dinucleotide (NADH) to the hydroxylase, and a regulatory protein that 
controls electron transfer and substrate oxidation. In addition to studying the biomolecules 
directly, our laboratory has employed a complementary approach using synthetic modeling to 
interrogate the structure and reactivity of the carboxylate-bridged diiron unit of the BMM active 
sites.  
 To place the work in this thesis into context, a chronological review of diiron modeling in 
the Lippard laboratory is presented in Chapter 1. This account highlights the various strategies 
utilized to prepare mimics of non-heme diiron protein active sites, with particular emphasis on 
rational ligand design. Despite the advances that have been made since the early 1980s, 
developing a functional protein mimic is still a significant challenge. To obtain a scaffold that 
can support a diiron core having the same coordination environment/geometry as that in the 
protein, a series of syn N-donor ligands were prepared. The diiron complexes assembled using 
these ligands, however, were too substitutionally labile to be useful as model compounds. 
Chapter 2 describes our attempt to prepare a more kinetically stabilizing ligand framework; the 
bis(phenoxylpyridine) and bis(phenoxylimine) ligands are anionic when deprotonated and form 
six-membered chelate rings upon complexation with iron. These ligands, however, 
spontaneously form bis(syn N-donor)diiron units when treated with iron(II) salts. To prevent 
undesired association of two syn N-donor ligands in a diiron complex, the two phenyl groups of 
the bis(phenoxylimine) compound were linked to afford a macrocycle, PIM2–. Chapter 3 reports 
the synthesis and characterization of di(µ-carboxylato)(PIM)diiron(II) complexes that are 
excellent structural models of the BMM active sites in their reduced state. The [Fe2PIM] unit is 
stable under oxidizing conditions and accommodates changes in the binding mode of the 
carboxylate moieties upon reaction with O2. Although further modifications to the aryl groups of 
PIM2– are necessary to prevent formation of tetranuclear species, the macrocyclic framework is 
an important breakthrough in our goal to access more advanced diiron protein models.  	   To gain insight into the O2 reaction pathway, another research objective was to examine 
the characteristics of well-defined diiron complexes that mimic the oxygenated intermediates 
formed during the BMM catalytic cycle. Extensive biochemical studies revealed that the 
generation and activation of [Fe2(O2)] units in the BMMs occur through proton dependent 
processes. To interrogate the possible role of protons in the biological O2 reduction mechanism, 
the study presented in Chapter 4 explores the effect of H+ on the stability of a synthetic (µ-1,2-
peroxo)(carboxylato)diiron(III) model compound. Resonance Raman (RR), infrared (IR), nuclear 
magnetic resonance (NMR), and Mössbauer spectroscopic studies indicate that the carboxylate is 
protonated rather than the dioxygen moiety upon treating the synthetic [Fe2(O2)] complex with 
H+. These results suggest that during O2 activation in the catalytic cycle of the BMMs, protons 
might induce a carboxylate shift in the diiron core, possibly increasing the electrophilicity of the 
[Fe2(O2)] unit or facilitating substrate access to the active site. 
	   10	  
 Inspired by nuclear resonance vibrational spectroscopic (NRVS) studies of mononuclear 
iron complexes, we initiated a project to evaluate the feasibility of applying this technique to 
probe the vibrational profile of diiron protein intermediates. As described in Chapter 5, to obtain 
spectroscopic benchmarks for possible [Fe2(O2)] species that occur during the BMM reaction 
cycle, the vibrational spectra of two (peroxo)diiron(III) model compounds were recorded using 
the synchrotron facility at SPring8, Japan. For one of the compounds, 16O2/18O2 studies revealed 
three isotopic sensitive peaks in the NRVS, one of which was not previously detected by RR 
spectroscopy. Normal coordinate analyses provide a qualitative description of the modes that 
involve vibrations of the [Fe2(O2)] core. These results suggest that NRVS may be a useful tool 
for studying diiron protein samples if an appropriate set of conditions can be met. 
  As a spectroscopic standard of an [FeIV2(O)2] unit for the NRVS studies described above, 
attempts were made to prepare a di(µ-oxo)bis(tris(pyridyl-2-methyl)amine)diiron(IV) complex 
that was reported in the literature. As summarized in Appendix A, our efforts led to several 
unexpected observations that prompted a re-evaluation of the identity of the diiron(III) precursor. 
Our data suggest that the (µ-oxo)(hydroxo)(aquo)diiron(III) compound reported is only present 
in sufficient amounts in wet solvent at low temperature. Furthermore, the diron(III) complex 
mediates hydrolysis of acetonitrile to acetate when H2O is present. These findings raise some 
concerns regarding the purported generation of high-valent diiron(IV) species derived from the 
mischaracterized diiron(III) starting material.   
 Diiron modeling has been at the heart of our research program for many years and will 
continue to be a vital research area for many more. The sophistication of today’s chemical 
toolbox should enable synthetic chemists to overcome the obstacles that have previously limited 
significant advances in biomimetic chemistry.  
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6Me2-BPP bis((6-methylpyridyl)-2-methyl)propionate amine 
6-Me3TPA tris((6-methylpyridyl)-2-methyl)amine 
[BIPSMe,Ph]2– anion of bis((phenylphenoxyl)iminephenyl)sulfone 
[G3]CO2– third generation dendrimer appended terphenylcarboxylate 
[LH,H]2– anion of bis(phenoxylpyridyl)diethynylbenzene 
[LH,Ph]2– anion of bis((phenylphenoxyl)pyridyl)diethynylbenzene 
[LMe,Ph]2– anion of bis(phenyl(p-cresol)pyridyl)diethynylbenzene 
[LtBu,Ph]2– anion of bis((o-phenyl-p-tert-butylphenoxyl)pyridyl)diethynylbenzene 
[LVH,H]2– anion of bis(phenoxylpyridyl)diethynylveratrole 
Abs absorption 
AMO alkene monooxygenase 
APD avalanche photodiode detector 
Ar4-FPhCO2– 2,6-bis(p-fluorophenyl)benzoate 
ArtBuCO2– 2,6-bis(p-(tert-butyl)phenyl)benzoate 
ArTolCO2– 2,6-bis(p-tolyl)benzoate 
Asp aspartate 
bdptz 1,4-bis(2,2ʹ -dipyridylmethyl)phthalazine 
BEPEAN 2,7-bis(bis(2-(2-(5-ethyl)pyridyl)ethyl)aminomethyl)-1,8-napthyridine 
BIPhMe bis(1-methylimidazol-2-yl)phenylmethoxymethane 
BMMs bacterial multi-component monooxygenases  
BPEAN 2,7-bis(bis(2-(2-(5-methyl)pyridyl)ethyl)aminomethyl)-1,8-napthyridine 
BPMAN 2,7-bis(bis(2-pyridylmethyl)aminomethyl)-1,8-napthyridine 
bpy 2,2ʹ -bipyridine 
BVS bond valence sum 
BXDK2– benzyl substituted variant of XDK2– 
Cp cyclopentadienyl 
CV cyclic voltammetry 
deoxyHr reduced form of hemerythrin, with no dioxygen bound 
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DAFA2– 1,8-bis(dimethylaminomethylethynyl)-3,6-di(tert-butyl)fluorine-9-yl-acetate 
DFT density functional theory 
DMF dimethylformamide 
DMSO dimethyl sulfoxide 
DNA deoxyribonucleic acid 
DPV differential pulse voltammetry 
EPR electron paramagnetic resonance 
E1/2 average of anodic and cathodic redox potential 
ET electron transfer 
Et2BCQEBEt 
1,2-bis(3-ethynyl-8-carboxylatequinoline)-4,5-diethynylbenzene methyl 
ester 
EXAFS extended X-ray absorption fine structure 
Fc ferrocene 
Fc+ ferrocenium 
FTIR fourier transform infrared 
GC-MS gas chromatography-mass spectrometry 
Glu glutamate 
H[BArF4] bis(diethyl ether)hydronium tetrakis((3,5-trifluoromethyl)phenyl)borate 
His histidine 
HMDS hexamethyldisilazide 
Hmv mixed-valent diiron(II,III) state of soluble methane monooxygenase 
Hr hemerythrin 
Im2DET bis(N-methylimidazole)diethynyltriptycene 
iPrCO2– isobutyrate 
IR infrared 
k kinetic rate constant 
Kcom comproportionation constant 
Lut 2,6-lutidine 
MArTolCO22– 
1,3-bis(aminomethyl)-4,6-diisopropylbenzene linked 
bis(terphenylcarboxylate) 
Mc Methylococcus capsulatus 
Mes 2,4,6-trimethylphenyl 
metHr the oxidized inactive form of hemerythrin 
MPDP2– m-phenylenedipropionate 
NADH the reduced form of nicotinamide adenine dinucleotide 
N-EtHPTB anion of N,N,Nʹ ,Nʹ -tetrakis((N-ethylbenzimidazolyl)methyl)-2-hydroxy-
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1,3-diaminopropane 
N-MeIm N-methylimidazole 
NMR nuclear magnetic resonance 
N,N-Bn2en N,N-dibenzylethylenediamine 
NRVS nuclear resonance vibrational spectroscopy 
N-tBuIm N-tert-butylimidazole 
oxyHr dioxygen-bound form of hemerythrin 
PDK4– anion of α,α-5,15-bis(α-N-(Kemp’s triacid imido)-o-tolyl)-2,8,12,18-tetraethyl-3,7,13,17-tetramethylporphyrin 
PIC2DET bis(picolinic methyl ester)diethynyltriptycene 
PIM2– dibenzylether linked bis(3-(methylphenoxylimine)phenyl)sulfone 
PH phenol hydroxylase 
Ph4DBA2– dibenzofuran-4,6-bis(diphenylacetate) 
PhCO2– benzoate 
PhCyCO2– 1-phenylcyclohexylcarboxylate 
Ph-bimp 2,6-bis(bis(2-(1-methyl-4,5-diphenylimidazolyl)methyl)aminomethyl)-4-methylphenolate 
pKa acid dissociation constant, log scale 
PXDK2– propyl substituted varient of XDK2– 
py pyridine 
R2 ribonucleotide reductase subunit containing the diiron active site 
R3TPA tris((3,5-dimethyl-4-methoxypyridyl)-2-methyl)amine 
RNR ribonucleotide reductase 
RR resonance Raman 
RT room temperature 
sMMO soluble methane monooxygenase 
sMMOH soluble methane monooxygenase hydroxylase 
sMMOHred the active form of soluble methane monooxygenase hydroxylase 
sMMOHox the resting state of soluble methane monooxygenase hydroxylase 
sMMOR soluble methane monooxygenase reductase 
t-BuCH2CO2– 1-tert-butylacetate 
t-BuCO2– pivalate 
T4MoH toluene 4-monooxygenase hydroxylase 
THF tetrahydrofuran 
TMEDA N,N,Nʹ ,Nʹ -tetramethylethylenediamine 
ToMO toluene/o-xylene monooxygenase 
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TP– tris(pyrazolyl)borate 
TPA tris(pyridyl-2-methyl)amine 
TrpCO2– triptycenecarboxlate 
UV-vis ultraviolet-visible 
XDK2– anion of m-xylenediamine bis(Kemp’s triacid)imide 
δ  isomer shift  
ΔEQ quadrupole splitting 
Γ linewidth 
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LIST OF COMPOUND IDENTIFIERS 
 
Chapter 1  
1 [FeIII2(µ-O)(µ-CH3CO2)2(TP)2] 
2 [FeIII2(µ-OH)(µ-CH3CO2)2(TP)2]+ 
3 [FeII2(µ-HCO2)3(HCO2)(BIPhMe)2] 
4 [FeIII2(µ-O)(µ-HCO2)2(HCO2)2(BIPhMe)2] 
5 [FeIII2(µ-O)(MPDP)(bpy)2Cl2] 
6 [FeIII2(µ-O)(MPDP)(BIPhMe)2Cl2] 
7 [FeIII2(µ-O)(MPDP)(TP)2] 
8 [FeIII2(µ-O)(XDK)(CH3OH)5(H2O)]2+ 
9 [FeII2(XDK)(µ-PhCyCO2)(PhCyCO2)(py)2] 
10 [FeII2(µ-OH)(Ph4DBA)(TMEDA)2(CH3CN)]+ 
11 oxygenated species of [FeII2(µ-OH)(Ph4DBA)(TMEDA)2(CH3CN)]+ 
12 [FeII3(PDK)(Lut)(Br)2(HBr)] 
13 [FeII2(µ-ArTolCO2)2(ArTolCO2)2(THF)2] 
14A quadruply-bridged form of [FeII2(ArTolCO2)4(4-tBupy)2] 
14B triply-bridged form of [FeII2(ArTolCO2)4(4-tBupy)2] 
14C doubly-bridged form of [FeII2(ArTolCO2)4(4-tBupy)2] 
15 [FeIIFeIII(ArTolCO2)4(4-tBupy)2]+ 
16 putative [FeIIIFeIV(µ-O)2] species 
17 [FeIII2(µ-OH)2(µ-ArTolCO2)2(ArTolCO2)2(4-tBupy)2] 
18 [FeII2(µ-ArTolCO2)2(ArTolCO2)2(N,N-Bn2en)2] 
19 [FeIII2(µ-OH)2(µ-ArTolCO2)(ArTolCO2)3(N-Bnen)(N,N-Bn2en)] 
20 [FeII2([G3]-CO2)4(4-CNpy)2] 
21 [FeII2(µ-H2O)2(µ-ArTolCO2)2(ArTolCO2)2(4-tBupy)2] 
22 [FeII2(µ-H2O)2(µ-Ar4-FPhCO2)2(Ar4-FPhCO2)2(THF)2(H2O)] 
23 [FeII2(µ-ArTolCO2)4(4-CNpy)2] 
24 [FeII2(µ-OH)(BPEAN)(SO3CF3)]2+ 
25 [FeII2(µ-OH)(BEPEAN)(SO3CF3)]2+ 
26 putative [FeIII2(OOH)] species 
27 [FeII2(BPMAN)(µ-PhCyCO2)2]2+ 
28 [FeII2(µ-OH)(µ-ArTolCO2)(bdptz)(CH3CN)(SO3CF3)]+ 
29 [FeIII2(µ-O)(µ-ArTolCO2)(bdptz)(acetone)(SO3CF3)]2+ 
30 [FeII2(Et2BCQEBEt)(µ-ArTolCO2)3]+ 
31 [FeIINa(PIC2DET)(µ-TrpCO2)3] 
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32 [FeII2(LMe,Ph)2(THF)2] 
33 [FeIII2(µ-O)(LMe,Ph)2] 
34 [FeII2(µ-ArTolCO2)2(PIM)] 
35 [FeII2(µ-Ph3CCO2)2(PIM)] 
36 [FeIII2(µ-O)(ArTolCO2)2(PIM)] 
37 [FeIII2(µ-OH)2(ArTolCO2)2(PIM)] 
38 [FeIII4(µ-OH)6(PIM)2(ArTolCO2)2] 
39 [FeII2(µ-RCO2)2(bulky PIM)] 
40 [FeIII2(µ-OH)2(RCO2)2(L)(bulky PIM)] 
41 [FeIII4(µ-OH)6(bulky PIM)2(RCO2)2] 
  
Chapter 2  
A 1-Benzyloxy-2-iodobenzene 
B 2-(2-Benzyloxyphenyl)-5-bromopyridine 
C 5-Bromo-2-(2-methoxyphenyl)pyridine 
D 2-Phenylanisole 
E 2-Bromo-6-phenylanisole 
F 5-Bromo-2-(2-methoxybiphenyl-3-yl)pyridine 
G 1-Benzyloxy-2,6-dibromo-4-methylbenzene 
H 1-Benzyloxy-2,6-dibromo-4-tert-butylbenzene 
I 1-Benzyloxy-2-bromo-4-methyl-6-phenylbenzene 
J 1-Benzyloxy-2-bromo-6-phenyl-4-tert-butylbenzene 
K 5-Bromo-2-(2-benzyloxy-5-methylbiphenyl-3-yl)pyridine 
L 5-Bromo-2-(2-benzyloxy-5-tert-butylbiphenyl-3-yl)pyridine 
M 2-(5-Methylbiphenyl-2-yloxy)tetrahydro-2H-pyran 
N 3-Bromo-5-methylbiphenyl-2-ol 
O 1-Benzyloxy-2,6-dibromo-4-methyl-benzene 
P 2-Benzyloxy-3-bromo-5-methylbenzaldehyde 
Q 2-Benzyloxy-5-methyl-3-phenylbenzaldehyde 
R 2-Hydroxy-5-methyl-3-phenylbenzaldehyde 
1 [FeII2(LMe,Ph)2(THF)2] 
2 [FeIII2(µ-O)(LMe,Ph)2] 
  
Chapter 3  
A 3,3'-[Oxybis(methylene)]bis(bromobenzene) 
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B 2,2'-[(Oxybis(methylene))bis(5-methyl-[1,1'-biphenyl]-3',2-diyl)] bis(oxy)bis(tetrahydro-2H-pyran) 
C Bis(3-(2-hydroxy-5-methylphenyl)benzyl)ether 
D Bis(3-(2-hydroxy-5-methylphenyl-3-carbaldehyde)benzyl)ether 
1 [FeII2(PIM)(Ph3CCO2)2] 
2 [FeII2(PIM)(ArTolCO2)2] 
3 [FeIII2(µ-OH)2(ClO4)2(PIM)(ArTolCO2)Ag] 
4 [FeIII2(µ-OH)(PIM)(Ph3CCO2)3] 
5 [FeIII4(µ-OH)6(PIM)2(Ph3CCO2)2] 
6 [FeIII2(µ-O)(PIM)(ArTolCO2)2] 
7 [FeIII2(µ-OH)2(PIM)(ArTolCO2)2] 
8 [FeIII4(µ-OH)6(PIM)2(ArTolCO2)2] 
  
Chapter 4  
1a [FeII2(N-EtHPTB)(Ph12CO2)]2+ 
1b [FeII2(N-EtHPTB)(Ph13CO2)]2+ 
1a·16O2 [FeIII2(µ-16O2)(N-EtHPTB)(Ph12CO2)]2+ 
1a·18O2 [FeIII2(µ-18O2)(N-EtHPTB)(Ph12CO2)]2+ 
1b·16O2 [FeIII2(µ-16O2)(N-EtHPTB)(Ph13CO2)]2+ 
1b·18O2 [FeIII2(µ-18O2)(N-EtHPTB)(Ph13CO2)]2+ 
[1a·16O2]H+ [FeIII2(µ-16O2)(N-EtHPTB)(Ph12CO2H)]3+ 
[1a·18O2]H+ [FeIII2(µ-18O2)(N-EtHPTB)(Ph12CO2H)]3+ 
[1b·16O2]H+ [FeIII2(µ-16O2)(N-EtHPTB)(Ph13CO2H)]3+ 
[1b·18O2]H+ [FeIII2(µ-18O2)(N-EtHPTB)(Ph13CO2H)]3+ 
2 [FeII2(N-EtHPTB)(C6F5CO2)]2+ 
2·16O2 [FeIII2(µ-16O2)(N-EtHPTB)(C6F5CO2)]2+ 
2·18O2 [FeIII2(µ-18O2)(N-EtHPTB)(C6F5CO2)]2+ 
[2·16O2]H+ [FeIII2(µ-16O2)(N-EtHPTB)(C6F5CO2H)]3+ 
[2·18O2]H+ [FeIII2(µ-18O2)(N-EtHPTB)(C6F5CO2H)]3+ 
  
Chapter 5  
1 [FeII2(N-EtHPTB)(PhCO2)]2+ 
1·16O2 [FeIII2(µ-16O2)(N-EtHPTB)(PhCO2)]2+ 
1·18O2 [FeIII2(µ-18O2)(N-EtHPTB)(PhCO2)]2+ 
2·O2 [FeIII2(µ-O2)(N-EtHPTB)(OPh3)2]3+ 
3·O2 [FeIII2(µ-O2)(Ph-bimp)(PhCO2)]2+ 
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4-Br [FeII(HB(iPrpz)3)Br] 
4 [FeII(HB(iPrpz)3)(PhCH2CO2)] 
4·16O2 [FeIII2(µ-16O2)(HB(iPrpz)3)2(PhCH2CO2)2] 
4·18O2 [FeIII2(µ-18O2)(HB(iPrpz)3)2(PhCH2CO2)2] 
  
Appendix A  
A [FeIIIFeIV(µ-O)2(5-Et-TPA)2]3+ 
B [FeIII2(µ-O)(OH)(H2O)(R3TPA)2]3+ 
C [FeIII2(µ-O)(OOH)(R3TPA)2]3+ 
D [FeIV2(µ-O)(OH)(O)(R3TPA)2]3+  
E [FeIIIFeIV(µ-O)(OH)(O)(R3TPA)2]2+ 
F [FeIIIFeIV(O)2(R3TPA)2]3+  
G [FeIV2(O)2(R3TPA)2]4+  
1 [FeIII2(µ-O)(µ-OH)(R3TPA)2]3+ 
2 [FeIII2(µ-O)(OH)(CH3CN)(R3TPA)2]3+ 
3 [FeIII2(µ-O)(µ-CH3CONH)(R3TPA)2]3+ 
4A [FeIII2(µ-O)(µ-CH3CO2)(R3TPA)2](ClO4)3·(CH3CN)3 
4B [FeIII2(µ-O)(µ-CH3CO2)(R3TPA)2](ClO4)3·(CH3CN)2.5(Et2O)0.5 
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Chapter 1 
Rationally Designed Synthetic Mimics of Diiron Protein Active Sites: 
 A Chronological Perspective 
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1.1. Introduction 
 Understanding the role of metal ions in dictating protein structure and function is a 
central theme in bioinorganic research.1-4 In addition to the arsenal of modern physical 
techniques and instrumentation available for studies of biomolecules,5 synthetic modeling has 
been pursued as a complementary tool to interrogate complex biological systems.6 It provides a 
convenient simplification of elaborate macromolecules in a real, rather than a virtual (e.g. 
computational),7 platform. By reducing a metalloprotein to its functional core, it is possible to 
gain insight into whether the chemistry that occurs at the metal center is predominantly a result 
of the inorganic component alone or a consequence of the protein complex as a whole. Synthetic 
modeling also provides an opportunity to access chemistry that has not yet been achieved 
artificially using simple biological building blocks under ambient conditions. Some of the most 
remarkable transformations in nature, such as nitrogen fixation,8-11 water splitting,12 and 
hydrogen production,13 are performed by metalloenzymes. Reproducing such chemical reactivity 
in an efficient manner would not only revolutionize the chemical industry but also provide new 
sustainable sources of energy.14 Finally, the synthetic challenges of modeling chemistry will 
push the limits of current synthetic methodologies. Although natural product synthesis has been 
largely aided by an understanding of organic chemistry,15 inorganic synthesis is not governed by 
the same set of well-defined rules.16 Controlling the nuclearity and kinetic stability of metal 
clusters or components using organic ligands is still a significant challenge.  
Small-molecule metalloprotein mimics are prepared using one of two design strategies.4 
The biomimetic approach seeks to duplicate the active site structure as faithfully as possible, 
particularly in matching the identity and geometric arrangement of ligands in the primary 
coordination sphere. The bio-inspired approach, on the other hand, only requires that the 
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synthetic model shares some common features with those of the protein core, unrestricted by the 
type or position of ligands coordinated to the metal center. For modeling studies, the former is 
preferred over the latter because biomimetic complexes more accurately reproduce the 
characteristics of the biological center under investigation.  
The following is a chronological account of the strategies and tactics employed in the 
Lippard group to prepare structural and functional mimics of diiron protein active sites. This 
work will describe the rational basis for ligand design and selection as well as the notable 
findings that resulted from studies of the various model systems. The reader is referred elsewhere 
for more general reviews of synthetic diiron modeling.17-22 
 
1.2. Non-Heme Diiron Proteins 
 Non-heme carboxylate-bridged diiron proteins are involved in essential physiological 
processes.23,24 Although their roles vary, the first step in their respective reaction mechanisms 
involves binding and activation of dioxygen. In hemerythrin (Hr),25 the O2 molecule coordinates 
to a single iron site and acquires two electrons and a proton to generate a 
(hydroperoxo)diiron(III) unit (Scheme 1.1, top). This process is reversible and is the basis for O2 
transport in some marine invertebrates. Unlike hemerythrin, ribonucleotide reductase (RNR)26 
and bacterial multi-component monooxygenases (BMMs)27 consume dioxygen to perform 
catalytic reactions (Scheme 1.1, middle and bottom, respectively). Activation of O2 by these 
enzymes leads to formation of (peroxo)diiron(III) or di(µ-oxo)diiron(IV) complexes that are 
capable of oxidizing organic moieties.28-32 The high-valent diiron intermediate in the R2 subunit 
of RNR generates a tyrosyl radical that initiates the first step in DNA biosynthesis, whereas that 
in the hydroxylase component of the BMMs is responsible for inserting an oxygen atom into the 
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C–H bond of hydrocarbon substrates. The most well-studied member of the BMM family is 
soluble methane monooxygenase (sMMO),33 which is unique for its ability to hydroxylate 
methane to methanol. Recent studies have revealed that other classes of enzymes containing 
carboxylate-bridged diiron motifs also exist in biology.34-36 
 
 
Scheme 1.1. Dioxygen reactivity of hemerythrin (Hr, top), ribonucleotide reductase (RNR, 
middle), and soluble methane monooxygenase hydroxylase (sMMOH, bottom). The active site 
structures of the proteins in various redox states are depicted. 
 
These diiron proteins contain two iron atoms that are coordinated by imidazole and 
carboxylate residues, where at least one of the carboxylate groups bridges the two metal 
centers.23 The structural similarities between the active sites of this protein family indicate that 
their functional differences are derived from variations in their Asp/Glu/His amino acid 
combinations and/or careful tuning of their tertiary and quaternary protein structures. Discerning 
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the factors that contribute to their mechanism of action is an important goal in synthetic model 
studies.19,20  
1.3. Mononucleating N-Heterocyclic Ligands 
  The first successful attempt to prepare a mimic of the Hr core was achieved using 
tris(pyrazolyl)borate (TP–) (Table 1.1),37,38 a tripodal ligand commonly employed in inorganic 
coordination chemistry. Reaction of TP–, iron(III), and acetate led to the spontaneous self-
assembly of [FeIII2(µ-O)(µ-CH3CO2)2(TP)2] (1), the structure of which closely matches that of 
metHr, the inactive form of Hr.25  Reaction of 1 with an H+ donor led to formation of [FeIII2(µ-
OH)(µ-CH3CO2)2(TP)2]+ (2), a stable protonated analogue of 1.39 Spectroscopic and magnetic 
measurements of the (µ-oxo)di(µ-carboxylato)diiron(III) and (µ-hydroxo)di(µ-
carboxylato)diiron(III) compounds provided, for the first time, benchmarks for identifying such 
units in biology.40,41 When 1 was exposed to H218O, the 16O bridge was readily exchanged for 
18O, indicating that a lack of exchange with water in the protein is due to inaccessibility of H2O 
to the diiron core rather than an intrinsic property of the [FeIII2O] unit. An undesirable feature of 
1 and 2 is that the facial capping nature of the TP– ligands blocks having open sites for binding 
of O2. Furthermore, reduction of the diiron(III) species resulted in irreversible dissociation to 
monoiron complexes.38  
 To access the asymmetric iron centers in Hr, the denticity of the capping ligand was 
reduced from three to two, using bis(1-methylimidazol-2-y1)phenylmethoxymethane (BIPhMe) 
(Table 1.1).42,43 Stirring iron(II) formate with BIPhMe in a methanol solution provided [FeII2(µ-
HCO2)3(HCO2)(BIPhMe)2] (3). X-ray crystallography revealed a dinuclear structure with both 
five- and six-coordinate iron sites, in which each metal ion is bound by a BIPhMe ligand and 
bridged by three formate groups. A terminal acetate group completes the coordination sphere of 
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Table 1.1. Various Ligands Employed to Prepare Diiron Protein Model Complexes. 
Ligand/ Example of Iron Complex* Desirable  Characteristics 
Undesirable  
Characteristics 
Reference  
No. 
Mononucleating N-Heterocyclic Ligands 
 
B
N
N
H N
N
N
N
 
TP– 
 
FeIII FeIII
O
O OO
N
N
N
N
N
NO
 
[Fe2(O)(CH3CO2)2(TP)2] (1) 
 
 Forms stable 
tripodal chelate with 
iron 
 N-donors similar to 
histidine residues 
 Easy to synthesize 
 
 Capping unit 
restricts binding to  
the metal center 
 Does not enforce 
dinuclearity 
 
37-39, 41 
 
OCH3
N
N
N
N
H3C
CH3
 
 
BIPhMe 
 
FeII FeII
O
O OO
H H
N
N
O
N
NO
OH
O H  
[Fe2(HCO2)4(BIPhMe)2] (3) 
 
 
 Contains biomimetic 
imidazole groups 
 Bidentate chelate 
allows assembly of 
asymmetric diiron 
unit with open sites 
 Easy to synthesize 
 
 
 Does not enforce 
dinuclearity  
 
42, 43 
Dicarboxylate Ligands 
 
 
O
O
O O
 
 
MPDP2– 
FeIII FeIII
O
O OO
Cl
N
N
N
NO
Cl
 
[Fe2(O)(MPDP)(BIPhMe)2Cl2] 
(6) 
 
 Enables assembly of 
[FeIII2O] units that 
could not be 
accessed using 
simple carboxylates 
 
 Does not enforce 
dinuclearity 
 
44, 45 
 
N
O
OO
O
N
O
O O
O
 
 
XDK2– 
 
FeII FeII
O
O O
O
O
O
N NO
O
CyPh
CyPh
 
[Fe2(XDK)(CyPhCO2)2(Py)2] 
(9) 
 
 
 Supports a diiron 
core with open sites 
for substitution with 
external bases 
 Maintains a di-
nuclear structure 
upon reaction with 
dioxygen 
  
 Endo positioning of 
carboxylates may be 
too geometrically 
restrictive 
 Does not prevent 
polynuclear 
aggregation 
 
49-57  
 
O Ph
Ph
O
O
Ph
Ph
O
O
 
 
Ph4DBA2– 
 
FeII FeII
H
O
O OO
N
N
N
N
N
O
C
CH3
+
 
[Fe2(OH)(Ph4DBA)(TMEDA)2 
(CH3CN)]+ (10) 
 
 
 Supports an 
[FeII2(OH)] core with 
an open metal 
binding site 
 Stabilizes an 
oxygenated adduct 
to the diiron center 
 
 Does not prevent 
formation of 
tetranuclear 
complexes 
 
60, 61 
 
 
PDK4– 
 
FeIIFeII
BrH
OO OO
FeIIN
N
N
N
Br
Br
N
 
 
[Fe3(PDK)(Lut)(Br)2(HBr)] (12) 
 
  
 Provides both a 
porphyrin and non-
porphyrin binding 
sites 
 
 Does not prevent 
formation of polyiron 
clusters 
 Difficult to prepare 
in gram quantities 
 
62-64 
* The donor atoms highlighted in red in the iron complexes (second column) are derived from the donor groups, also 
shown in red, of the featured ligand (first column). 
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Table 1.1. (Continued) 
Ligand/ Example of Iron Complex* Desirable  Characteristics 
Undesirable  
Characteristics 
Reference 
No. 
 
Terphenylcarboxylate Ligands 
 
 
OO
 
 
ArTolCO2– 
ArTol
FeII FeII
O O
O
ArTol
ArTol
O
O O
O O
ArTol
NN
 
[Fe2(ArTolCO2)4(4-tBuPy)2] 
(14A) 
 
 
 Forms diiron 
complexes in the 
presence of Fe(II) 
salts and an 
appropriate base 
 Stabilizes high-
valent iron species 
 Easy to synthesize 
 
 The steric 
encumbrance of 
the 2,6-aryl 
groups restricts 
access to the 
diiron core. 
 Does not 
prevent 
formation of 
polyiron species 
 
69-72,  
74-90  
Dinucleating Polynitrogen Ligands 
N N
N N
N N NN
 
 
BPEAN 
 
 
FeII FeII
H
O
F3CO2SO
N N
N
N
N
N
N
N
2+
 
 
[Fe2(OH)(BPEAN)(SO3CF3)]2+ 
(24) 
 
 Contains a “masked 
carboxylate” to 
bridge two metal 
centers 
 Stabilizes diiron 
species in multiple 
oxidation states 
 
 Nitrogen-rich, 
rather than 
carboxylate-rich 
 
 
95-98 
 
N N
N N
NN
 
 
bdptz 
 
FeII FeII
H
O
F3CO2SO
N NN
N
N
N
+
O O
ArTol
N
C
CH3
 
 
[Fe2(OH)(bdptz)(ArTolCO2) 
(SO3CF3)(CH3CN)]+ (28) 
 
 
 Forms very stable 
bimetallic 
compounds 
 
 
 
 Nitrogen-rich, 
rather than 
carboxylate-rich 
 
 
99, 100 
syn N-Donor Ligands 
NN
EtO
O
OEt
O
 
 
Et2BCQEBEt 
 
 
O
FeII FeII
O O
O
ArTol
ArTol
OO
ArTol
NN
O O
+
 
 
[Fe2(ArTolCO2)3(Et2BCQEBEt)]+ 
(30) 
 
 Enforces the syn 
stereochemistry of 
nitrogen donors 
relative to the Fe–Fe 
vector 
 Accommodates 
binding of external 
carboxylates to the 
diiron core 
 
 Neutral oxygen 
donors, rather 
than anionic 
 Quinoline ester 
groups do not 
sufficiently 
stabilize the iron 
centers 
 
 
101,  
102-108 
 
N N
O
O
 
DAFA– 
 
 
 
 
N.A. 
 
 Contains a bridging 
carboxylate unit in 
addition to two 
adjacent amine 
groups 
 
 Not sufficiently 
pre-organized, 
could not 
metallate with 
iron 
 No clear 
advantage over 
Et2BCQEBEt 
design 
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* The donor atoms highlighted in red in the iron complexes (second column) are derived from the donor groups, also 
shown in red, of the featured ligand (first column).  
	   34 
Table 1.1. (Continued) 
Ligand/ Example of Iron Complex* Desirable  Characteristics 
Undesirable  
Characteristics 
Reference 
No. 
 
Macrocyclic Ligands 
OO
OO
H
N
N
H
N
H
H
N
 
 
MArTolCO22– 
 
 
 
 
 
N.A. 
 
 May help control the 
nuclearity of the 
resulting iron 
complex 
 
 Metallation of 
this ligand was 
not successful  
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O
H3C O O CH3
N N
S
O O  
 
PIM2– 
 
O
FeII FeII
O O
ArTol
O
ArTol
NN
O O
 
 
[Fe2(ArTolCO2)2(PIM)] 
(34) 
 
 Supports a 
carboxylate-bridged 
diiron(II) unit 
 Maintains a 
dinuclear core upon 
reaction with O2 
 Can be sterically 
tuned without 
obstructing access 
to the metal binding 
pocket. 
 
 
 Does not 
prevent 
formation of 
tetrairon species 
 Phenolate and 
imine donors are 
not biomimetic 
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* The donor atoms highlighted in red in the iron complexes (second column) are derived from the donor groups, also 
shown in red, of the featured ligand (first column).  
 
the octahedral iron atom. Complex 3 reacts instantaneously with dioxygen to give [FeIII2(µ-O)(µ-
HCO2)2(HCO2)2(BIPhMe)2] (4), with no detectable intermediates. Manometric measurements 
indicated that 0.5 equiv of O2 was consumed per diiron(II) complex, suggesting that 4 is formed 
through a tetranuclear dioxygen species. Unfortunately, the behavior of 3 toward dioxygen is 
markedly different than that of deoxyHr, which binds O2 reversibly (Scheme 1.1, top).25 
 
1.4. Dicarboxylate Ligands 
 To increase the structural integrity of the model compounds, several dicarboxylate 
ligands were explored as dinucleating platforms. The first of these is m-phenylenedipropionate 
(MPDP2-, Table 1.1),44,45 which was selected because the distance between its β-methylene 
carbon atoms matches the 6 Å separation between the acetate methyl carbons in [FeIII2(µ-O)(µ-
CH3CO2)2(TP)2] (1).37 The use of MPDP2– facilitated synthesis of [FeIII2(µ-O)(MPDP)(bpy)2Cl2] 
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(5) (bpy = 2,2’-bipyridine) and [FeIII2(µ-O)(MPDP)(BIPhMe)2Cl2] (6, Table 1.1), complexes that 
could not be obtained from self-assembly with simple monocarboxylate anions. The cyclic 
voltammogram of [FeIII2(µ-O)(MPDP)(TP)2] (7), an analogue of 1, showed that mononuclear 
[FeII(TP)2] and [FeIII(TP)2]+ species were generated upon electrochemical reduction and 
oxidation, respectively. These results demonstrated that linking the carboxylate groups using 
MPDP2– does not impart additional stability to the diiron models.  
 To obtain a more stable bridging framework, m-xylenediamine bis(Kemp’s triacid)imide 
(H2XDK, Table 1.1), a compound developed from studies of molecular recognition in organic 
chemistry,46,47 was employed. The rigid conformation of the carboxylate units in XDK2– provides 
a well-defined cleft for assembly of homo- and heterodimetallic complexes.48-51 A diiron(III) 
compound, [FeIII2(µ-O)(XDK)(CH3OH)5(H2O)](NO3)2 (8), was readily prepared from iron(III) 
nitrate and XDK2–.52 Kinetic studies of the substitution of 2,2´-bipyridine or N-methylimidazole 
with the coordinated solvents in 8 suggested that anion binding and exchange at the active site of 
hemerythrin proceed with rates similar to those exhibited by small-molecules; thus, the protein 
scaffold of Hr does not alter the intrinsic rate of terminal ligand exchange at the diiron center. 
Preparation of a series of pseudohalide bound diiron(III) compounds, with the formula [FeIII2(µ-
O)(XDK)(bpy)2(X)2] (where X = NCS–, NCSe–, or N3–), allowed detailed studies of the 
spectroscopic signatures of molecules with terminal ligation to carboxylate-bridged diiron 
units.53 A notable discovery is that the appearance of only one asymmetric 15NNN– stretch is not 
sufficient to discount the possibility of a terminally coordinated azide group, for isotopically 
shifted peaks may occur too close to one another in energy to be resolved.  
 The XDK2– ligand also supports carboxylate-bridged diiron(II) units with the general 
composition [FeII2(XDK)(µ-RCO2)(RCO2)(N-donor)2], where R = t-Bu- (pivalate), PhCy- (1-
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phenylcyclohexylcarboxylate), Ph- (benzoate), iPr- (isobutyrate), or tBuCH2- (1-tert-
butylacetate);  N-donor = py (pyridine), 3-Fpy (3-fluoropyridine), N-MeIm (N-methylimidazole), 
or N-tBuIm (N-tert-butylimidazole).54-56 More sterically-protecting XDK2– variants, containing 
either propyl (PXDK2–) or benzyl (BXDK2–) substituents in place of the methyl groups on the 
Kemp’s triacid moiety, were also successfully employed to assemble similar diiron(II) 
compounds. The asymmetric bridging mode of the ancillary carboxylate to the diiron(II) core is 
determined by both steric and electronic factors.56 X-ray structural studies suggested that greater 
steric repulsion, between XDK2– and the external carboxylate, and more basic N-donors favor a 
syn,syn-bidentate bridging mode of the ancillary carboxylate rather than a syn,anti-monodentate 
one. For complexes that have sufficiently bulky groups, such as [FeII2(XDK)(µ-
PhCyCO2)(PhCyCO2)(py)2] (9, Table 1.1), exposure to O2 led to formation of stable peroxo 
adducts at low temperature.56 Although these (peroxo)diiron(III) species could not be crystallized 
for X-ray diffraction analysis, resonance Raman measurements indicate that the dioxygen 
molecule is bound in a µ-1,2 fashion. Reactivity studies of the [FeIII2(O2)] units revealed that they 
are nucleophilic,57 rather than electrophilic like the oxygenated intermediates in the BMMs.58,59 
When warmed above -65°C, the [FeIII2(O2)] species rapidly decayed, initiating a radical chain 
pathway that oxidized solvents with weak to intermediate C–H bond strengths. Despite having 
the same ligand stoichiometry as that of the (peroxo)diiron(III) species in sMMOH (Hperoxo) and 
related enzymes,33 the synthetic analogues do not reproduce the substrate scope, product 
selectivity, or reaction mechanism of the diiron monooxygenases. It is possible that the doubly-
bridging XDK2– ligand is too rigid in the synthetic models to achieve an Hperoxo-like structure, a 
prerequisite that may be necessary to attain the high oxidizing power of the oxygenated diiron 
protein intermediates. 
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  The search for a ligand that is sufficiently pre-organized yet structurally flexible led to 
examination of other dicarboxylate motifs. One potential candidate was the compound 
dibenzofuran-4,6-bis(diphenylacetate) (Ph4DBA2-, Table 1.1).60,61 Similar to XDK2–, Ph4DBA2– 
has two orthogonal carboxylate groups that can support an {FeIII2O}4+ core. The Ph4DBA2– 
ligand, however, has more conformational freedom because the C–C bond between its 
carboxylate groups and the dibenzofuran linker can rotate freely. The compound [FeII2(µ-
OH)(Ph4DBA)(TMEDA)2(CH3CN)]+ (10, Table 1.1), where TMEDA = N,N,N´,N´-
tetramethylethylenediamine, was prepared from Ph4DBA2–, triethylamine, TMEDA, and iron(II) 
triflate. The structure of 10 is unique because it is the first synthetic complex to reproduce the (µ-
hydroxo)di(µ-carboxylato)diiron(II) core of deoxyHr25 with an open coordination site for binding 
of a terminal ligand. When 10 was treated with dioxygen at -78 °C in the presence of 3 equiv of 
N-MeIm in CH2Cl2 or in neat EtCN, a red-orange species (11) appeared that decayed after ~10 
min.  The UV-vis, Mössbauer, resonance Raman, and EXAFS spectra of the transient 
intermediate closely match those of oxyHr (Scheme 1.1, top), strongly suggesting that 11 
contains a (hydroperoxo)(µ-oxo)diiron(III) unit. Unfortunately, oxygenation of 10 is irreversible 
and led to decomposition to a tetrairon(III) cluster.  
 A fourth dicarboxylate ligand, α,α-5,15-bis(α-N-(Kemp’s triacid imido)-o-tolyl)-
2,8,12,18-tetraethyl-3,7,13,17-tetramethylporphyrin (H4PDK, Table 1.1), was prepared by 
replacing the m-xylenediamine linker of XDK2– with a porphyrin unit.62 The construct was 
designed so that activation of O2 within a trimetallic cavity would offer the possibility of 
supplying additional electrons to the carboxylate-bridged diiron centers, much like the reductase 
component of sMMO.33 A triiron(II) compound, [FeII3(PDK)(Lut)(Br)2(HBr)] (12, where Lut = 
2,6-lutidine, Table 1.1), was successfully prepared from metallation with iron(II) bromide.63 
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When iron(II) chloride was used instead of iron(II) bromide in the preparation, a mixed-valent 
heptairon chloride cluster was isolated.64 Due to the complicated nature of the iron complexes of 
PDK4–, no further studies were pursued using this ligand.  
 The more pre-organized dicarboxylate ligands XDK2– and Ph4DBA2– impart enhanced 
stability to their respective diiron complexes and allow detection of O2 adducts at low 
temperature. A common problem with the dicarboxylate ligands, however, is that they do not 
prevent aggregation of the diiron compounds into oligo- and polynuclear clusters,65 an undesired 
reaction that is detrimental to the synthesis of accurate models. Furthermore, the 
conformationally rigid ligand framework may be a liability in terms of accessing oxygenated 
diiron species that could further react with external substrates. 
 
1.5. Terphenylcarboxylate Ligands  
 To reduce the geometric constraints of the ligand platform, bulky terphenylcarboxylates 
were employed. Unlike simple benzoates that form polynuclear clusters with iron, 66-68 the 
sterically-hindered 2,6-bis(p-tolyl)benzoate (ArTolCO2–, Table 1.1) and 2,6-bis(p-
fluorophenyl)benzoate (Ar4-FPhCO2–) self-assemble into discrete diiron compounds in the 
presence of iron salts and an appropriate base.69,70 The first iron complex synthesized in this 
series is [FeII2(µ-ArTolCO2)2(ArTolCO2)2(THF)2] (13), which adopts a windmill structure with two 
syn,syn-bridging carboxylates and two bidentate terminal carboxylates in the solid-state. The 
coordinated THF molecules in 13 can be readily substituted with N-donors to afford the 
corresponding [FeII2(ArTolCO2)4(N-donor)2] complex. Use of 4-tert-butylpyridine (4-tBuPy) as 
the ancillary base provided a quadruply-bridged [FeII2(ArTolCO2)4(4-tBupy)2] (14A, Table 1.1) 
paddlewheel compound. Interconversion between the windmill and paddlewheel structures in 
	   39 
solution was demonstrated by variable temperature NMR spectroscopy.70 Oxygenation of 14A at 
-78°C resulted in irreversible formation of a deep green intermediate that decayed to a [FeIII2(µ-
OH)2(µ-ArTolCO2)2(ArTolCO2)2(4-tBupy)2] (17) product.71,72 The di(µ-hydroxo)diiron(III) unit of 
17 closely resembles that of the oxidized core of sMMOH.73 Characterization of the green 
intermediate revealed two mixed-valent complexes, a diiron(II,III) (15) and a diiron(III,IV) (16) 
species, that are present in equal amounts. EPR and magnetic Mössbauer measurements 
indicated that 15 and 16 have spin states of 9/2 and 1/2, respectively.  The assignment of 15 as a 
diiron(II,III) compound was confirmed by comparing its spectroscopic properties to those of a 
crystallographically characterized [FeIIFeIII(ArTolCO2)4(4-tBupy)2] complex.74,75 As shown in the 
proposed mechanism in Scheme 1.2, reaction of 14A with dioxygen proceeds through a 
carboxylate shift, in which either one or two of the bridging ArTolCO2– groups rearrange to adopt 
terminal positions, providing an open site for O2. Binding of dioxygen to 14B or 14C affords a 
(µ-peroxo)diiron(III) or a di(µ-oxo)diiron(IV) intermediate that further reacts with 14A, giving 
an equal mixture of 15 and 16. This reaction is noteworthy because it is the first synthetic 
example in which treatment of a diiron(II) precursor with O2 resulted in formation of an iron(IV) 
species, a process that parallels the chemistry of several non-heme diiron enzymes.23  
 Although the steric hindrance provided by the terphenycarboxylates could suppress 
undesired reactions involving bond-making processes, it could not eliminate deleterious 
intermolecular electron transfer (ET) reactions.71,72 To prevent the paddlewheel diiron(II) 
complex from quenching the oxygenated intermediates, bidentate ancillary ligands were used to 
favor the assembly of windmill rather than paddlewheel species. The doubly-bridged [FeII2(µ-
ArTolCO2)2(ArTolCO2)2(N,N-Bn2en)2] (18) complex, where N,N-Bn2en = N,N-
dibenzylethylenediamine, was successfully prepared to test this strategy.76,77 Compound 18 
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Scheme 1.2. A proposed mechanism for the reaction of [FeII2(µ-ArTolCO2)4(4-tBupy)2] (14A) 
with O2.71,72 
  
reacted with dioxygen, but instead of producing a green intermediate, N-dealkylation occurred 
affording [FeIII2(µ-OH)2(µ-ArTolCO2)(ArTolCO2)3(N-Bnen)(N,N-Bn2en)] (19) (where N-Bnen = N-
benzylethylenediamine) and benzaldehyde. Isotopic labeling with 18O2 demonstrated that the 
oxygen atom in benzaldehyde was derived from dioxygen. When a non-coordinating N,N-Bn2en 
analogue, such as N,N-dibenzylpropylamine, was treated with O2 in the presence of either 
mononuclear or dinuclear iron(II) complexes, the yield of benzaldehyde was significantly 
reduced. Detailed mechanistic studies suggested that oxidative N-dealkylation of 18 involved 
single electron transfer, proton abstraction, and rearrangement.78,79 The fortuitous discovery that 
high-valent diiron terphenylcarboxylate complexes could be intercepted by tethered substrates 
enabled studies of the reactivity of oxygenated intermediates toward organic moieties. 
Attachment of benzyl,80,81 ethyl,81 ethynyl,82 phenoxyl,83 phosphido,80,84 or sulfido84,85 units to an 
amine or pyridine ligand afforded a series of tethered substrates that could be easily incorporated 
into 13, giving the corresponding diiron(II) compounds. After exposing the substrate/diiron(II) 
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complex to O2, the reaction products were analyzed by gas chromatography-mass spectrometry 
(GC-MS). Chart 1.1 depicts the substrates that were successfully oxidized by this method.  When 
2-pyridyldiphenylphosphine (2-Ph2Ppy) was employed in excess, catalytic oxidation to 2-
pyridyldiphenylphosphine oxide (2-Ph2P(O)py) was observed.80,84 Because external non-
coordinating substrates cannot be oxidized by [Fe2(ArTolCO2)4(THF)2]/O2, these results suggest 
that intramolecular reactions are preferred over intermolecular ones in the terphenylcarboxylate 
diiron complexes. This behavior is most likely due to reaction of the active diiron oxidant with 
solvent or adventitious reductants before it can be intercepted by the desired external substrates. 
 
 
Chart 1.1. The tethered substrates that were successfully oxidized with O2 when integrated into 
a diiron(II) terphenylcarboxylate complex. The starting substrate is depicted on top and the 
product isolated after oxygenation is shown directly below. 
 
 
 One strategy to prevent premature deactivation of the oxygenated diiron intermediate was 
to attach dendritic groups to the terphenylcarboxylate ligand that would shield the diiron core 
from participating in intermolecular ET reactions.86 The complex [FeII2([G-3]CO2)4(4-CNpy)2] 
(20) (where [G-3]CO2– = third-generation dendrimer-appended terphenylcarboxylate and 4-
CNpy = 4-cyanopyridine) was synthesized in a manner analogous to that for the simpler 
diiron(II) compounds. Treatment of 20 with dioxygen resulted in formation of a diiron(II,III) 
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intermediate that was postulated to have a superoxo moiety. This colored intermediate is capable 
of oxidizing dihydroanthracene, albeit in only modest yields. 
 The influence of water on the structure and reactivity of the diiron(II) 
terphenylcarboxylate compounds was also examined. Treatment of 14A with excess water 
afforded a diaqua-bridged diiron(II) species, [FeII2(µ-H2O)2(µ-ArTolCO2)2(ArTolCO2)2(4-tBupy)2] 
(21), in which the terminal carboxylates exhibit strong hydrogen-bonding interactions with the 
bridging waters.87 In addition to having a diaqua bridge, a third H2O molecule occupies a 
terminal position in [FeII2(µ-H2O)2(µ-Ar4-FPhCO2)(Ar4-FPhCO2)3(THF)2(H2O)] (22).88 When a 
large excess of water was added to 22 complete dissolution occurred, giving the fully aquated 
[FeII(H2O)2]2+ cation. These observations suggest that the accessibility of water within diiron 
enzyme active sites may be a control element for achieving different functions using a common 
structural motif. Furthermore, the presence of excess amounts of water may be destructive to the 
integrity of the carboxylate-bridged diiron core. Stopped-flow kinetic studies using [FeII2(µ-
ArTolCO2)4(4-CNpy)2] (23) showed that it reacts with H2O ~1000 times faster than with O2 and 
that aquated 23 reacts with O2 ~10 times faster than anhydrous 23.89,90 Coordination of water to 
23 most likely induces rearrangement from a paddlewheel to a windmill complex, facilitating 
more rapid binding of dioxygen to the diiron centers. 
  The iron chemistry of a variety of other monocarboxylate ligands was evaluated. When 
the steric bulk of the terphenylcarboxylate was increased using 2,6-bis(p-(tert-
butyl)phenyl)benzoate (ArtBuCO2–), reaction with iron(II) salts afforded a tetrairon cluster.91 
When the steric demand of the carboxylate was reduced using 2-biphenylcarboxylate, an 
assortment of di-, tri-, and tetranuclear species was obtained.92 Replacing the 
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terphenylcarboxylate with 9-triptycenecarboxylate resulted in diiron paddlewheel complexes that 
could not convert to the more reactive windmill structure.93 
 Terphenylcarboxylate ligands are a simple alternative to the conformationally restricting 
dicarboxylate compounds. Diiron complexes derived from ArTolCO2– or Ar4-FPhCO2– can access 
high valent iron(IV) species from O2, which are capable of hydroxylating hydrocarbons, a first 
for synthetic modeling studies. Although the 2,6-aryl substituents of ArTolCO2– and Ar4-FPhCO2– 
are effective in shielding against metal cluster assembly, they also contribute to excessive steric 
crowding at the diiron core that prevent facile entry of external guest molecules. 
 
1.6. Dinucleating Polynitrogen Ligands 
 Polydentate nitrogen donors are commonly utilized as ligands in synthetic modeling 
studies.19,94 Although these compounds provide a nitrogen-rich, rather than a caboxylate-rich, 
coordination environment they are well suited for stabilizing kinetically labile first row transition 
metal ions. Efforts to mimic the syn, syn coordination of the bridging carboxylate in the active 
site of diiron enzymes led to use of a napthyridine framework as a “masked carboxylate.”95 
Several 1,8-substituted napthyridine compounds were prepared and successfully employed to 
assemble dicopper(II), dizinc(II), dinickel(II), and diiron(II) complexes.96 The most notable of 
these are [FeII2(µ-OH)(BPEAN)(SO3CF3)]2+ (24, where BPEAN = 2,7-bis(bis(2-(2-(5-
methyl)pyridyl)ethyl)aminomethyl)-1,8-napthyridine, Table 1.1)   and [FeII2(µ-OH)(BEPEAN)-
(SO3CF3)]2+ (25, where BEPEAN = 2,7-bis(bis(2-(2-(5-ethyl)pyridyl)ethyl)aminomethyl)-1,8-
napthyridine).97 Exposing either 24 or 25 to O2 at room temperature resulted in rapid 
decomposition without any detectable intermediates. When the more sterically-hindered 25 was 
treated with excess hydrogen peroxide at -30 °C a red-brown species (26) appeared, which 
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decayed upon warming to room temperature. Spectroscopic characterization of 26 suggested that 
it is a (hydroperoxo)diiron(III) species. The decay of 26 is accompanied by O2 evolution and 
formation of a diiron(II) unit, the identity of which is different from that of 25. Although the 
mechanism of this reaction is uncertain, the release of O2 from 26 may mimic a process similar 
to that in hemerythrin. 
 The stability of the diiron(II) napthyridine compounds afforded an opportunity to 
investigate how the redox properties of the model complexes vary depending on their 
composition and structure. Because activation of O2 in the diiron enzymes invariably results in 
oxidation of the metal center, knowledge of the redox potential of the diiron(II) models may  
help explain their dioxygen reactivity. The cyclic voltammogram of [FeII2(BPMAN)(µ-
PhCyCO2)2]2+ (27, where BPMAN = 2,7-bis(bis(2-pyridylmethyl)aminomethyl)-1,8-
napthyridine) displayed two reversible redox waves at +296 and +681 mV (vs. 
ferrocene/ferrocenium) that have been attributed to two one-electron oxidation processes, of 
diiron(II,II) to diiron(II,III) and diiron(II,III) to diiron(III,III), respectively.98 The presence of 
two reversible metal-centered redox couples is unprecedented for diiron(II) compounds having 
no single atom bridge. Comparing the first oxidation potential of 27 to that of 
[FeII2(ArTolCO2)4(4-tBupy)2] (14A) (E1/2 = -216 mV) revealed that addition of each anionic 
carboxylate group lowers the redox potential of the diiron center by ~ 250 mV. These results also 
suggested that diiron(II) sites bridged only by Asp and Glu residues in biology could supply up 
to two electrons without significant change in geometry. 
 Another polynitrogen donor compound, 1,4-bis(2,2ʹ -dipyridylmethyl)phthalazine (bdptz, 
Table 1.1) was explored as a potential dinucleating platform.99 Reaction of bdptz with iron(II) 
triflate and ArTolCO2– afforded a stable diiron(II) complex, [FeII2(µ-OH)(µ-
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ArTolCO2)(bdptz)(CH3CN)(SO3CF3)](SO3CF3) (28, Table 1.1). Treatment of 28 with dioxygen 
instantaneously led to formation of a (µ-oxo)diiron(III) product, [FeIII2(µ-O)(µ-
ArTolCO2)(bdptz)(acetone)(SO3CF3)](SO3CF3)2 (29) with no detectable intermediates. A bulkier 
derivative of bdptz was prepared to block the possible formation of tetranuclear species, but no 
remarkable oxygenation chemistry was observed with the diiron complex of this compound.100 
 Although the napthryridine and phthalazine bridged diiron model complexes are 
structurally robust, they do not exhibit the same O2 reactivity observed in the diiron proteins. 
Perhaps polydentate ligands with internal bridging units are too rigid to accommodate binding of 
O2 to the diiron center. 
 
1.7. Syn N-Donor Ligands 
 An important structural feature that has been difficult to reproduce in carboxylate-bridged 
diiron model complexes is the syn coordination of nitrogen donors relative to the iron-iron 
vector.19 Despite the different arrangement of carboxylate ligands within the active sites of the 
BMMs, RNR, and related enzymes, ligation of the two histidine residues always occurs with syn 
stereochemistry.23 To enforce the syn arrangement of nitrogen donors within a single ligand 
framework, two quinoline ester moieties were covalently attached using a diethynylbenzene 
linker, giving 1,2-bis(3-ethynyl-8-carboxylatequinoline)-4,5-diethynylbenzene ethyl ester 
(Et2BCQEBEt, Table 1.1).101 Metallation of Et2BCQEBEt using iron(II) trilate and ArTolCO2– 
afforded the compound [FeII2(Et2BCQEBEt)(µ-ArTolCO2)3]+ (30, Table 1.1).  X-ray structural 
analysis of 30 revealed a diiron complex with three bridging carboxylates and syn binding of the 
quinoline moieties.  Although 30 is a close structural mimic of sMMOHred (Scheme 1.1, 
bottom),73 exposing the compound to dioxygen resulted in unidentified iron products. Other 
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neutral derivatives of Et2BCQEBEt were synthesized and examined as syn N-donor ligands.102 
The compound bis(picolinic methyl ester)diethynyltriptycene (PIC2DET) containing pyridine 
methyl ester groups afforded a heterometallic [FeIINa(PIC2DET)(µ-TrpCO2)3] (31) complex that 
could exchange sodium for iron; the resulting diiron(II) compound could not be structurally 
characterized, however.103 Two syn N-donor ligands can also bridge two iron(II) centers, giving 
[FeII2(syn N-donor)2] species.104-106 Several examples are shown in Chart 1.2. Such undesired 
[FeII2(syn N-donor)2] species were avoided by the use of ligands bearing polydentate nitrogen-
rich metal binding groups.107 Only diiron(III) complexes, however, could be prepared from these 
ligands. 
 To obtain a kinetically more stabilizing platform, 2-phenoxylpyridine groups were 
attached to a 1,2-diethynylbenzene backbone.108 Reaction of bis(phenyl(p-cresol)pyridyl)-
diethynylbenzene ([LMe,Ph]2–, Chart 1.2) with iron(II) in tetrahydrofuran (THF) led to 
spontaneous formation of [FeII2(LMe,Ph)2(THF)2] (32). Once again, rotation about the C–C bond 
of the ethnyl arms allowed association of two syn N-donor ligands. Unlike complex 30, however, 
reaction of 32 with dioxygen resulted in the formation of a (µ-oxo)diiron(III) [FeIII2(µ-
O)(LMe,Ph)2] (33) product. No intermediates were detected during the oxygenation reaction.  
 Several other ligand designs based on the syn N-donor concept were also explored. An 
attempt was made to incorporate both a bridging carboxylate and adjacent amino moieties into a 
dinucleating platform using 1,8-bis(dimethylaminomethylethynyl)-3,6-di(tert-butyl)fluorene-9-
yl-acetate (DAFA2–, Table 1.1).109 Efforts to metallate DAFA2– with iron(II) were unsuccessful, 
possibly due to a lack of pre-organization among the amino and carboxylate donor groups of the 
ligand. A two-component system was also proposed as a method to assemble diiron(II) model 
	   47 
 
 Chart 1.2. Examples of crystallographically characterized [FeII2(syn N-donor)2] species isolated 
from reaction of iron(II) salts and the corresponding syn N-donor ligand. Additional external 
carboxylate ligands were used in the preparation in some cases. PIC2DET = bis(picolinic methyl 
ester)diethynyltriptycene;102 Im2DET = bis(N-methylimidazole)diethynyltriptycene;102 [LMe,Ph]2– 
= bis(phenyl(p-cresol)pyridyl)diethynylbenzene;108 ArTolCO2– = 2,6-(p-tolyl)benzoate. 
 
complexes. In addition to a syn N-donor, a “C-clamp” ligand with two endo-oriented 
dicarboxylate groups may enforce a doubly-bridging motif and form a hydrophobic pocket 
around the diiron center.110 Complexation reactions with a C-clamp and syn N-donor ligands 
have not yet afforded the desired [FeII2(syn N-donor)(C-clamp)] unit, however. 
 Linking two N-heterocycles with a 1,2-diethynylarene spacer effectively enforces the syn 
coordination of nitrogen donors in a diiron complex. Because the compounds do not have an 
internal bridging group to link the two metal ions like other dinucleating ligands, their terminal 
metal-binding units must be sufficiently stabilizing to prevent dissociation of the dinuclear core. 
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Additional ligand modifications are needed to eliminate the possibility of forming [FeII2(syn N-
donor)2] species. 
 
1.8. Macrocyclic Ligands 
 Macrocyclic ligands are excellent hosts for transition metal ions, as evident from 
examples in biology3,4 as well as synthetic coordination chemistry.111,112 Initial efforts to prepare 
a dinucleating macrocycle led to synthesis of a bis(terphenylcarboxylate) compound linked by 
1,3-bis(aminomethyl)-4,6-diisopropylbenzene (MArTolCO22–, Table 1.1).113 The endo-
carboxylate groups in MArTolCO22– were designed to bridge two iron atoms to form a pre-
organized platform for binding of additional external ligands. Failure to complex MArTolCO22– 
with iron, however, was attributed to either the flexibility of the ligand architecture or an 
improper spacing provided by the phenylene linker.  
 An improved macrocyclic design was obtained with the compound PIM2– (Table 1.1), 
which contains two phenoxylimine metal binding units linked by diphenylsulfone and 
dibenzylether moieties.114 Reaction of H2PIM, the protonated form of PIM2–, with [FeII2(2,4,6-
trimethylphenyl)4] and sterically-hindered carboxylic acid afforded di(µ-carboxylato)diiron(II) 
complexes in good yield. Use of terphenylcarboxylic acid and triphenylacetic acid gave [FeII2(µ-
ArTolCO2)2(PIM)] (34, Table 1.1)  and [FeII2(µ-Ph3CCO2)2(PIM)] (35), respectively. X-ray 
structural analysis revealed that both compounds accurately mimic the active site structure of 
sMMOHred (Scheme 1.1, bottom),73 including the asymmetric µ–η1,η1 and µ–η1,η2 binding mode 
of carboxylates as well as the syn stereochemistry of nitrogen donors. When 34 was exposed to 
dioxygen, a mixture of (µ-oxo)diiron(III) [FeIII2(µ-O)(ArTolCO2)2(PIM)] (36) and di(µ-
hydroxo)diiron(III) [FeIII2(µ-OH)2(ArTolCO2)2(PIM)] (37) species was isolated. Further treatment 
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of 36 and 37 with excess water resulted in dimerization of the complexes to form tetranuclear 
[FeIII4(µ-OH)6(PIM)2(ArTolCO2)2] (38) species. To eliminate this decomposition pathway, the 
PIM2– ligand could be modified with sterically more hindering groups at the para position of the 
phenolate (Scheme 1.3). Having a more bulky platform would also allow smaller carboxylate 
ligands to be employed, which may facilitate dioxygen binding or substrate access to the diiron 
center. Unlike other platforms that have been investigated to date, the planar nature of the 
macrocycle allows for steric tuning of the diiron complex without obstructing access to the 
dimetallic center.  
Scheme 1.3. A cartoon depiction of a diiron(II) model complex (39) containing a more 
sterically-hindering PIM2– ligand, where the dark wedges represent a bulky organic substituent. 
Reaction of 39 with dioxygen may lead to a carboxylate shift and formation of a di(µ-
hydroxo)diiron(III) product (40). The steric repulsion between the bulky PIM2– substituents 
should prevent undesired formation of [FeIII4(µ-OH)6(bulky PIM)2(RCO2)2] (41) complexes. 
 
1.9. Concluding Remarks 
  The early years of synthetic modeling in the Lippard group were characterized by use of 
simple chelating ligands to prepare structural mimics of diiron protein active sites. Efforts to 
replicate the functional aspects of these proteins, however, required that more elaborately 
designed ligands be employed. The search for an ideal synthetic platform is complicated by a 
number of factors, such as constructing ligands that can complex with iron to afford the desired 
coordination geometry, tuning of ligand steric properties to prevent unproductive decomposition 
of reactive oxygenated species, and developing short and convenient routes to obtain the target 
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compounds. Although there is no substitute for direct studies of biomolecules, the work 
described in this account illustrates that investigations using synthetic mimics can provide insight 
into metallobiochemistry in ways that could not be achieved through other means. 
 Synthetic diiron modeling still offers many unexplored frontiers. One area of interest is 
understanding the chemical nature as well as the requirements for generating highly oxidizing 
diiron(IV) units. One strategy to access such chemically reactive species is to prepare diiron 
complexes that have optimally positioned functional groups to stabilize key transition states 
along the O2 reaction pathway. Identifying which transition state structures to target can be aided 
by the use of quantum mechanical calculations.115,116 This concept has been successfully 
demonstrated in de novo protein design,117-119 but has not yet been seriously applied to construct 
small-molecule protein models. Another avenue of research that would help advance diiron 
modeling chemistry is to establish a clear structure-function relationship between the model 
compounds and their oxygenation behavior.120 For example, although it has been shown that 
exposing dioxygen to a synthetic diiron(II) complex can lead to formation of a 
(peroxo)diiron(III) species, this reactivity is not general to all diiron(II) model compounds. In 
many cases, it is unclear whether the oxygenated diiron units are not observed because they are 
rapidly quenched by external reactants, do not form under the experimental conditions employed, 
or the starting complexes are too sterically hindered to bind O2. To evaluate the various factors 
that contribute to the dioxygen reactivity in a synthetic model, it is necessary to study the effects 
of introducing systematic structural and electronic modifications to the complex. Unfortunately, 
most model systems are not amenable to such investigations because the integrity of the 
complexes may be comprised upon introducing such changes. Because PIM2– is a remarkably 
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robust dinucleating platform and has many potential sites for derivatization, it is an excellent 
framework for such studies.  
Although this review has focused exclusively on diiron modeling chemistry in our 
laboratory, many other research groups have made significant contributions to the development 
of carboxylate-bridged diiron protein model complexes and the investigation of their chemical 
and physical characteristics. A large number of synthetic platforms have been devised for the 
assembly of non-heme diiron model complexes, ranging from simple carboxylate/pyridine 
donors121 to tailored-made dinucleating ligands19,122 and synthetic peptides.123,124 Although many 
of the diiron model compounds reported are structurally robust,19,122 they do not capture the 
unique coordination sphere of the bioinorganic unit of interest. Perhaps as a consequence of the 
incomplete match, the synthetic complexes do not typically exhibit the same reactivity profile as 
that of the diiron proteins.21,125 It is unlikely that every element of a protein active site, including 
especially the second coordination sphere, can be reproduced in a single model system. But 
given the extent of the synthetic methodologies available today, it should be possible to 
overcome many of the obstacles that have impeded the development of more sophisticated diiron 
protein mimics.20  
Extensive reactivity studies utilizing molecular oxygen, hydrogen peroxide, alkyl 
peroxides, and oxygen atom transfer reagents with diiron model compounds have led to a much 
improved understanding of the oxidation chemistry that takes place in the active sites of non-
heme diiron proteins.17,22 For example, characterization of diiron(III,IV) and diiron(IV,IV) 
species in synthetic models126-129 has shed some light on similar high-valent states that are 
accessible within the diiron protein cores. These achievements help us to formulate possible 
reaction schemes that reconcile the biochemical data23,24 with the proposed biological 
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mechanisms suggested by theory.130-133 Beyond the O2 activation step, some synthetic systems 
are even able to perform catalytic hydrocarbon oxidation.18,134,135 Although these reactions are 
typically not as efficient as those catalyzed by the bacterial monooxygenases, they represent a 
good start. The current challenge in diiron model chemistry is to achieve regio- and 
stereospecific oxidation of external substrates by non-“free radical” reaction pathways. Use of 
the earth-abundant molecule dioxygen, rather than other more reactive but environmentally less 
friendly chemical oxidants, to facilitate this chemistry is the ultimate goal. The tasks set forth for 
future researchers in biomimetic modeling are numerous and complex, but the advances that 
have been made over the past thirty years promise a future that is full of many exciting 
discoveries.   
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Chapter 2 
Kinetic Stabilization of Diiron Complexes Using 
Phenoxylpyridine and Phenoxylimine Syn N-Donor Ligands 
 
 
 
 
 
 
 
 
 
 
 
 
 
Portions of this chapter have appeared in print: 
Loi H. Do, Stephen J. Lippard. “2-Phenoxypyridyl Dinucleating Ligands for Assembly of 
Diiron(II) Complexes; Efficient Reactivity with O2 to Form µ-Oxodiiron(III) units.” Inorg. 
Chem., 2009, 48(22), 10708–10719.  
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2.1. Introduction 
 Our recent synthetic efforts have been largely inspired by the bacterial multi-component 
monooxygenase (BMM) family of enzymes.1-3 These multi-component systems, which include 
soluble methane monooxygenase (sMMO),1 phenol hydroxylase (PH),4 and toluene/o-xylene 
monooxygenase (ToMO),4,5 perform oxygen-atom transfer reactions in aerobic environments 
under mild conditions. Although substrate oxidation is believed to occur at the diiron centers of 
the hydroxylase component, the BMM machinery also requires both reductase and regulatory 
proteins to function efficiently. Attempts to mimic monooxygenase activity in synthetic systems 
by our group, as discussed in Chapter 1, as well as others have led to the preparation of a rich 
assortment of diiron compounds that display structural, spectroscopic, and/or functional features 
similar to those of the protein active sites.6-9 To date, however, no diiron model complexes have 
been able to match the biological systems in terms of catalytic efficiency, chemoselectivity, and 
oxygenation ability.10-12 
  To overcome the shortcomings of existing model designs, our strategy has been to 
construct diiron compounds with organic ligands that more accurately resemble the primary 
coordination spheres of the BMM hydroxylase active sites. The structure of each diiron protein 
core comprises four carboxylate amino acid side chains, two histidine imidazole groups syn to 
the Fe–Fe vector, and an internal O2-binding cavity.13-15 A representative view of the reduced 
form of soluble methane monooxygenase hydroxylase (sMMOHred) is provided in Chart 2.1 
(left). To achieve such an architecture in a small-molecule host, we have synthesized 
dinucleating ligands derived from 1,2- diethynylbenzene.16,17 Our studies with this class of 
ligands have resulted in the preparation of several dinuclear compounds, most notably with 8-
carboxylquinoline ester16 and 2-carboxylpyridyl ester18 metal-binding groups. These dimetallic 
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complexes, however, are substitutionally labile and readily dissociate upon exposure to 
dioxygen. To obtain a more kinetically stable platform, we introduced 2-phenoxylpyridine 
moieties into the 1,2-diethynylbenzene backbone. Although the diiron sites in the BMM 
hydroxylases do not contain phenolate donors, iron-bound tyrosinate ligands occur in the O2-
activating enzymes intradiol dioxygenases19,20 and the phosphate ester hydrolyzing proteins 
mammalian purple acid phosphatases.21 Incorporating phenol rings into the ligand design also 
facilitates synthetic modifications, such as appending bulky moieties for steric protection or 
introducing electron-donating/or -withdrawing groups for electronic tuning. Our initial synthetic 
target based on the 2-phenoxylpyridine motif is shown in Chart 2.1 (right). In this design, the 
exogenous carboxylates are unrestrained so that the diiron complex could accommodate 
structural rearrangements upon reaction with dioxygen.  
 
Chart 2.1. Active site structure of reduced soluble methane monooxygenase hydroxylase 
(sMMOHred, left) and a proposed synthetic analog with a dinucleating ligand, [LH,Ph ]2– (right), 
containing 2-phenoxylpyridine metal binding groups. Sol = solvent molecule. 
 
 In the present chapter, we report a systematic study of the coordination chemistry of 
phenoxylpyridine- and phenoxylimine-appended ligands with iron(II). The importance of 
incorporating sterically protecting groups to the ligand periphery and its implication for future 
ligand designs is discussed. This work led to the synthesis of a diiron(II) complex that reacted 
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rapidly with dioxygen and demonstrated the ability to perform O-atom transfer to phosphines, 
although it did not yield the target structure in Chart 2.1.  
 
2.2. Experimental  
Materials and Methods. Reagents were obtained from Strem, Aldrich Chemical Co., and Alfa 
Aesar and used as received. The iron(II) starting material [Fe2(Mes)4] (where Mes = 2,4,6-
trimethylphenyl) was prepared according to a literature procedure.22 Air-sensitive manipulations 
were performed using standard Schlenk techniques or under a nitrogen atmosphere inside a 
MBraun drybox. All solvents were saturated with argon and purified by passage through two 
columns of activated Al2O3. Labeled dioxygen (~98% 18O2) was obtained from Isotech and used 
without further purification.  
General Physical Methods. NMR spectra were recorded on a 500 MHz Varian Mercury 
spectrometer and chemical shifts for 1H and 13C spectra were referenced to residual solvent 
peaks. IR spectra were recorded on a ThermoNicolet Avatar 360 spectrophotometer with the 
OMNIC software. Absorption spectra were recorded on a Cary 50 spectrophotometer using 6Q 
Spectrosil quartz cuvettes (Starna) with 1 cm path lengths. Cyclic voltammetry and differential 
pulse voltammetry measurements were made using a VersaSTAT3 potentiostat from Princeton 
Applied Research using the V3 Studio software. Electrospray ionization mass spectra were 
acquired on an Agilent Technologies 1100 Series LC-MSD Trap. Gas-chromatographic mass 
spectra were obtained using an Agilent Technologies 6890 N GC system equipped with a 5973N 
mass selective detector (MSD) unit.  
 65 
X-ray Collection and Data Refinement. Single crystals were mounted in Paratone oil on a 
cryo-loop and frozen under a 110 K KRYO-FLEX nitrogen cold stream. Data were collected on 
a Bruker APEX CCD X-ray diffractometer with Mo Kα radiation (λ = 0.71073 Å) controlled by 
the SMART software package.23 Empirical absorption corrections were applied using 
SADABS.24 The structures were solved by Patterson methods with refinement by full-matrix 
least squares based on F2 using the SHELXTL-97 software package.25 All non-hydrogen atoms 
were located and refined anisotropically. Hydrogen atoms were assigned idealized positions 
based on a riding model. X-ray refinement data for complex 1 is given in Table 2.1 
57Fe Mössbauer Spectroscopy. Mössbauer spectra were recorded on a MSI spectrometer (WEB 
Research Company) with a 57Co source in a Rh matrix maintained at room temperature. 
Polycrystalline samples were prepared by suspending in Apiezon M grease and placed in a nylon 
sample holder. Data were acquired at 90 K, and the isomer shift (δ) values are reported with 
respect to metallic iron that was used for velocity calibration at room temperature. The spectra 
were fit to Lorentzian lines using the WMOSS plot and fit program (WEB Research, 
Minneapolis). 
Stopped-flow UV-visible Spectrophotometry. Ambient-pressure kinetic studies were 
performed using a Canterbury SF-41 stopped-flow instrument (Hi-Tech) and a fused-silica fiber 
optics spectrometer (Oriel Corp.). Data were acquired using a KinetAsyst v.3.16 software (TgK 
Scientific Limited) at a sampling rate of 300 scans in 30 s. To remove moisture and air, the 
stainless-steel lines were washed with dioxygen-free anhydrous THF before loading the sample 
syringes. The mixing cell was maintained at -50.0 ± 0.1 ºC. Before mixing, the concentration of 
complex 1 was 26 µM in THF and that of the dioxygen solution was assumed to be 10 mM.26 
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Synthesis 
1-Benzyloxy-2,6-dibromo-4-tert-butylbenzene (H). Solid 2,6-dibromo-4-tert-butylphenol (10.0 
g, 32.5 mmol), K2CO3 (6.7 g,48.8 mmol), and benzyl bromide (4.7 mL, 39.0 mmol) were 
combined in 300 mL of CH3CN and refluxed for 3 h. Water was added to the reaction mixture 
and the organic phase was extracted with CH2Cl2 (3 x 200 mL). The organic layer was separated, 
dried over Na2SO4, and evaporated to dryness. Purification of the crude material by silica gel 
column chromatography (5:95 EtOAc/hexanes) gave a yellow oil (5.54 g, 42%). 1H NMR 
(CDCl3, 500 MHz): δ 7.64 (d, J = 7.0 Hz, 2H), 7.55 (s, 2H), 7.44 (t, J = 7.0 Hz, 2H), 7.40 (d, J = 
7.0 Hz, 1H), 5.03 (s, 2H), 1.32 (s, 9H). 13C NMR (CDCl3, 125 MHz): δ 150.55, 150.35, 136.63, 
130.14, 128.68, 128.66, 128.54, 118.23, 74.78, 34.84, 31.37. GC-MS = 398 [M]+ (Calcd = 398 
[M]+).  
3-Bromo-5-methylbiphenyl-2-ol (N). The tetrahydropyran protected 2-(5-methylbiphenyl-2-
yloxy)tetrahydro-2H-pyran (M)27 (20.0 g, 74.6 mmmol) was dissolved in 100 mL of 
CH3OH/CH3CN (1:1). The mixture was treated with conc. HCl (10 mL), refluxed for 1 h, and 
concentrated by evaporation. About 200 mL of H2O was added and the product was extracted 
with CH2Cl2 (3x 100 mL). The organic layer was dried over Na2SO4, filtered, and evaporated to 
afford a white solid. The resulting 5-methylbiphenyl-2-ol was re-dissolved in CH2Cl2 (100 mL) 
and cooled to 0 ºC. Liquid bromine (3.8 mL, 74.6 mmol) was added dropwise to the reaction 
flask. The reaction mixture was stirred for 1 h, washed with sat. Na2SO2 (aq), dried over Na2SO4, 
and evaporated to yield a pale brown oil (18.8 g, 96%). 1H NMR (CDCl3, 500 MHz): δ 7.58 (d, J 
= 9 Hz, 2H), 7.50 (t, J = 8 Hz, 2H), 7.42 (t, J = 8 Hz, 1H), 7.35 (s, 1H), 7.11 (s, 1H), 5.59 (s, 
1H), 2.36 (s, 3H). 13C NMR (CDCl3, 125 MHz): δ 147.10, 137.50, 131.73, 131.29, 130.96, 
129.31, 129.26, 128.63, 127.81, 110.78, 20.42. GC-MS = 262 [M]+ (Calcd = 262 [M]+).  
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1-Benzyloxy-2-bromo-4-methyl-6-phenylbenzene (I). Method A: Solid 1-benzyloxy-2,6-
dibromo-4-methylbenzene (G)28 (12.0 g, 33.7 mmol), phenyl boronic acid (4.11 g, 33.7 mmol), 
and [Pd(PPh3)4] (1.94 g, 1.68 mmol) were combined in 100 mL of THF and 100 mL of 1.0 M 
aqueous Na2CO3 in a 500 mL Schlenk flask. The mixture was degassed with nitrogen for 30 min 
and then refluxed for 20 h. The organic phase was then extracted with CH2Cl2 (3 x 150 mL), 
dried over Na2SO4, and evaporated to dryness. Purification of the crude material by silica gel 
column chromatography (5:95 EtOAc/hexanes) gave a colorless oil (10.12 g) that contained a 
mixture of 1-benzyloxy-2,6-dibromo-4-methylbenzene (929 mg, 7%), 1-benzyloxy-2,6-diphenyl-
4-methylbenzene (1.83 g, 15%) and 1-benzyloxy-2-bromo-4-methyl-6-phenylbenzene (7.26 g, 
62%). The three compounds could not be separated; therefore, the mixture was used in the next 
step. GC-MS = 356 [1-benzyloxy-2,6-dibromo-4-methylbenzene]+ (Calcd = 356 [M]+), 350 [1-
benzyloxy-2,6-diphenyl-4-methylbenzene]+ (Calcd = 350 [M]+), and 352 [1-benzyloxy-2-bromo-
4-methyl-6-phenylbenzene]+ (Calcd = 352 [M]+). Method B: Solid 3-bromo-5-methylbiphenyl-
2-ol (N) (18.8 g, 71.5 mmol) and benzyl bromide (9.3 mL, 78.6 mmol) were dissolved in CH3CN 
(400 mL). The solution was refluxed for 4 h, evaporated to dryness, and the residue was re-
dissolved in CH2Cl2 (300 mL). The organic phase was washed with H2O (3 x 100 mL), dried 
over Na2SO4, filtered, and evaporated to give an oil. The crude material was purified by silica gel 
column chromatography (5:95 EtOAc/ hexanes) and re-crystallized from hot hexanes to give a 
white solid (16.0 g, 72%). 1H NMR (CDCl3, 125 MHz): δ 7.62 (m, 2H), 7.48-7.43 (m, 4H), 7.32 
(m 3H), 7.22 (m, 2H), 7.18 (s, 1H), 4.55(s, 2 H), 2.40 (s, 3H). 13C NMR (CDCl3, 500 MHz): δ 
150.89, 137.99, 137.00, 136.61, 135.57, 132.98, 131.06, 129.46, 128.90, 128.42, 128.39, 128.24, 
127.76, 118.29, 74.95, 20.78. GC-MS: m/z = 352 [M]+ (Calcd = 352 [M]+). Mp = 64-65 °C.  
 68 
1-Benzyloxy-2-bromo-6-phenyl-4-tert-butylbenzene (J). The same procedure was employed as 
described for the synthesis of 1-benzyloxy-2-bromo-4-methyl-6-phenylbenzene (I) (Method A), 
except that 1-benzyloxy-2,6-dibromo-4-tert-butylbenzene (H) was used in place of 1-benzyloxy-
2,6-dibromo-4-methylbenzene (G). The reaction was performed with the following reagents: 1-
benzyloxy-2,6-dibromo-4-tert-butylbenzene (1.0 g, 2.51 mmol), phenyl boronic acid (306 mg, 
2.51 mmol), [Pd(PPh3)4] (146 mg, 0.126 mmol), and 1.0 M Na2CO3 (20 mL, H2O/THF). 
Purification of the crude material by silica gel column chromatography (2:1 hexanes/CH2Cl2) 
gave a colorless oil (997 mg) that contained a mixture of 1-benzyloxy-2,6-dibromo-4-tert-
butylbenzene (170 mg, 17%), 1-benzyloxy-2,6-diphenyl-4-tert-butylbenzene (257 mg, 26%), and 
1-benzyloxy-2-bromo-6-phenyl-4-tert-butylbenzene (576 mg, 57%). The three compounds could 
not be separated so the mixture was used in the next step. GC-MS = 398 [1-benzyloxy-2,6-
dibromo-4-tert-butylbenzene]+ (Calcd = 398 [M]+), 392 [1-benzyloxy-2,6-diphenyl-4-tert-butyl-
benzene]+ (Calcd = 392 [M]+), and 394 [1-benzyloxy-2-bromo-6-phenyl-4-tert-butylbenzene]+ 
(Calcd = 394 [M]+). 
2-(2-Benzyloxyphenyl)-5-bromopyridine (B).  The compound 1-benzyloxy-2-iodobenzene 
(1.00 g, 3.22 mmol) was dissolved in 15 mL of dry THF in a 50 mL Schlenk flask and the 
mixture was cooled to -78 °C. A 1.6 M hexanes solution of n-butyllithium (2.0 mL, 3.22 mmol) 
was added slowly to the reaction flask. The mixture was stirred at -78 °C for 30 min. Solid 
anhydrous ZnCl2 (351 mg, 3.22 mmol) was added and the mixture was stirred at RT for 30 min. 
The reaction flask was brought inside a drybox and charged with 2,5-dibromopyridine (694 mg, 
2.93 mmol) and [Pd(PPh3)4] (169 mg, 0.146 mmol). The resulting solution was transferred to a 
sealed reaction vessel and stirred at 80 °C for 15 h. Water was added to the reaction mixture and 
the organic phase was extracted with dichloromethane (3x15 mL). The organic layer was 
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separated, dried over Na2SO4, and evaporated to dryness. The crude material was purified by 
silica gel column chromatography (5:95 EtOAc/hexanes) to afford a white solid (368 mg, 37%). 
1H NMR (CDCl3, 500 MHz): δ 8.77 (d, J = 2.00 Hz,1H), 7.86 (m, 2H), 7.78 (dd, J = 11.0, 2.5 
Hz, 1H), 7.40-7.33 (m, 6H), 7.12 (t, J = 8.0 Hz, 1H), 7.07 (d, J = 8.5 Hz, 1H), 5.15 (s, 2H). 13C 
NMR (CDCl3, 125 MHz): δ 156.19, 154.44, 150.48, 138.34, 136.87, 131.27, 130.55, 128.74, 
128.35, 128.09, 127.29, 126.61, 121.72, 119.01, 113.25, 70.77. GC-MS: m/z = 339 [M]+ (Calcd 
= 339 [M]+). Mp = 69-70 °C.  
5-Bromo-2-(2-methoxyphenyl)pyridine (C). The same procedure was employed as for the 
synthesis of 2-(2-benzyloxyphenyl)-5-bromopyridine (B), except that 2-bromoanisole was used 
in place of 1-benzyloxy-2-iodobenzene. The reaction was performed with the following reagents: 
2-bromoanisole (2.97 g, 15.9 mmol), 1.6 M n-butyllithium in hexanes (10 mL, 15.9 mmol), 
anhydrous ZnCl2 (1.73 g, 15.9 mmol), [Pd(PPh3)4] (873 mg, 0.755 mmol), and 2,5-
dibromopyridine (3.58 g, 15.1 mmol). Purification of the crude material by silica gel column 
chromatography (5:95 EtOAc/hexanes) gave a light yellow oil (2.29 g, 57%). 1H NMR (CDCl3, 
500 MHz): δ 8.75 (d, J = 2.5 Hz, 1H), 7.81-7.75 (m, 3H), 7.38 (t, J = 1.0 Hz, 1H), 7.08 (t, J = 1.0 
Hz, 1H), 6.99 (d, J = 10 Hz, 1H), 3.85 (s, 3H). 13C NMR (CDCl3, 125 MHz): δ 156.94, 154.53, 
150.40, 138.32, 131.03, 130.46, 127.86, 126.40, 121.19, 118.88, 111.47, 55.65. GC-MS = 263 
[M]+ (Calcd = 263 [M]+).  
5-Bromo-2-(2-methoxybiphenyl-3-yl)pyridine (F). The same procedure was employed as for 
the synthesis of 2-(2-benzyloxyphenyl)-5-bromopyridine (B), except that 2-bromo-6-
phenylanisole (E) was used in place of 1-benzyloxy-2-iodobenzene (A). The reaction was 
performed with the following reagents: 2-bromo-6-phenylanisole (1.16 g, 4.43 mmol), 1.6 M n-
butyllithium in hexanes (2.8 mL, 4.43 mmol), anhydrous ZnCl2 (483 mg, 4.43 mmol), 
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[Pd(PPh3)4] (243 mg, 0.211 mmol), and 2,5-dibromopyridine (1.00 g, 4.22 mmol). Purification of 
the crude material by silica gel column chromatography (5:95 EtOAc/hexanes) gave a white 
crystalline solid (868 mg, 57%).  1H NMR (CDCl3, 500 MHz): δ 8.80 (s, 1H), 7.87 (s, 2H), 7.74 
(dd, J = 9.5, 2.0 Hz, 1H), 7.62 (d, J = 10 Hz, 2H), 7.47-7.42 (m, 3H), 7.39 (t, J = 7.5 Hz, 1H), 
7.30 (t, J = 7.5 Hz, 1H). 13C NMR (CDCl3, 125 MHz): δ 155.49, 154.91, 150.66, 138.82, 138.44, 
136.03, 133.20, 132.26, 130.43, 129.40, 128.44, 127.46, 126.25, 124.79, 119.41, 61.1l. GC-MS 
= 339 [M]+ (Calcd = 339 [M]+). Mp = 88-89 °C. 
5-Bromo-2-(2-benzyloxy-5-methylbiphenyl-3-yl)pyridine (K). The same procedure was 
employed as for the synthesis of 2-(2-benzyloxyphenyl)-5-bromopyridine (B), except that 1-
benzyloxy-2-bromo-4-methyl-6-phenylbenzene (I) was used in place of 1-benzyloxy-2-
iodobenzene (A). The reaction was performed with the following reagents: 1-benzyloxy-2-
bromo-4-methyl-6-phenylbenzene (~60% purity, 6.00 g, ~10.2 mmol), 1.6 M n-butyllithium in 
hexanes (10 mL, 16.3 mmol), anhydrous ZnCl2 (1.78 g, 16.3 mmol), [Pd(PPh3)4] (751 mg, 0.65 
mmol), and 2,5-dibromopyridine (3.06 g, 12.9 mmol). Purification of the crude material by silica 
gel column chromatography (10:90 EtOAc/hexanes) gave a white solid (2.47 g, ~ 60%).  1H 
NMR (CDCl3, 500 MHz): δ 8.77 (d, J = 2.0 Hz, 1H), 7.85 (d, J = 8.5 Hz, 1H), 7.78 (dd, J = 12, 
2.5 Hz, 1H), 7.65 (d, J = 8.5 Hz, 2H), 7.56 (d, J = 1.5 Hz, 1H), 7.46 (t, J = 7.5 Hz, 2H), 7.41 (d, J 
= 7.5 Hz, 1H), 7.28 (d, J = 2.0 Hz, 1H), 7.20 (d, J = 7.0 Hz, 1H), 7.16 (t, J = 7.5 Hz, 2H), 6.75 
(d, J = 8.0 Hz, 2H). 4.24 (s, 2H). 2.44 (s, 3H). 13C NMR (CDCl3, 125 MHz): δ 155.05, 151.72, 
138.62, 138.46, 136.48, 136.38, 134.57, 133.50, 132.84, 130.65, 129.76, 128.82, 128.41, 128.27, 
128.12, 127.50, 126.86, 119.30, 75.91, 21.08. ESI-MS = 430.3 [M+H]+ (Calcd = 430.1 [M+H]+). 
Mp = 93-95 °C.  
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5-Bromo-2-(2-benzyloxy-5-tert-butylbiphenyl-3-yl)pyridine (L). The same procedure was 
employed as for the synthesis of 2-(2-benzyloxyphenyl)-5-bromopyridine (B), except that 1-
benzyloxy-2-bromo-6-phenyl-4-tert-butylbenzene (J) was used in place of 1-benzyloxy-2-
iodobenzene (A). The reaction was performed with the following reagents: 1-benzyloxy-2-
bromo-6-phenyl-4-tert-butylbenzene (~60% purity, 3.26 g, ~8.25 mmol), 1.6 M n-butyllithium in 
hexanes (5.9 mL, 9.43 mmol), anhydrous ZnCl2 (1.03 g, 9.43 mmol), [Pd(PPh3)4] (454 mg, 0.393 
mmol), and 2,5-dibromopyridine (1.86 g, 7.86 mmol). Purification of the crude material by silica 
gel column chromatography (5:95 EtOAc/hexanes) gave a white solid (909 mg, 39%). 1H NMR 
(CDCl3, 500 MHz): δ 8.83 (s, 1H), 7.89 (d, J = 8.0 Hz, 1H), 7.81 (s, 2H), 7.70 (d, J = 7.0 Hz, 
2H), 7.52-7.44 (m, 4H), 7.24-7.20 (m, 3H), 6.80 (d, J = 7.0 Hz, 2H), 4.29 (s, 2H), 1.45 (s, 9H). 
13C NMR (CDCl3, 125 MHz): δ 155.40, 151.76, 150.58, 147.69, 139.03, 138.39, 136.63, 135.96, 
133.05, 129.84, 129.45, 128.70, 128.39, 128.26, 128.06, 127.44, 127.22, 126.87, 119.27, 75.87, 
34.82, 31.66. ESI-MS = 472.2 [M+H]+ (Calcd = 472.1 [M+H]+. Mp = 164-166 °C. 
Benz2LVH,H (5,5'-(4,5-dimethoxy-1,2-phenylene)bis(ethyne-2,1-diyl)bis(2-(2-(benzyloxy) 
phenyl)-pyridine). Solid 2-(2-benzyloxyphenyl)-5-bromopyridine (B) (600 mg, 1.76 mmol), 
4,5-diethynylveratrole (149 mg, 0.802 mmol), [Pd(PPh3)4] (93 mg, 80.2 µmol), and triethylamine 
(0.28 mL, 2.00 mmol) were combined with 20 mL of dry THF in a sealed reaction vessel. The 
reaction was stirred at 80 °C for 3 d. A 20 mL solution of dichloromethane was added and the 
mixture was washed with H2O (2 x 50 mL). The organic layer was separated, dried over Na2SO4, 
and evaporated to dryness. The crude material was purified by silica gel column chromatography 
(20:80 EtOAc/hexanes) to afford a beige solid (381 mg, 67%). 1H NMR (CDCl3, 500 MHz): δ 
8.91 (d, J = 1.5 Hz, 2H), 7.96 (d, J = 8.0 Hz, 2H), 7.91 (dd, J = 9.0, 1.5 Hz, 2H), 7.80 (dd, J = 
10.5, 2.0 Hz, 2H), 7.38-7.31 (m, 8H), 7.25 (d, J = 7.5 Hz, 2H), 7.13-7.05 (m, 8H), 5.14 (s, 4H), 
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3.96 (s, 6H). 13C NMR (CDCl3, 125 MHz): δ 156.38, 154.94, 151.82, 149.55, 137.98, 136.96, 
131.46, 130.50, 128.93, 128.70, 128.00, 127.21, 124.85, 121.70, 118.57, 118.34, 114.27, 113.32, 
91.57, 89.76, 70.79, 56.28. ESI-MS = 705.6 [M+H]+ (Calcd = 705.3 [M+H]+). Mp = 51-54 °C.   
Me2LH,H (1,2-bis((6-(2-methoxyphenyl)pyridin-3-yl)ethynyl)benzene). The same procedure 
was employed as for the synthesis of Benz2LVH,H, except that 5-bromo-2-(2-
methoxyphenyl)pyridine (C) was used instead of 2-(2-benzyloxyphenyl)-5-bromopyridine (B), 
and 1,2-diethynylbenzene was used instead of 4,5-diethynylveratrole. The reaction was 
performed with the following reagents: 1,2-diethynylbenzene (331 mg, 2.63 mmol), 5-bromo-2-
(2-methoxyphenyl)pyridine (2.00 g, 5.78 mmol), [Pd(PPh3)4] (304 mg, 0.263 mmol), and 
triethylamine (0.92 mL, 6.58 mmol). Purification of the crude material by silica gel column 
chromatography (20:80 EtOAc/hexanes) gave a light yellow solid (341 mg, 26%). 1H NMR 
(CDCl3, 500 MHz): δ 8.91 (d, J = 3.0 Hz, 2H), 7.92-7.86 (m, 6H), 7.63 (m, 2H), 7.42-7.37 (m, 
4H), 7.11 (t, J = 7.5 Hz, 2H), 7.02 (2, J = 8.0 Hz, 2H), 3.89 (s, 6H).  13C NMR (CDCl3, 125 
MHz): δ 157.32, 155.33, 151.98, 138.42, 132.34, 131.41, 130.67, 128.72, 128.43, 125.57, 
124.83, 121.36, 118.26, 111.63, 91.44, 91.08, 55.84. ESI-MS = 493.3 [M+H]+ (Calcd = 493.2 
[M+H]+). Mp = 150-151 °C. 
Me2LH,Ph (1,2-bis((6-(2-methoxybiphenyl-3-yl)pyridin-3-yl)ethynyl)benzene). The same 
procedure was employed as for the synthesis of Benz2LVH,H, except that 5-bromo-2-(2-
methoxybiphenyl-3-yl)pyridine (F) was used instead of 2-(2-benzyloxyphenyl)-5-bromopyridine 
(B), and 1,2-diethynylbenzene was used instead of 4,5-diethynylveratrole. The reaction was 
performed with the following reagents: 1,2-diethynylbenzene (529 mg, 4.20 mmol), 5-bromo-2-
(2-methoxybiphenyl-3-yl)pyridine (3.0 g, 8.82 mmol), [Pd(PPh3)4] (486 mg, 0.420 mmol), and 
triethylamine (1.5 mL, 10.5 mmol). Purification of the crude material by silica gel column 
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chromatography (CH2Cl2) gave a light yellow solid (1.84 g, 68%). 1H NMR (CDCl3, 500 MHz): 
δ 8.96 (d, J = 1.0 Hz, 2H), 8.00 (d, J = 8.5 Hz, 2H), 7.92 (dd, J = 10.5, 1.5 Hz, 2H), 7.81 (dd, J = 
9.0, 1.5 Hz, 2H), 7.66-7.62 (m, 6H), 7.47-7.38 (m, 10H), 7.31 (t, J = 8.0 Hz, 2H), 3.26 (s, 6H). 
13C NMR (CDCl3, 125 MHz): δ 155.70, 155.63, 152.08, 138.61, 138.54, 136.02, 133.63, 132.28, 
130.65, 129.45, 128.73, 128.42, 127.42, 125.44, 124.76, 124.47, 118.53, 91.65, 90.84, 61.15. 
ESI-MS = 645.5 [M+H]+ (Calcd = 645.2 [M+H]+). Mp = 128-130 °C. 
Benz2LMe,Ph (1,2-bis((6-(2-(benzyloxy)-5-methylbiphenyl-3-yl)pyridin-3-yl)ethynyl)benzene). 
Method A: The same procedure was employed as for the synthesis of Benz2LVH,H, except that 
5-bromo-2-(2-benzyloxy-5-methylbiphenyl-3-yl)pyridine (K) was used instead of 2-(2-
benzyloxyphenyl)-5-bromopyridine (B), and 1,2-diethynylbenzene was used instead of 4,5-
diethynylveratrole. The reaction was performed with the following reagents: 1,2-
diethynylbenzene (345 mg, 2.74 mmol), 5-bromo-2-(2-benzyloxy-5-methylbiphenyl-3-
yl)pyridine (2.47 g, 5.74 mmol), [Pd(PPh3)4] (317 mg, 0.274 mmol), and triethylamine (1 mL, 
6.85 mmol). Purification of the crude material by silica gel column chromatography (10:90 
EtOAc/hexanes) gave a light yellow solid (1.26 g, 56%). Method B: Solid 1,2-
bis((trimethylsilyl)ethynyl)benzene (1.31 g, 4.85 mmol) was dissolved in THF (50 mL) and 
treated with a 1.0 M solution of NBu4F (10.2 mL in THF, 10.2 mmol). The mixture was stirred 
for 4.5 h and then charged with 5-bromo-2-(2-benzyloxy-5-methylbiphenyl-3-yl)pyridine (K) 
(5.21 g, 12.1 mmol), [Pd(PPh3)]4 (560 mg, 0.485 mmol), and NEt3 (2.0 mL, 14.6 mmol). The 
reaction was stirred at 70 ºC for 2 d. The workup and purification procedure was identical to 
method A. The product was obtained in 45% yield (1.80 g). 1H NMR (CDCl3, 500 MHz): δ 8.96 
(d, J = 1.5 Hz, 2H), 8.02 (d, J = 8.5 Hz, 2H), 7.86 (dd, J = 10.5, 2.0 Hz, 2H), 7.69-7.67 (m, 8H), 
7.47 (t, J = 7.0 Hz, 4H), 7.42-7.41 (m, 4H), 7.29 (d, J = 2.0 Hz, 2H), 7.17-7.14 (m, 6H), 6.78 (dd, 
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J = 9.0, 1.5 Hz, 4H), 4.27 (s, 4H), 2.46 (s, 6H). 13C NMR (CDCl3, 125 MHz): δ 155.82, 152.07, 
151.99, 138.79, 138.40, 136.58, 136.48, 134.62, 133.93, 132.97, 132.41, 131.03, 129.90, 128.96, 
128.87, 128.48, 128.36, 128.20, 127.55, 125.54, 125.20, 118.52, 91.71, 91.05, 76.02, 21.18. ESI-
MS = 825.8 [M+H]+ (Calcd = 825.3 [M+H]+). Mp = 111-114 °C. 
Benz2LtBu,Ph (1,2-bis((6-(2-(benzyloxy)-5-tert-butylbiphenyl-3-yl)pyridin-3-yl)ethynyl)-
benzene). The same procedure was employed as for the synthesis of Benz2LVH,H, except that 5-
bromo-2-(2-benzyloxy-5-tert-butylbiphenyl-3-yl)pyridine (L) was used instead of 2-(2-
benzyloxyphenyl)-5-bromopyridine (B), and 1,2-diethynylbenzene was used instead of 4,5-
diethynylveratrole. The reaction was performed with the following reagents: 1,2-
diethynylbenzene (64 mg, 0.508 mmol), 5-bromo-2-(2-benzyloxy-5-tert-butylbiphenyl-3-
yl)pyridine (576 mg, 1.22 mmol), [Pd(PPh3)4] (59 mg, 0.051 mmol), and triethylamine (0.2 mL, 
1.27 mmol). Purification of the crude material by silica gel column chromatography (5:95 to 
10:90 EtOAc/hexanes) gave a yellow solid (260 mg, 56%). 1H NMR (CDCl3, 500 MHz): δ 8.97 
(d, J = 1.5 Hz, 2H), 7.99 (d, J = 8.0 Hz, 2H), 7.86-7.83 (m, 4H), 7.69-7.67 (m, 6H), 7.49-7.46 
(m, 6H), 7.43-7.41 (m, 4H), 7.15-7.14 (m, 6H), 6.78-6.76 (m, 4H), 4.26 (s, 4H), 1.42 (s, 18H). 
ESI-MS = 909.9 [M+H]+ (Calcd = 909.4 [M+H]+). Mp = 176-177 °C. 
2-Benzyloxy-3-bromo-5-methylbenzaldehyde (P).  Solid 1-benzyloxy-2,6-dibromo-4-methyl-
benzene (O) (27.7 g, 77.8 mmol) was dissolved in 500 mL of dry toluene and cooled to -78 °C. 
A 1.6 M n-butyllithium solution in hexanes (58 mL, 93.4 mmol) was added slowly to the 
reaction mixture and stirred for 1.5 h. The mixture was then treated with anhydrous DMF (9.0 
mL, 117 mmol) and continued to stir at -78 °C for 10 h. Once the reaction was complete, 
formation of a white precipitate was observed. The reaction mixture was washed with H2O 
(3x200 mL), dried over Na2SO4, and evaporated to dryness. The resulting oil was dissolved in 
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MeOH (200 mL) and cooled to -25 °C to induce crystallization. After 4 h, the material was 
isolated by filtration to give a white solid (15.5 g, 65%). 1H NMR (CDCl3, 125 MHz): δ 10.09 (s, 
1H), 7.67 (d, J = 2.5 Hz, 1H), 7.57 (d, J = 2.0 Hz, 1H), 7.47-7.39 (m, 5H), 5.09 (s, 2H), 2.35 (s, 
3H). 13C NMR (CDCl3, 500 MHz): δ 189.18, 156.28, 140.06, 136.08, 135.44, 130.96, 128.8, 
127.85, 118.08, 77.85, 20.57. GC-MS = 304 [M]+ (Calcd = 304 [M]+). Mp = 53-55 °C. 
2-Benzyloxy-5-methyl-3-phenylbenzaldehyde (Q). Solid 2-Benzyloxy-3-bromo-5-methyl-
benzaldehyde (P) (5.26 g, 17.2 mmol), phenyl boronic acid (3.16 g, 25.9 mmol), Pd(PPh3)4 (0.99 
g, 0.86 mmol), and NaCO3 (3.65 g, 34.4 mmol) were combined with 100 mL of H2O/THF (1:1) 
and degassed with N2 for 30 min. The reaction mixture was stirred vigorously and refluxed for 
12 h. Dichloromethane (200 mL) was added and the organic phase was separated from the 
aqueous layer. The organic mixture was dried over Na2SO4 and evaporated to yield an oil. The 
crude material was purified by silica gel column chromatography (5:95 EtOAc/hexanes) and the 
desired product was further crystallized from hot hexanes to afford a white solid (3.92 g, 76 %). 
1H NMR (CDCl3, 500 MHz): δ 10.32 (s, 1H), 7.64 (m, 3H), 7.50-7.43 (m, 4H), 7.30-7.27 (m, 
3H), 7.08-7.06 (m, 2H), 4.53 (s, 2H), 2.42 (s, 3H). 13C NMR (CDCl3, 125 MHz): δ 190.22, 
157.07, 138.05, 137.30, 136.04, 135.66, 134.27, 129.78, 129.12, 128.73, 128.57, 128.44, 127.80, 
127.34, 77.06, 20.71. GC-MS = 302 [M]+ (Calcd = 302 [M]+). Mp = 98-99 °C. 
2-Hydroxy-5-methyl-3-phenylbenzaldehyde (R). The 2-benzyloxy-5-methyl-3-phenyl-
benzaldehyde compound (Q) (3.92 g, 13 mmol) was dissolved in 50 mL of dry CH2Cl2 and 
cooled to 0 °C. A 1.0 M boron tribromide solution in CH2Cl2 (26 mL, 26 mmol) was added 
slowly to the reaction flask and the solution immediately became a dark red-orange color. The 
reaction was stirred for 2 h and then quenched with H2O (50 mL). The organic layer was 
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separated, dried over Na2SO4 and evaporated to dryness. The crude material was purified by 
silica gel column chromatography (5:95 EtOAc/hexanes) to give the desired product as a yellow 
oil (3.92 g, 76%). 1H NMR (CDCl3, 500 MHz): δ 11.40 (s, 1H), 9.90 (s, 1H), 7.62 (d, J = 8 Hz, 
2H), 7.49-7.45 (m, 3 H), 7.39 (m, 1H), 7.34 (s, 1H), 7.40 (s, 3H). 13C NMR (CDCl3, 125 MHz): 
δ 197.56, 157.52, 139.64, 137.17, 133.78, 130.90, 129.99, 129.88, 129.01, 126.33, 121.35, 21.06. 
GC-MS = 212 [M]+ (Calcd = 212 [M]+). 
H2LVH,H (2,2'-(5,5'-(4,5-dimethoxy-1,2-phenylene)bis(ethyne-2,1-diyl)bis(pyridine-5,2-diyl)) 
di-phenol) . Solid Benz2LVH,H (5,5'-(4,5-dimethoxy-1,2-phenylene)bis(ethyne-2,1-diyl)bis(2-(2-
(benzyloxy)phenyl)pyridine)) (46.0 mg, 65.3 µmol) and iodotrimethylsilane (0.02 mL, 163 
µmol) were combined in 2 mL of dry CH2Cl2 in a 10 mL Schlenk flask. The reaction mixture 
was stirred at RT for 22 h. A diluted solution of HCl(aq) was added and the organic phase was 
extracted with CH2Cl2. The organic layer was separated, dried over Na2SO4, filtered, and 
evaporated to dryness. The crude material was purified by silica gel column chromatography 
(CH2Cl2) to afford a yellow solid (10 mg, 29%). 1H NMR (CDCl3, 500 MHz): δ 8.70 (s, 2H), 
7.95 (d, J = 2.0 Hz, 4H), 7.80 (dd, J = 9.5, 1.5 Hz, 2H), 7.34 (t, J = 8.5 Hz, 2H), 7.08-7.04 (m, 
4H). 6.93 (t, J = 8.5 Hz, 2H), 3.98 (s, 6H). ESI-MS = 525.3 [M+H]+ (Calcd = 525.2 [M+H]+). 
Mp = 166-167 °C. 
H2LH,H (2,2'-(5,5'-(1,2-phenylenebis(ethyne-2,1-diyl))bis(pyridine-5,2-diyl))diphenol). Solid 
Me2LH,H (1,2-bis((6-(2-methoxyphenyl)pyridin-3-yl)ethynyl)benzene) (340 mg, 0.690 mmol) 
was dissolved in 15 mL of dry CH2Cl2 and cooled to -78°C. A 1.0 M CH2Cl2 solution of BBr3 
(3.4 mL, 3.45 mmol) was added slowly to the reaction mixture and stirred for 6 h at 0 °C. The 
reaction was quenched with trifluoroacetic acid (2 mL) and washed with K2CO3 (aq). The 
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organic layer was separated, dried over Na2SO4, filtered, and evaporated to dryness. Purification 
of the crude material by silica gel column chromatography (20:80 EtOAc/Hexanes) gave a 
yellow solid (122 mg, 38%). 1H NMR (CDCl3, 500 MHz): δ 11.74 (bs, 2H), 8.73 (s, 2H), 8.10-
8.01 (m, 4H), 7.86 (d, J = 8.0 Hz, 2H), 7.60 (s, 2H), 7.38 (s, 2H), 7.21 (t, J = 7.0 Hz, 2H), 6.87-
6.81 (m, 4H). 13C NMR (CDCl3, 125 MHz): δ 161.47, 158.28, 149.50, 141.05, 133.09, 132.72, 
129.84, 127.62, 126.02, 120.01, 119.57, 119.44, 119.39, 118.72, 92.52, 90.93. ESI-MS = 465.3 
[M+H]+ (Calcd = 465.2 [M+H]+). Mp = 141-145 °C. 
H2LH,Ph (3,3'-(5,5'-(1,2-phenylenebis(ethyne-2,1-diyl))bis(pyridine-5,2-diyl))dibiphenyl-2-
ol). The foregoing procedure was employed except that Me2LH,Ph (1,2-bis((6-(2-
methoxybiphenyl-3-yl)pyridin-3-yl)ethynyl)benzene) was used in place of Me2LH,H. The reaction 
was performed using Me2LH,Ph (1.50 g, 2.32 mmol) and 1.0 M BBr3 in CH2Cl2 (12 mL, 12 
mmol). Purification of the crude material by silica gel column chromatography (20:80 
THF/hexanes) gave a yellow solid (393 mg, 27%). 1H NMR (CDCl3, 500 MHz): δ 14.50 (bs, 
2H), 8.66 (s, 2H), 8.00-7.95 (m, 4H), 7.82 (d, J = 8.0 Hz, 2H), 7.66-7.61 (m, 6H), 7.47-7.34 (m, 
10H), 7.00 (t, J = 8.0 Hz, 2H). 13C NMR (CDCl3, 125 MHz): δ 157.60, 157.22, 148.33, 140.07, 
138.57, 133.35, 132.34, 131.57, 129.69, 129.03, 128.25, 127.23, 126.06, 125.19, 119.31, 119.06, 
118.68, 118.10, 92.33, 90.04. ESI-MS = 617.4 [M+H]+ (Calcd = 617.2 [M+H]+). Mp = 104-106 
°C. 
H2LMe,Ph (3,3'-(5,5'-(1,2-phenylenebis(ethyne-2,1-diyl))bis(pyridine-5,2-diyl))bis(5-methyl-bi 
phenyl-2-ol). Method A: Solid Benz2LMe,Ph (1,2-bis((6-(2-(benzyloxy)-5-methylbiphenyl-3-
yl)pyridin-3-yl)ethynyl)benzene) (1.20 g, 1.45 mmol) and iodotrimethylsilane (2.1 mL, 14.9 
mmol) were combined in 50 mL of dry toluene and stirred in a sealed reaction vessel at 130 °C 
for 3 d. Dilute HCl (aq) was added to quench the reaction and the organic phase was extracted 
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into CH2Cl2 (3 x 30 mL). The organic layer was separated, dried over Na2SO4, filtered, and 
evaporated to dryness. Purification of the crude material by silica gel column chromatography 
(50:50 hexanes/CH2Cl2) gave a yellow solid (630 mg, 67%). Method B: Solid Benz2LMe,Ph (1.65 
g, 2.00 mmol) was dissolved in CH2Cl2 (75 mL) and cooled to -78ºC. A 1.0 M BBr3 solution in 
CH2Cl2 (4.40 mL, 4.40 mmol) was added dropwise into the reaction flask. After stirring for 2 h, 
the mixture was quenched with H2O (100 mL). The organic product was extracted with CH2Cl2 
(3 x 50 mL), dried over Na2SO4, filtered, and evaporated to afford an oil. About 50 mL of 
CH3OH was added to the residue and a large amount of yellow solid appeared after 1 h. The 
product was isolated by filtration and re-crystallized form hot CH2Cl2/CH3OH to give the desired 
material (0.99 g, 78 %). 1H NMR (CDCl3, 500 MHz): δ 14.38 (bs, 2H), 8.64 (s, 2H), 7.95 (dd, J 
= 8.5 Hz, 4H), 7.68-7.61 (m, 8H), 7.48-7.35 (m, 8H), 7.35 (s, 2H), 2.40 (d, 6H). 13C NMR 
(CDCl3, 125 MHz): δ 155.31, 148.30, 139.94, 138.65, 134.28, 132.28, 131.23, 129.64, 128.96, 
128.21, 127.89, 127.15, 126.20, 125.15, 119.24, 118.30, 117.89, 92.26, 90.09, 20.96. ESI-MS = 
645.4 [M+H]+ (Calcd = 645.2 [M+H]+). Mp = 137-140 °C. 
H2LtBu,Ph (3,3'-(5,5'-(1,2-phenylenebis(ethyne-2,1-diyl))bis(pyridine-5,2-diyl))bis(5-tert-
butylbiphenyl-2-ol)). The same procedure was employed as for the synthesis of H2LMe,Ph 
(Method A), except that Benz2LtBu,Ph (1,2-bis((6-(2-(benzyloxy)-5-tert-butylbiphenyl-3-
yl)pyridin-3-yl)ethynyl)benzene) was used instead of Benz2LMe,Ph. The reaction was performed 
with Benz2LtBu,Ph (260 mg, 0.286 mmol) and iodotrimethylsilane (0.4 mL, 2.86 mmol). 
Purification of the crude material by silica gel column chromatography (50:50 CH2Cl2/Hexanes) 
gave a yellow solid (43 mg, 21%). 1H NMR (CDCl3, 500 MHz): δ 14.39 (bs, 2H), 8.68 (d, 2.5 
Hz, 2H), 8.93 (d, J = 8.5 Hz, 2H), 7.97 (dd, J = 10.5, 2.0 Hz, 2H), 7.83 (d, J = 2.5 Hz, 2H), 7.69-
7.68 (m, 4H), 7.65-7.63 (m, 2H), 7.50-7.47 (m, 6H), 7.41-7.37 (m, 4H), 1.42 (s, 18H). 13C NMR 
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(CDCl3, 125 MHz): δ 157.54, 155.28, 148.46, 141.42, 139.93, 139.07, 132.35, 131.08, 130.98, 
129.73, 128.98, 128.24, 127.14, 125.14, 122.39, 119.21, 117.86, 117.85, 92.21, 90.12, 34.49, 
21.77. ESI-MS = 729.5 [M+H]+ (Calcd = 729.3 [M+H]+). Mp = 125-128 °C. 
H2BIPSMe,Ph (3,3'-(1E,1'E)-(3,3'-sulfonylbis(3,1-phenylene)bis(azan-1-yl-1-ylidene))bis 
(methan-1-yl-1-ylidene)bis(5-methylbiphenyl-2-ol)). In a 100 mL round-bottom flask, 2-
hydroxy-5-methyl-3-phenylbenzaldehyde (R) (2.60 g, 12.3 mmol) and 3,3’-
diaminodiphenylsulfone (1.38 g, 5.56 mmol) were dissolved in 50 mL of MeOH. The mixture 
was treated with formic acid (0.46 mL, 12.3 mmol) and stirred at room temperature for 5 h. The 
resulting bright orange precipitate was isolated by filtration and washed with MeOH. Purification 
of the reaction product by silica gel column chromatography (CH2Cl2  15:85 EtOAc/CH2Cl2) 
gave the desired product (2.1 g, 48 %). A small amount of the starting aldehyde and singly 
condensed product (< 2 %) were still present in the purified material, presumably due to 
hydrolysis of H2BIPSMe,Ph. 1H NMR (CDCl3, 500 MHz): δ 13.19 (s, 2H), 8.59 (s, 2H), 7.88 (m, 
2H), 7.61-7.57 (m, 6H), 7.47-7.44 (m, 4H), 7.38-7.24 (m, 6 H), 2.38 (s, 6H). 13C NMR (CDCl3, 
125 MHz): δ 164.97, 156.52, 149.62, 142.86, 137.58, 136.23, 132.41, 130.84, 130.18, 129.47, 
126.68, 128.37, 127.48, 126.99, 125.88, 119.99, 118.88, 20.61. ESI-MS = 637.2 [M+H]+ (Calcd 
= 637.2 [M+H]+). Mp = 141-145 °C. 
[Fe2(LMe, Ph)2(THF)3] (1). Inside a drybox, solid H2LMe,Ph (200 mg, 310 µmol) and [Fe2(Mes)4] 
(91.3 mg, 155 µmol) were dissolved in 10 mL of THF in a 25 mL flask to give a dark red 
solution. The mixture was stirred at RT for 10 min and the solvent was removed in vacuo. A 
solution of Et2O (10 mL) was added and the resulting suspension was stirred for 10 min. The 
solid material was isolated by filtration and crystallized by layering pentane (2 mL) over a 
solution of the compound in THF (10 mL). The crystals were isolated by filtration and dried 
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under vacuum to give a red-brown powder (116 mg, 46%). Crystals suitable for X-ray diffraction 
studies were obtained by vapor diffusion of pentane into a solution of the complex in THF. 1H 
NMR (THF-d8, 500 MHz): δ = 44.45 (bs), 42.20 (bs), 38.08 (bs), 36.30 (bs), 34.14 (bs, methyl), 
11.01 (bs), 6.84 (bs), 6.25 (bs), 5.61 (bs), 4.61 (bs). IR (KBr): v = 3442, 2918, 2851, 1595, 1555, 
1495, 1453, 1420, 1368, 1292, 1250, 1222, 1045, 840, 821, 757, 698 cm-1. λmax = 395 (ε = 5130 
M-1 cm-1), 332 (ε = 63,300 M-1 cm-1), 306 (ε = 94100 M-1 cm-1), 235 (ε = 137000 M-1 cm-1) nm. 
57Fe Mössbauer (90 K): δ = 1.13 mm/s, ΔEQ = 1.88 mm/s, ΓL/R = 0.47 mm/s. Mp > 400 ºC. Anal. 
Calc. for 1, Fe2C104H84N4O7: C, 77.42; H, 5.25; N, 3.47. Found: C, 76.66, 76.91; H, 4.50, 4.22; 
N, 4.16, 4.65. Drying of the samples under vacuum at 80 ºC and repeated measurements of 
independently prepared material gave similar results. Deviations between calculated and 
observed values are ascribed to residual solvent molecules and possibly partial oxidation to form 
2 since 1 is quite air-sensitive. Because we have crystal structure information on 1, which has 
disordered THF and pentane in the crystal lattice, and the crystalline samples looked identical 
with copious amounts of material, there is no doubt about the composition of 1. 
[Fe2(µ-O)(LMe, Ph)2] (2). Method A. The [Fe2(LMe, Ph)2(THF)3] complex (50 mg, 31 mmol) was 
dissolved in THF (2 mL) in a 5 mL Schlenk flask under a nitrogen atmosphere. An excess 
amount of dry O2 gas was introduced and the reaction was stirred for 5 min. The solvent mixture 
was evaporated to dryness and the resulting dark red residue was extracted into dry toluene (2 
mL). The desired material was crystallized from vapor diffusion of pentane into a solution of the 
complex in toluene to give a dark red material (35 mg, 80%). Method B. The dinucleating ligand 
H2LMe,Ph (137 mg, 213 µmol) and NaHMDS (82 mg, 447 µmol) were dissolved in THF (3 mL) 
to give a bright orange solution. A solution of (NEt4)2[Fe2OCl6]29 (141 mg, 234 µmol) in CH3CN 
(0.5 mL) was added and the dark red mixture was stirred for 15 min. The solvent was removed in 
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vacuo and the resulting product was extracted into toluene. Evaporation of the toluene solution 
gave the desired complex as a red solid (70 mg, 47 %). Crystals suitable for X-ray diffraction 
studies were obtained by vapor diffusion of pentane into a solution of the complex in THF. 1H 
NMR (THF-d8, 500 MHz): δ = 16.42 (bs), 13.90 (bs), 11.75 (bs), 8.56 (bs), 8.25 (bs), 7.59 (bs), 
7.52 (bs), 6.96 (bs), 6.60 (bs). IR (KBr): v = 3431, 3030, 2917, 2851, 1598, 1493, 1418, 1367, 
1290, 1250, 1225, 833, 758, 697 cm-1. λmax = 390 (sh, ε = 37,500 M-1 cm-1), 312 (ε = 108,000 M-
1 cm-1) nm. 57Fe Mössbauer (90K): δ = 0.43 mm/s, ΔEQ = 1.35 mm/s, ΓL/R = 0.42 mm/s. Mp = 
335 ºC (decomposition). Anal. Calc. for 2⋅(THF)4, Fe2C108H92N4O9: C, 76.96; H, 5.50; N, 3.33. 
Found: C, 76.23; H, 5.45; N, 3.29. This result is consistent with the four THF molecules found in 
a low-resolution X-ray crystal structure of 2. 
UV-Vis Spectrophotometric Studies 
Reaction of Na2LR,R’ or Na2BIPSMe,Ph with Fe(II) in THF. Inside a nitrogen drybox, stock 
solutions of either Na2LR,R’ or Na2BIPSMe,Ph were prepared by dissolving the H2LR,R’ or 
H2BIPSMe,Ph ligand in THF containing two equiv of NaHMDS, giving a concentration of ~20 
µM. A 3.0 mL portion of either the Na2LR,R’ or Na2BIPSMe,Ph stock solution was added via a 
septum to a sealed UV-vis quartz cuvette and brought outside of the drybox. An anaerobic 
CH3CN solution of Fe(OSO2CF3)2 (~3 mM) was loaded into a 25 µL gas-tight syringe. Small 
aliquots (~ 5 µL, 0.25 equiv relative to Na2LR,R’ or Na2BIPSMe,Ph) of the Fe(OSO2CF3)2 solution 
were added to the sample in the cuvette and the absorption spectra were recorded.  
Reaction of 2 Fe(II) and Na2LH,Ph with Ph3CCO2Na in THF. Inside a nitrogen drybox, a 
THF solution containing Fe(OSO2CF3)2 (60 µM ) and Na2LH,Ph (30 µM) was prepared in a 25 mL 
volumetric flask. A 4.0 mL portion of the iron-ligand mixture was added into a septum-sealed 
UV-vis quartz cuvette and brought outside of the drybox. A 250 µL air-tight syringe was loaded 
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with a degassed THF solution containing Ph3CCO2Na (13 mM). Aliquots of the carboxylate 
solution (~ 10 µL, 1.0 equiv relative to Na2LH,Ph ) were added to the UV-vis cell and the 
absorption spectra were recorded.  
Reaction of [Fe2(LMe, Ph)2(THF)3] (1) with [FeCp2](BF4) (Cp = cyclopentadiene) in THF. 
Inside a nitrogen drybox, a stock solution of [Fe2(LMe, Ph)2(THF)3] (13 µM) in THF was prepared 
using a 25 mL volumetric flask. A 3.0 mL portion of the [Fe2(LMe, Ph)2(THF)3] solution was 
added to a septum-sealed UV-vis quartz cuvette and brought outside of the drybox. Small 
aliquots of an anaerobic CH2Cl2 solution of [FeCp2](BF4) (~ 10 µL, which equals 0.5 equiv 
relative to [Fe2(LMe, Ph)2(THF)3]) were added into the UV-vis cell and the absorption spectra were 
recorded.  
 
2.3. Results and Discussion 
 Ligand Design and Synthesis. Controlling the coordination chemistry of kinetically 
labile iron complexes is a formidable challenge.30,31 Reaction of iron salts with simple ligands, 
such as alkoxides or carboxylates, typically results in formation of oligo- or polymeric metal 
clusters.31-35 In contrast, when the ligands are too sterically hindered, mononuclear iron species 
are obtained.36,37 To construct functional protein models using carboxylate-bridged diiron 
assemblies, certain design elements must be considered. First, the diiron framework should be 
sufficiently stable towards changes of the metal oxidation state. Reaction of the reduced 
diiron(II) form of sMMOH with dioxygen generates transient diiron(III) and diiron(IV) 
intermediates.1,38 To access such species outside of the protein environment, the ligand must be 
able to stabilize iron in the +2, +3, and +4 oxidation states. Second, the diiron assembly should 
be structurally flexible to allow for geometric reorganization. In the biological systems, changes 
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in ligation of a glutamate side chain to the diiron center occur concomitantly with changes in its 
redox states. Such carboxylate shifts are believed to be functionally important during dioxygen 
activation. Third, the ligand scaffold should provide an open site for dioxygen binding between 
the two iron atoms. To obtain a quadrilateral core, such as the proposed di(µ-oxo)diiron(IV) 
structure of intermediate Q in sMMOH,39 the diiron unit should be coordinatively unsaturated or 
have bridging ligands that could be displaced readily. Finally, the ligand framework should be 
amenable to synthetic modifications. This feature is important because it allows tuning of the 
geometric and electronic properties of a given construct using the fewest synthetic steps. 
 Based on the above prerequisites, we designed a series of dinucleating ligands that share 
a common “V-shaped” architecture (Chart 2.2). These compounds can bind two metal ions, 
forming stable six-membered ring chelates, and enforce a planar arrangement of O2N2 donor 
atoms. We envisioned that the planar nature of the ligand would allow for axial coordination of 
external carboxylates, which would match the arrangement of aspartate and glutamate side 
chains that are bound to the diiron protein active sites (Chart 2.1). The unique “V-shaped” ligand 
motif also provides an internal pocket for binding of a small molecule, such as dioxygen. Five of 
these compounds are derived from phenoxylpyridyl binding units tethered to a 1,2-
diethynylbenzene linker. The protonated forms of these ligands are designated as H2LR,R’, where 
R = H, Me, or t-Bu and R’ = H or Ph. The steric constraints of H2LR,R’ are adjusted by appending 
alkyl or phenyl moieties to either the ortho or para positions of the phenol ring. A sixth ligand, 
H2BIPMe,Ph, was also synthesized using a different covalent bridge. Replacement of the 
diethynylbenzene unit in H2LR,R’ with a bis(iminephenyl)sulfone linker alters the rotational 
freedom of the ligand framework. The parent bis-(3-(2-hydroxybenzylideneamino)phenyl) 
sulfone compound was synthesized as a ligand for preparing dinuclear copper complexes.40  
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Chart 2.2. The series of phenoxylpyridyl- (left) and phenoxylimine- (right) dinucleating ligands 
synthesized. 
 
 Several routes were explored to obtain H2LR,R’. The synthetic routes for H2LVH,H, H2LH,H, 
H2LH,Ph, and H2LtBu,Ph are provided in Schemes 2.1 and 2.2. The most efficient synthetic strategy 
is illustrated for the preparation of H2LMe,Ph in Scheme 2.3. As described previously,27 protection 
of the commercially available 2-bromo-4-methylphenol with tetrahydro-2H-pyran, followed by a 
Suzuki cross-coupling reaction with phenylboronic acid, gave M as a colorless oil. Deprotection 
with aqueous HCl, followed by bromination with Br2, afforded N in quantitative yield. 
Compound N was subjected to a second protection procedure with benzyl bromide and isolated, 
after purification, as a colorless material. Negishi coupling of I with 2,5-dibromopyridine gave K 
as a white solid. A Sonogashira procedure was employed to couple K and 1,2-diethynylbenzene. 
Solid 1,2-diethynylbenzene is susceptible to decomposition upon storage; therefore, it was 
generated in situ from 1,2-bis((trimethylsilyl)ethynyl)benzene41 and tetrabutylammonium 
fluoride before use in the cross-coupling reaction. This procedure afforded the benzyl-protected 
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ligand Benz2LMe,Ph in moderate yield after purification. Finally, the desired H2LMe,Ph compound 
was obtained by treatment of Benz2LMe,Ph with boron tribromide in CH2Cl2 and crystallization 
from CH2Cl2/MeOH. The  H2LMe,Ph ligand was isolated as a yellow solid.  
 
Scheme 2.1. Part 1: i) a. n-BuLi, THF, -78°C, b. ZnCl2, c. 2,5-dibromopyridine, [Pd(PPh3)4]; ii) 
4,5-diethynylveratrole, [Pd(PPh3)4], NEt3, THF, reflux; iii) TMSI, CH2Cl2. Part 2: i) a. n-BuLi, 
THF, -78°C, b. ZnCl2, c. 2,5-dibromopyridine, [Pd(PPh3)4]; ii) 1,2-diethynylbenzene, 
[Pd(PPh3)4], NEt3, THF, reflux; iii) a. BBr3, CH2Cl2, b. CF3CO2H. 
 
 The sulfone bridged compound H2BIPSMe,Ph was synthesized according to Scheme 2.3. 
Benzylation of 2,6-dibromo-4-methylphenol with benzyl bromide provided O as a colorless 
crystalline solid. To introduce an aldehyde functionality, O was treated with n-butyllithium and 
quenched with dimethylformamide to give P. This precursor was coupled to phenylboronic acid 
to provide Q in good yield. Cleavage of the benzyl protecting group by boron tribromide in 
CH2Cl2 cleanly gave R as a yellow oil. The final product was obtained by an acid-catalyzed 
condensation reaction between R and the commercially available 3,3ʹ -diaminodiphenyl sulfone 
in MeOH. The desired bright orange solid, H2BIPMe,Ph, readily precipitated from the reaction 
mixture and was isolated in moderate yield. 
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Scheme 2.2. Part 1: i) a. NaH, THF, 0°C, b. CH3I, reflux; ii) a. TMEDA, Et2O, b. Br2; iii) a. n-
BuLi, THF, -78°C. b. ZnCl2, c. 2,5-dibromopyridine, [Pd(PPh3)4]; iv) 1,2-diethynylbenzene, 
[Pd(PPh3)4], NEt3, THF, reflux; v) BBr3, CH2Cl2, 0°C. Part 2: i) benzyl bromide, K2CO3, 
CH3CN, reflux; ii) phenylboronic acid, [Pd(PPh3)4], Na2CO3(aq), THF, reflux; iii) a. nBuLi, 
THF, -78 oC, b. ZnCl2, c. 2,5-dibromopyridine, [Pd(PPh3)4]; iv) 1,2-diethynylbenzene, 
[Pd(PPh3)4], NEt3, THF, reflux; v) TMSI, toluene, reflux. Part 3: i) a. HCl (aq), b. Br2, CH2Cl2; 
ii) benzyl bromide, K2CO3, CH3CN; iii) a. nBuLi, THF, -78ºC, b. ZnCl2, c. 2,5-dibromopyridine, 
[Pd(PPh3)4]; iv) a. 1,2-bis(trimethylsilylacetylene)benzene, NBu4F, THF, b. [Pd(PPh3)4], NEt3; v) 
BBr3, CH2Cl2. 
 
Scheme 2.3. i) benzyl bromide, K2CO3, CH3CN; ii) a. nBuLi, toluene, -78ºC, b. anhydrous 
DMF; iii) phenylboronic acid, [Pd(PPh3)4], Na2CO3 THF/H2O; iv) BBr3, CH2Cl2; v) 3,3’-
bis(aminophenyl)sulfone, CF3CO2H, MeOH 
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 Gram quantities of the final ligands, H2LMe,Ph and H2BIPMe,Ph, were obtained. These 
synthetic routes facilitate systematic modification of ligand substituents without significant 
changes to the overall synthetic strategy.  
UV-Vis Spectrophotometric Studies. For systems that display strong optical features, a 
convenient method to examine metal-ligand binding is to conduct UV-vis spectrophotometric 
titrations.42-44 If [LR,R’]2– or [BIPSMe,Ph]2– (where [LR,R’]2– and [BIPSMe,Ph]2– are the doubly 
deprotonated forms of H2LR,R’ and H2BIPSMe,Ph, respectively) are capable of serving as 
dinucleating hosts, addition of iron(II) salts to the apo-ligands should yield a 2:1 metal-to-ligand 
stoichiometry. 
Titration experiments were first performed with the parent H2LH,H compound (Figure 
2.1A). Deprotonation of H2LH,H with 2.0 equiv of sodium hexamethyldisilazide (NaHMDS) in 
THF afforded Na2LH,H, which displays an intense absorption at 415 nm (dotted trace). When the 
Na2LH,H solution was treated with various aliquots of Fe(OSO2CF3)2, formation of two sequential 
isosbestic points were observed, at 392 and 365 nm. This data suggest an ABC reaction 
scheme, which would be consistent with the binding of a single iron atom followed by binding of 
a second iron atom to Na2LH,H. A plot of the absorbance change at 350 nm versus equiv of Fe(II) 
added (relative to Na2LH,H) is shown in Figure 2.2A. A gradual increase in the optical feature at 
350 nm upon successive additions of iron(II) indicates that Na2LH,H is capable of coordinating at 
least two iron atoms. Saturation behavior was not observed when ≥ 2.0 equiv of Fe(II) were 
added. 
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Figure 2.1. Absorption spectra of A) addition of Fe(II) to a solution containing Na2LH,H, B) 
addition of Fe(II) to a solution containing Na2LH,Ph, C) addition of sodium triphenylacetate to a 
solution containing Fe(II) and Na2LH,Ph, and D) addition of Na2LH,Ph to a solution containing 
Fe(II) and sodium triphenylacetate. For A and B, the equiv of Fe(II) added is relative to the 
amount of the ligand. For C, the equiv of triphenylacetate added is relative to the amount of 
Na2LH,Ph. For D, the equiv of Na2LH,Ph added is relative to the amount of Fe(II). All experiments 
were performed in tetrahydrofuran at RT. Panel A: black dotted line = Na2LH,H, solid lines = 
spectra after addition of up to 2.0 equiv of Fe(II). Panel B: black dotted line = Na2LH,Ph, solid 
lines = spectra after addition of up to 2.0 equiv of Fe(II). Panel C: blue line = Na2LH,Ph/2 Fe(II), 
green line = spectrum after addition of 20 equiv of NaO2CCPh3. Panel D: black line = Fe(II)/ 20 
equiv of NaO2CCPh3, colored lines = spectra after addition of up to 2.0 equiv of Na2LH,Ph. 
 
For comparison to Na2LH,H, reaction of the ortho substituted derivative Na2LH,Ph to Fe(II) 
was examined. Treatment of H2LH,Ph with NaHMDS in THF gave Na2LH,Ph, as indicated by the 
formation of a prominent absorption band at 424 nm (Figure 2.1B). When aliquots of 
Fe(OSO2CF3)2 were added to Na2LH,Ph, a hypsochromic shift of the feature at 424 nm to 382 nm 
occurred. The optical spectra were unchanged after ≥ 1.0 equiv of Fe(II) was introduced (relative 
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to Na2LH,Ph) (Figure 2.2B). This result suggests that in the presence of Fe(II), Na2LH,Ph forms a 
complex having a 1:1 metal-to-ligand stoichiometry. To test the stability of this new species, 
increasing amounts of sodium triphenylacetate were added to the FeII/Na2LH,Ph mixture and the 
reaction was followed by UV-vis spectroscopy (Figure 2.1C). The absorbance spectrum did not 
change after the addition of 20 equiv of triphenylacetate (relative to Na2LH,Ph). If coordination of 
the carboxylate to the iron centers resulted in significant structural rearrangement, such a change 
would be reflected in the absorption spectrum. Because no optical changes were observed, it was 
conclude that the 1:1 Fe(II)-to-[LH,Ph]2– species is too stable to be disrupted by triphenylacetate. 
When the reaction order was reversed, adding Na2LH,Ph to a THF solution containing 1.0 equiv of 
Fe(II) and 20.0 equiv of triphenylacetate, a band at 382 nm also appeared (Figure 2.1D). Once 
again, formation of the 1:1 Fe(II) to [LH,Ph]2– species was preferred. We assigned this optical 
spectrum to the diiron(II) [Fe2(LH,Ph)2] complex (vide infra). 
 To investigate the effect of bulkier ligand substituents on the iron binding of [LR,R’]2–, 
titration studies were also carried out with Na2LtBu,Ph. We postulated that by appending tert-butyl 
groups to the para position of the phenol ring, the increased steric demand at the ligand periphery 
would prevent any possible ligand-ligand interactions in the presence of Fe(II). When treated 
with NaHMDS in THF, H2LtBu,Ph was converted to Na2LtBu,Ph. The deprotonated ligand displays a 
characteristic absorption at 437 nm (Figure 2.3A). Upon addition of Fe(OSO2CF3)2 to a solution 
of Na2LtBu,Ph, the band at 437 nm decreased, concomitant with an absorption increase at 393 nm. 
Similar to that of Na2LH,Ph, the absorbance profile is unchanged after addition of 1.0 equiv of 
Fe(II) (Figure 2.2C). A 1:1 metal-to-ligand stoichiometry would also be consistent with the 
formulation [Fe2(LtBu,Ph)2]. 
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Figure 2.2. Plots of the absorbance change at a single wavelength (nm) from reaction of Fe(II) 
with a THF solution containing A) Na2LH,H, B) Na2LH,Ph, C) Na2LtBu,Ph, and D) Na2BIPSMe,Ph. 
The wavelengths were chosen to show the maximum change between successive Fe(II) titrations.  
 
Figure 2.3. Absorption spectra from the addition of Fe(II) to a THF solution containing A) 
Na2LtBu,Ph and B) Na2BIPSMe,Ph. Panel A: black dotted line = Na2LtBu,Ph, solid lines = spectra after 
addition of up to 2.0 equiv of Fe(II). Panel B: black dotted line = Na2BIPSMe,Ph, solid lines = 
spectra after addition of up to 2.0 equiv of Fe(II).   
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 The similar results obtained for [LH,Ph]2– and [LtBu,Ph]2– led us to hypothesize that, 
although [LtBu,Ph]2– is more sterically encumbering, free rotation about the ethynyl arms allows 
the [LR,R’]2– ligands to interdigitate. To explore whether we could maintain the “V-shaped” 
architecture of the [LR,R’]2– ligand design but restrict rotation of the metal-binding arms, 
H2BIPSMe,Ph (Chart 2.2) was conceived. The bis(iminephenyl)sulfone unit is a promising 
alternative linker to 1,2-diethynylbenzene because it provides an ideal N–N distance for a 
dinucleating framework.40 Deprotonation of H2BIPSMe,Ph with NaHMDS in THF gave 
Na2BIPSMe,Ph, which has a strong absorbance at 428 nm (Figure 2.3B). When various equiv of 
Fe(II) were added to Na2BIPSMe,Ph the band at 428 nm decreased. By evaluating the absorbance 
change at 275 nm, it is clear that a saturation point is reached upon addition of 1.0 equiv of Fe(II) 
(Figure 2.2D). Once again, this experiment indicates that a 1:1 metal-to-ligand complex is 
formed preferentially in solution.  
Isolation and Characterization of Iron Complexes. Because the parent [LH,H]2– ligand 
appeared to accommodate a 2:1 metal-to-ligand ratio, we attempted to prepare a discrete diiron 
complex in the presence of Fe(II), H2LH,H, and carboxylates (Chart 2.1, left). When H2LH,H (1.0 
equiv) and triphenylacetic acid (2.0 equiv) were combined with [Fe(Mes)4]22 (where Mes = 
2,4,6-trimethylphenyl, 1.0 equiv) in THF, a dark red solid precipitated from the reaction mixture 
(Scheme 2.4A). This material was insoluble in both polar and non-polar organic solvents. When 
the reaction was repeated using either benzoate or acetate, instead of triphenylacetate, similar 
results were obtained. Because phenolate groups are well known to bridge multiple metal ions,45-
47 it is possible that reaction of the [LH,H]2– ligand with Fe(II) led to the formation of undesired 
polymetallic species.  
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Scheme 2.4. Reaction of H2LH,H with Fe(II) (A, top) and H2LMe,Ph with Fe(II) and O2 (B, 
bottom). Mes = 2,4,6-trimethylphenyl, NaHMDS = sodium hexamethyldisilazide. 
 
The titration experiments with [LR,R’]2– and [BIPSMe,Ph]2– demonstrated that when the 
ortho positions of the phenolate rings were substituted with phenyl groups complexes having a 
1:1 metal-to-ligand stoichiometry were observed. To determine the identity of these species, we 
prepared the iron complex of H2LMe,Ph. Treatment of H2LMe,Ph (2.0 equiv) with Fe2(Mes)4 (1.0 
equiv) in THF led to formation of a homogeneous dark red solution (Scheme 2.4B). 
Crystallization of the crude material from THF and pentane gave a dark red material in moderate 
yield. Single crystal X-ray diffraction analysis revealed that the complex has a diiron(II) 
structure with two bridging [LMe,Ph]2– ligands (Figure 2.4). Crystallographic data and refinement 
details are given in Table 2.1. Coordination of the iron centers by additional THF molecules 
resulted in the overall molecular formula [Fe2(LMe,Ph)2(THF)3] (1). The five-coordinate iron 
atom, Fe(1), adopts a distorted square pyramidal geometry, with two phenoxyl oxygen (Fe–O = 
~ 1.94 Å) and two pyridyl nitrogen (Fe–N = ~ 2.12 Å) atoms at the basal sites and a THF oxygen 
atom (Fe–O = 2.19 Å) at the apical position. The pseudo-octahedral iron center is coordinated by 
two phenoxyl oxygen (Fe–O = ~ 1.97 Å), two pyridyl nitrogen (Fe–N = ~2.18 Å), and two THF 
oxygen (Fe–O = ~ 2.28 Å) atoms, with each set of donors trans to one another. A distance of 
A) Reaction of H2LH,H with Fe(II)
H2LH,H  +  [FeII2(Mes)4]  +  2 Ph3CO2H insoluble solid
B) Reaction of H2LMe,Ph with Fe(II) and O2
H2LMe,Ph
[FeII2(Mes)4] [FeII2(LMe,Ph)2(THF)3] [FeIII2(O)(LMe,Ph)2]
O2
THF THF
2 NaHMDS  +  (NEt4)2[FeIII2OCl6]
THF/ CH3CN
THF
1 2
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7.20 Å separates the two iron centers. The 1:1 Fe(II) to [LR,R’]2– stoichiometry observed from the 
titration studies is reflected in the [Fe2(LMe,Ph)2(THF)3] formulation. Thus, it appears that in both 
the solid and solution states, 1 maintains the same molecular structure. A survey of the literature 
revealed that only a limited number of Fe(II) complexes with terminal phenolate ligands have 
been characterized.48,49 Most iron-containing phenolate compounds are found in the Fe(III) state 
and/or have multiple metals bridged by the phenolate moiety.50-52  
 
Table 2.1. X-ray Crystallographic Data and Refinement for [Fe2(LMe,Ph)2(THF)3] (1). 
 
 1•(THF)3.5(pentane)0.5 
Empirical formula Fe2C120.5H118N4O10.5 
Formula weight 1901.89 
Temperature 110 K 
Wavelength 0.71073 Å 
Crystal system, space group Triclinic, P1¯  
Unit cell dimensions 
a = 15.624(3) Å      α = 90.39(3)° 
b = 17.712(4) Å      β = 98.51(3)° 
c = 18.838(4) Å      γ = 106.33(3)° 
Volume 4941.4(17) Å3 
Z, Calculated density 2, 1.278 g/mm3 
Theta range for data collection 2.07 – 26.37° 
Limiting indices -19 ≤ h ≤ 19, -21 ≤ k ≤ 22, -23 ≤ l ≤ 22 
Reflections collection/ unique 75842/ 20123 [Rint = 0.1207] 
Completeness to theta 99.5 % 
Data/ restraints/ parameters 20213/ 1390/ 1268 
Goodness of fit on F2 1.017 
Final R Indices R1 = 0.0854, wR2 = 0.1860 
* R1 = Σ ∣∣Fo∣–∣Fo∣∣/Σ∣Fo∣; wR2 = [Σ[w(Fo2– Fc2)2]/Σ[w(Fo2)2]]1/2; GOF = 
[Σ[w(Fo2– Fc2)2]/(n–p)]1/2, where n is the number of reflections and p is the 
total number of parameters refined. 
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Figure 2.4. Ortep thermal ellipsoid (50%) diagram of the X-ray crystal structure of 
[Fe2(LMe,Ph)2(THF)3] (1) with a partial numbering scheme. Hydrogen atoms and solvent 
molecules are omitted for clarity. The atoms are color coded according to the following: gray, 
carbon; red, oxygen; blue, nitrogen; orange, iron. Selected bond lengths (Å) and angles (deg): 
Fe(1)–O(1), 1.945(3); Fe(1)–O(2), 1.936(3); Fe(1)–N(3), 2.183(4); Fe(1)–N(4), 2.193(4), Fe(1)–
O(100), 2.123(3); Fe(2)–O(3), 1.967(3); Fe(2)–O(4), 1.977(3), Fe(2)–N(1), 2.180(4); Fe(2)–
N(2), 2.191(4); Fe(2)–O(200), 2.203(4), Fe(2)–O(300), 2.321(3); O(1)–Fe(1)–N(4), 84.37(14); 
O(2)–Fe(1)–N(3), 85.98(14); O(3)–Fe(2)–N(2), 85.68(14), O(4)–Fe(2)–N(1), 85.25(14). 
 
 The absorption spectrum of 1 shows several intense features, at 235 (ε = 137,000 M-1 cm-
1), 306 (ε = 94,100 M-1 cm-1), 332 (sh, ε = 63,300 M-1 cm-1) and 395 (ε = 5,130 M-1 cm-1) nm 
(Figure 2.5A). This spectrum matches those obtained from the Fe(II)/Na2LR,R’ titration studies 
(vide supra). Due to the limited examples of Fe(II)-phenolate compounds that have been reported 
in the literature, it is unclear whether any of the absorption bands correspond to a phenolate-to-
Fe(II) charge transfer.  
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Figure 2.5. Electronic spectra of A) complex 1 and B) complex 2 in tetrahydrofuran at RT. 
 
 The 1H NMR spectrum of 1 in THF-d8 reveals the complex to be paramagnetic in 
solution (Figure 2.6A). The downfield signals at 44.45, 42.20, 38.08, and 36.30 ppm are most 
likely due to protons located either on the phenoxyl or the pyridyl rings of [LMe,Ph]2– because they 
are located closest to the paramagnetic iron centers. The peak at 34.14 ppm is attributed to the 
methyl protons of [LMe,Ph]2– because it has the largest integrated area and is absent in the 
spectrum of [Fe2(LH,Ph)2], which does not contain methyl groups (data not shown). 
 The zero-field 57Fe Mössbauer spectrum of a polycrystalline sample of 1 was measured at 
90 K (Figure 2.7A). The data were fit to a single quadrupole doublet, with δ = 1.13 mm/s and 
ΔEQ = 1.88 mm/s. These parameters are typical for high-spin iron(II) centers in pseudo-
octahedral environments.9,53 Although there are two distinct iron atoms in the solid-state 
structure of complex 1, the similarities in their coordination environments make the sites 
indistinguishable in the absence of an applied magnetic field. This effect most likely accounts for 
the somewhat broadened linewidth of the quadrupole doublet (ΓR,L = 0.46 mm/s). 
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Figure 2.6. The 500 MHz 1H NMR spectra of complex 1 (A) and 2 (B) recorded in THF-d8. 
Only the paramagnetically shifted resonances (10-50 ppm) are shown. 
 
 
Figure 2.7. Zero-field 57Fe Mössbauer spectra of polycrystalline 1 (A) and 2 (B) recorded at 90 
K. Both spectra exhibit a single quadrupole doublet, with parameters δ = 1.13 mm/s, ΔEQ = 1.88 
mm/s, and ΓR,L = 0.46 mm/s for 1 and δ = 0.43 mm/s, ΔEQ = 1.35 mm/s, and ΓR,L = 0.42 mm/s 
for 2. Least-square fits (solid lines), assuming Lorentzian lineshapes, are overlaid on the 
experimental points (black hash marks). 
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The electrochemical properties of 1 were studied by cyclic voltammetry (CV). When the 
CV was performed in THF, two sequential quasi-reversible redox processes were observed, at 
E1/2 = -31 and -17 mV vs. ferrocene/ferrocenium (Fc/Fc+) (Figure 2.8A). A differential pulse 
voltammetry (DPV) measurement of 1 in THF revealed two oxidation peaks with maximum 
height at -31 and -17 mV (Figure 2.8C). These events are attributed to oxidation of 1 from 
Fe(II)Fe(II)Fe(II)Fe(III)Fe(III)Fe(III). When the CV of 1 was measured in DMF, rather than 
THF, the complex exhibited one quasi-reversible redox couple at E1/2 = -64 mV vs. Fc/Fc+ 
(Figure 2.8B). The DPV of 1 in DMF also confirmed that only a single redox event occurs at -64 
mV (Figure 2.8D). Presumably, this process corresponds to a two-electron oxidation of 1 from 
Fe(II)Fe(II)Fe(III)Fe(III). Attempts to quantify the number of electrons involved in these 
electrochemical processes using ferrocene as a standard gave ambiguous results and were not 
examined further. Nevertheless, these data suggest that electronic delocalization between the two 
iron centers in complex 1 is solvent dependent. From the electrochemical data, a 
comproportionation constant (Kcom)54 of 1 was calculated to be ~100 in THF and ~105 in DMF. 
According to the Robin-Day classification,55 1 behaves as a slightly charge-delocalized Class II 
species in THF, but becomes a completely charged-localized Class I complex in DMF. Because 
the UV-vis spectra of 1 in THF and DMF are identical, it is unlikely that the electrochemical 
differences are due to different speciation in solution. It is more likely that coordination of 
solvent molecules to the iron centers mediate the degree of electronic communication between 
the two iron atoms. 
 Because the CV of 1 shows quasi-reversible behavior, synthesis of the doubly oxidized 
[Fe2(LMe,Ph)2(THF)x]2+ complex was attempted. Based on the E1/2 values of 1 in THF (-31 and 
-17 mV vs. Fc/Fc+), [FeCp2]BF4 (Cp = cyclopentadienyl) should serve as a suitable oxidant. 
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When aliquots of [FeCp2]BF4 in CH2Cl2 were added to a THF solution containing 1, clean 
conversion to a new species occurred, as revealed by the UV-vis spectra (Figure 2.9). This 
process is accompanied by absorbance decreases at 242 and 395 nm as well as increases at 314 
and 626 nm. Efforts to crystallize the iron product for X-ray crystallographic analysis were not 
successful.  
 
 
Figure 2.8. Cyclic voltammograms of a 0.2 mM solution of complex 1 containing 0.1 M tetra-n-
butylammonium hexafluorophosphate in A) THF and B) DMF at a scan rate of 50 mV/s. 
Differential pulse voltammograms of 1 in C) THF and D) DMF are also shown. The 
measurements were carried out with a Pt electrode and referenced to the Fc/Fc+ redox couple. 
 
 99 
 
Figure 2.9. Absorption spectra from the addition of [FeCp2](BF4) to a THF solution containing 
complex 1. Black dotted line = 1, solid lines = spectra after addition of up to 2.0 equiv of 
ferrocenium. 
 
Reaction of Complex 1 with Dioxygen. The > 7 Å separation between the iron(II) sites 
in complex 1 raises the question, how will it react with dioxygen? If the metal centers are rigidly 
confined to a fixed position, exposure of 1 to O2 might lead to formation of two dioxygen 
adducts within the same molecule. Alternatively, if the [LMe,Ph]2– framework was rotationally 
flexible, it is conceivable that O2 might bridge the two iron centers. To determine the final 
oxygenation product, complex 1 was dissolved in a THF solution and stirred for 5 min in the 
presence of O2 (Scheme 2.4B). The reaction product was dried in vacuo and crystallized from 
pentane and toluene to afford a red solid in good yield. Single crystals for X-ray diffraction 
studies were grown by slow diffusion of pentane into a solution of the compound in THF. 
Because the red crystals were very small (approx. 0.20 x 0.08 x 0.05 mm3) a high-resolution X-
ray crystal structure could not be obtained. However, the low-resolution data show that the 
compound contains a µ-oxodiiron(III) unit having the composition [Fe2(µ-O)(LMe,Ph)2] (2, Figure 
2.10). The presence of an oxo bridge was also confirmed by several spectroscopic methods (vide 
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infra). The structure showed that rotation of the [LMe,Ph]2– ethynyl arms led to contraction of the 
iron-iron distance. Complex 2 was also prepared from a pre-assembled µ-oxodiiron(III) source. 
Upon deprotonation of H2LMe,Ph with NaHMDS in THF and addition of (NEt4)2[Fe2OCl6]29 a 
dark red solution formed (Scheme 2.4B). Evaporation of the solvent and extraction of the residue 
into toluene gave the desired product in moderate yield.  
 
Figure 2.10. A stick figure representation of the low-resolution X-ray crystal structure of [Fe2(µ-
O)(LMe,Ph)2] (2) in two different views. Due to the poor quality of the X-ray data, only the atoms 
connectivity of the structure could be obtained. The atoms are color coded according to the 
following: gray, carbon; red, oxygen; blue, nitrogen; orange, iron. 
 
 The presence of a µ-oxodiiron(III) center in 2 was further confirmed by both vibrational 
and 57Fe Mössbauer spectroscopy. When 2 was prepared by reaction of 1 with 18O2, instead of 
16O2, its infrared spectrum revealed a single peak shifted from 833 cm-1 to 798 cm-1. A survey of 
known µ-oxodiiron(III) complexes revealed that the asymmetric Fe–O–Fe stretch occurs 
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between ~700-850 cm-1 and shifts to lower energy by ~30-45 cm-1 when 18O2 is substituted for 
16O2.56,57 Because 2 exhibits an isotopically shifted peak within this range, the data strongly 
support the assignment of a µ-oxodiiron(III) core. To probe further the oxidation state and 
coordination environment of 2, its 57Fe Mössbauer spectrum was recorded. A Lorentzian least-
squares fit of the Mössbauer data gave a single quadrupole doublet with δ = 0.43 mm/s and ΔEQ 
= 1.35 mm/s (Figure 2.7B). These parameters are characteristic of high-spin iron centers 
coordinated by mixed O,N donors. In addition to overall charge considerations, the IR and 
Mössbauer data suggest that 2 should be formulated as a [Fe2(µ-O)(LMe,Ph)2] complex. 
 The electronic absorption spectrum of complex 2 was recorded in THF. An intense band 
at 312 nm (ε = 108,000 M-1 cm-1) and a shoulder at ~390 nm (ε = 37,500 M-1 cm-1) dominate the 
spectrum (Figure 2.5B). Because the band at ~310 nm also occurs in the spectrum of Na2LMe,Ph, 
it is assigned to a p(π)  p(π*) ligand transition. Since the spectrum of 2 shows an increased 
absorption between 350-390 nm, compared to that of 1, it is possible that this overlapping feature 
represents one of the phenolate-to-Fe(III) charge-transfer bands.50,58  
A bathochromic shift of the phenolate-to-iron LMCT band is reflected in smaller NMR 
contact shifts of the phenolate protons due to less mixing between the metal d and ligand 
orbitals.58 The 1H NMR spectrum of 2 (Figure 2.6B) contains only three signals outside the 
diamagnetic region, at 16.42, 13.90, and 11.75 ppm. Compared to the 1H NMR spectrum of 1, 
these peaks are less paramagnetically shifted. This result indicates that there is less unpaired spin 
density on the [LMe,Ph]2– ligand in complex 2 than in 1. Consequently, the phenolate-to-iron 
charge transfer bands should occur at a higher energy for 2 than for 1.  
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 The electrochemical behavior of 2 was investigated by cyclic voltammetry (Figure 2.11). 
When recorded in THF, an irreversible reduction wave was observed at -780 mV (vs. Fc/Fc+) 
and an irreversible oxidation wave appeared at +720 mV (vs. Fc/Fc+). The absence of any 
reversible electrochemical processes was unexpected because phenolate complexes are typically 
redox active due to involvement of phenolate radicals.59,60 A related µ-oxodiiron(III) complex 
containing salen ligands exhibits two reversible redox waves due to generation of ligand-
centered monoradical and diradical species.61 Perhaps due to the unique π-conjugation of the 
[LMe,Ph]2– ligand, the resulting iron complex does not exhibit any ligand-centered redox behavior, 
at least within the electrochemical window investigated.  
 
Figure 2.11. Cyclic voltammogram of a 0.2 mM solution of complex 2 containing 0.1 M tetra-n-
butylammonium hexafluorophosphate in THF at a scan rate of 50 mV/s. The measurement was 
carried out with a Pt working electrode and referenced to the Fc/Fc+ redox couple. 
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Figure 2.12. Single-mixing stopped-flowed spectral data from the reaction of 1 with O2 in THF. 
The absorbance spectra from 300-600 nm (A, top) show rapid conversion of 1 to 2, with no 
observable intermediate species. The kinetic traces at 350 nm (B) and 700 nm (C) were fit to 
single exponential functions, giving pseudo-first order rate constants of ~0.7 s-1. 
 
  The rapid conversion of 1 to 2 in the presence of O2 was studied by stopped-flow UV-vis 
spectrophotometry (Scheme 2.4). A single mixing experiment was carried out at -50 ºC, in which 
a 26 µM solution of 1 in THF was combined with a solution saturated with O2 (~10 mM). 
Spectral scanning between 300-750 nm revealed that the oxygenation reaction was complete in 
less than 10 s (Figure 2.12A). The reaction kinetics fit well to a single exponential function 
(Figure 2.12B and 2.12C), giving a pseudo-first order rate constant of ~0.7 s-1. Even on the 
stopped-flow timescale, no intermediates were observed for conversion of 1 to 2. Our inability to 
detect and characterize any transient species prevents us from speculating about the mechanism 
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by which 1 converts to 2. Recent work with the ToMO enzyme system has identified an 
optically-silent diiron(III) oxygenated intermediate that is catalytically competent to hydroxylate 
arenes.62 When the oxygenation of 1 was performed in the presence of triphenylphosphine, gas 
chromatographic mass spectral analysis of the reaction product indicated that triphenylphosphine 
oxide was formed. The nature of the active oxidizing species and the range of substrates that 
could be oxidized have not yet been evaluated. It is important to note that during the course of 
these studies no [LMe,Ph]2– ligand decomposition was observed. 
 
2.4. Conclusion 
 In our continuing search for novel frameworks to model the active sites of O2-activating 
diiron proteins, we prepared a new family of dinucleating ligands and provided a streamlined 
method for easy derivatization. By taking advantage of the chromophoric properties of [LR,R’]2– 
and [BIPSMe,Ph]2–, the coordination chemistry of these ligands with Fe(II) was examined by UV-
vis spectrophotometry. Incorporation of sterically demanding groups in the ligand scaffold 
prevented undesired polymer formation. A diiron(II) [Fe2(LMe,Ph)2(THF)3] (1) complex was 
synthesized having a large separation (7.2 Å) between the two metal centers. Rotation about the 
ethynyl arms led to a substantial contraction of the diiron distance, the structural flexibility being 
manifest in the oxygenation product (2) obtained from reaction of 1 with O2. [18O]-Isotopic 
infrared labeling studies and 57Fe Mössbauer spectroscopy measurements clearly reveal that 
solutions of 2 retain the µ-oxodiiron(III) core found in the solid state by X-ray crystallography. 
Formation of [Fe2(µ-O)(LMe,Ph)2] most likely involves binding of O2 and concerted reorientation 
of the [LMe,Ph]2– ligands. Preliminary studies indicate that triphenylphosphine is converted to 
triphenylphosphine oxide in the presence of 1 and dioxygen, but a comprehensive study of this 
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chemistry was not undertaken. The [LMe,Ph]2– ligand is chemically stable under these conditions 
and does not participate in ligand-centered redox reactions, despite the presence of the phenolate 
group. Although the desired diiron complex containing a single dinucleating [LMe,Ph]2– ligand was 
not achieved, the structure provides guidance for future modification of the [LR,R’]2– framework 
to preclude formation of [Fe2(syn N-donor)2] units. 
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Chapter 3 
Redox Behavior and Dioxygen Reactivity of a Macrocyclic 
Carboxylate-Bridged Diiron(II) Mimic of 
Bacterial Monooxygenase Active Sites 
	   112 
3.1. Introduction 
 Investigations using synthetic mimics have contributed to our understanding of dioxygen 
activation at carboxylate-bridged diiron units.1-5 Several notable achievements in diiron 
modeling include the X-ray structural characterization of (µ-1,2-peroxo)diiron(III) species,6-8 
generation of high-valent diiron(IV) intermediates,9,10 and identification of possible protonation 
sites in oxygenated diiron complexes.11 Some synthetic diiron compounds are capable of 
oxidizing aromatics, alkenes, and saturated hydrocarbons when exposed to dioxygen, hydrogen 
peroxide, alkyl peroxides, or O-atom transfer reagents.2,4,12-14 Generally, however, these 
reactions are unremarkable because the organic substrates have weak C–H bonds or the 
transformation is not performed using molecular oxygen. One significant difference between the 
diiron proteins and the model compounds is that most oxygenated synthetic complexes are low-
spin due to their nitrogen-rich coordination environment. In contrast, biological diiron centers are 
high-spin and are carboxylate-rich. Density functional theoretical (DFT) calculations suggest that 
high-spin oxygenated diiron species are necessary to react with more chemically inert 
molecules.9,15-17  
 
Scheme 3.1. The diiron(II) complex of soluble methane monooxygenase hydroxylase 
(sMMOHred) reacts with dioxygen and saturated hydrocarbons (RH) to give alcohols (ROH) and 
the resting diiron(III) state of the protein (sMMOHox). sMMOHox can be reduced back to 
sMMOHred by acquiring two electrons from a reductase protein (sMMOR). The active site 
structures of sMMOHred and sMMOHox are depicted. 
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Chart 3.1. Syn N-donor ligands containing mixed N,O metal binding units. Compounds H2L and 
H2BIPS spontaneously assemble into bis(ligand) diiron complexes in the presence of base and 
iron(II) salts. The macrocyclic variant H2PIM was designed to have a flexible ether linkage to 
prevent ligand interdigitation upon metal complexation.  
 
As discussed in the preceding chapters, no synthetic models accurately reproduce the 
carboxylate-bridged diiron active site structure of the BMMs.5 As shown in Scheme 3.1, the 
reduced form of soluble methane monooxygenase hydroxylase (sMMOHred) contains a diiron 
unit coordinated by four carboxylate residues, two bridging and two terminal, as well as two 
histidine groups syn with respect to the Fe–Fe vector.18-20 Although a few model compounds 
have the same carboxylate and N-heterocyclic donors stoichiometry as the diiron core of 
sMMOHred, the nitrogen groups are not adjacent to each other. 21-23 A recent approach in our 
laboratory to achieve syn N-stereochemistry has been to synthesize compounds that covalently 
link two N-donors into a single ligand platform. In this manner, complexation of the N-donors 
and external carboxylates to two iron atoms could afford dinuclear complexes with the same 
ligand arrangement as sMMOHred and similar protein active sites. Our early attempts using this 
strategy were encouraging,24,25 but the diiron(II) compounds were too kinetically labile to 
maintain their dinuclear structure after reaction with O2. To circumvent this problem, we 
designed ligands containing either phenoxylpyridyl (H2L) or phenoxylimine (H2BIPS) chelating 
groups that are anionic when deprotonated and form stable six-membered chelate rings when 
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bound to iron (Chart 3.1).26 Unfortunately, as discussed in Chapter 2, these constructs 
spontaneously assembled into bis(syn N-donor)diiron complexes when treated with iron(II) salts.  
In the present study, we prepared and investigated the iron chemistry of a new 
phenoxylimine ligand (H2PIM), which structurally resembles our previous ligand designs but is 
more preorganized due to its macrocyclic nature (Chart 3.1). We used H2PIM and sterically-
hindered carboxylates to synthesize the first accurate structural models of the diiron(II) active 
sites of bacterial multi-component monooxygenases. We also report some novel chemistry of 
these synthetic units, including their reactions with dioxygen and other chemical oxidants.  
 
3.2. Experimental 
Materials and Methods. Reagents obtained from Strem, Aldrich Chemical Co., and Alfa Aesar 
were used as received. The compounds 2,6-bis(p-tolyl)benzoic acid27 (ArTolCO2H, also referred 
to as terphenylcarboxylic acid for simplicity) and [Fe2(Mes)4]28 (Mes = 2,4,6-trimethylphenyl) 
were prepared as reported. All 57Fe-enriched compounds were prepared exactly as described for 
the unenriched analogues, except that [57Fe2(Mes)4] was used as the starting material. All air-
sensitive manipulations were performed using standard Schlenk techniques or under a nitrogen 
atmosphere inside an MBraun drybox. Solvents were saturated with argon and purified by 
passage through two columns of activated alumina. Dioxygen gas used in these experiments was 
obtained from a high-purity gas cylinder (Airgas) and passed through a 10-inch column of 
activated alumina before use. 
General Physical Methods. NMR spectra were recorded on 500 MHz Varian Mercury 
spectrometers and chemical shifts for 1H and 13C spectra were referenced to residual solvent. 1H 
NMR spectral data of paramagnetic compounds were obtained by widening the sweep window 
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(+100 to -30 ppm) and collecting for longer acquisition times (~1024 scans). IR spectra were 
recorded on a ThermoNicolet Avatar 360 spectrophotometer with the OMNIC software. 
Absorption spectra were recorded on a Cary 50 spectrophotometer using 6Q Spectrosil quartz 
cuvettes (Starna) with 1 cm path lengths. X-band EPR spectra were recorded at 5 K on a Bruker 
EMX spectrometer. Electrochemical measurements were performed with a VersaSTAT3 
Princeton Applied Research potentiostat running the V3-Studio electrochemical analysis 
software. A three-electrode setup was employed comprising a platinum working electrode, a 
platinum wire auxiliary electrode, and a 0.1 M Ag/AgNO3 solution in acetonitrile as the 
reference electrode. Tetra-n-butylammonium hexafluorophosphate (0.1 M) was used as the 
supporting electrolyte. Electrochemical potentials are referenced externally to the 
ferrocene/ferrocenium couple at 0.00 V.  
X-ray Data Collection and Refinement. Single crystals were mounted in Paratone oil using 30 
µm aperture MiTeGen MicroMounts (Ithaca, NY) and frozen under a 100 K KRYO-FLEX 
nitrogen cold stream. Data were collected on a Bruker SMART APEX CCD X-ray 
diffractometer with Mo Kα radiation (λ = 0.71073 Å) controlled by the APEX 2 (v. 2010.1-2) 
software package. Data reduction was performed using SAINT and empirical absorption 
corrections were applied using SADABS.29 The structures were solved by Patterson methods 
with refinement by full-matrix least squares based on F2 using the SHELXTL-97 software 
package30 and checked for higher symmetry by the PLATON software.31 All non-hydrogen 
atoms were located and refined anisotropically. Hydrogen atoms were fixed to idealized 
positions unless otherwise noted and given thermal parameters equal to either 1.5 (methyl 
hydrogen atoms) or 1.2 (non-methyl hydrogen atoms) times the thermal parameters of the atoms 
to which they are attached. 
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 X-ray diffraction quality crystals were selected out of the crystallization vials and 
immediately immersed in degassed Partone oil to prevent solvent loss and reaction with air. 
Complex 1 contains both benzene and pentane molecules in the asymmetric unit. Three of the 
benzene molecules were refined with full occupancy, whereas one of the benzene rings was 
substitutionally disordered with pentane. The benzene-to-pentane ratio refined to 55:45. The 
structure of 2 shows significant thermal motion within the tolyl groups of the 
terphenylcarboxylate ligands in the solid state, as indicated by the larger anisotropic 
displacement parameters of their carbon atoms compared to those of the rest of the molecule. 
Several solvent molecules were located in the crystal structure of 2. In each asymmetric unit 
there are 1.39 pentane and 0.45 dichloromethane molecules. A pentane that is located on an 
inversion center shares partial occupancy with a pentane that does not lie on a special position. 
Another pentane molecule shares partial occupancy with dichloromethane, with a 
pentane/dichloromethane ratio of 39:45. The silver atom in 3 occupies two positions and is 
coordinated to O(6) of a bridging hydroxide, O(5) of the PIM2- ligand, and an arene ring of the 
terphenylcarboxylate ligand. Because the H atoms of the bridging hydroxo groups in 3 could not 
be located from the difference electron density map, the hydrogen atoms attached to O(6) and 
O(7) were not included in the structure refinement. Four dichloromethane molecules per diiron 
complex occur in the structure of 3, three of which are ordered and one is disordered. Complex 4 
was unambiguously assigned as a (µ-hydroxo)diiron species because electron density 
corresponding to the hydrogen atom of O(6) was located from the difference electron density 
map. The asymmetric unit of 4 also contains two ordered and one disordered benzene molecules. 
The center of the tetranuclear complex 5 lies on an inversion center; thus, there is only half of the 
molecule in the asymmetric unit. In addition, there are four benzene molecules per asymmetric 
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cell. The structure of 6/7 clearly shows two different diiron cores, one containing a single 
bridging oxygen atom and another containing two bridging oxygen atoms. The occupancy of the 
one vs. two oxygen bridges was refined to be 76% to 24%, respectively. Each 6/7 unit also 
contains two ordered and one disordered acetonitrile solvent molecules. Complete X-ray 
refinement data for complexes 1-3 and 4-7 are shown in Tables 3.1 and 3.4, respectively. 
57Fe Mössbauer Spectroscopy. Mössbauer spectra were recorded on an MSI spectrometer 
(WEB Research Company) with a 57Co source in a Rh matrix maintained at room temperature. 
Solid samples were prepared by suspension of the complex (~5-40 mg, depending on whether 
the complex is enriched in 57Fe) in Apiezon M grease and placed in a nylon sample holder. 
Solution samples were prepared by freezing 400 µL of the complex (~20 mM) in a nylon sample 
cup and sealing with a screw cap. Samples containing natural abundance iron were measured 
over the course of ~5 d, whereas samples that are enriched in 57Fe were collected over ~12 h. 
Data were acquired at 80 K, and isomer shift (δ) values are reported with respect to metallic iron 
that was used for velocity calibration at room temperature. Spectra were fit to Lorentzian lines 
using the WMOSS plot and fit program.  
Synthesis 
3,3'-(Oxybis(methylene))bis(bromobenzene) (A). 3-Bromobenzylalcohol (3.72 g, 20 mmol) 
was dissolved in 50 mL of dry THF and cooled to 0 °C with an ice bath. Solid sodium hydride 
(0.96 g, 24 mmol, 60% dispersion in mineral oil) was added portionwise to the reaction flask and 
the mixture was stirred for 1 h. Liquid 3-bromobenzylbromide (5.0 g, 20 mmol) was then added 
and the solution was stirred at reflux for 12 h. Water was then slowly introduced to quench the 
reaction and the organic phase was extracted into diethyl ether, dried over Na2SO4, filtered, and 
evaporated to yield a light yellow oil (7.12 g, 99%). This material was determined to be > 98% 
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pure by NMR spectroscopy and gas chromatography. 1H NMR (CDCl3, 500 MHz): δ 7.56 (s, 
2H), 7.46 (d, J = 9.0 Hz, 2H), 7.31 (d, J = 7.5 Hz, 2H), 7.25 (t, J = 8.0 Hz, 2H), 4.53 (s, 4H) 
ppm. 13C NMR (CDCl3, 125 MHz): δ 140.38, 130.82, 130.62, 130.16, 126.18, 122.64, 71.82 
ppm. GC-MS = 356 [M]+ (Calcd = 355.9 [M]+). 
2,2'-((Oxybis(methylene))bis(5-methyl-(1,1'-biphenyl)-3',2-diyl))bis(oxy)bis(tetrahydro-2H-
pyran) (B). 2-(2-Bromo-4-methylphenoxy)-tetrahydro-2H-pyran32 (16.5 g, 61.1 mmol) was 
dissolved in 250 mL of dry THF and cooled to -78 °C. The solution was treated with n-
butyllithium (38 mL, 1.6 M in hexanes) and stirred for 2 h, giving a white slurry. A 50 mL 
solution of zinc chloride (6.66 g, 61.1 mmol) in THF was transferred by cannula to the reaction 
flask. After 1 h, the solution became nearly homogeneous. The reaction flask was charged with 
compound A (10.0 g, 28.1 mmol) and Pd(PPh3)4 (3.25 g, 2.81 mmol) and refluxed for 2 d. Once 
the reaction was complete, the solution was evaporated to dryness and the crude material was 
purified by silica gel column chromatography (5:95 ethyl acetate/hexanes) to afford a colorless 
oil (5.7 g, 35%). 1H NMR (CDCl3, 500 MHz): δ 7.67 (s, 2H), 7.58 (d, J = 8.0 Hz, 2H), 7.45 (t, J 
= 7.5 Hz, 2H), 7.40 (d, J = 7.5 Hz, 2H), 7.24 (s, 2H), 7.20 (d, J = 8.5 Hz, 2H), 7.15 (d, J = 8.5 
Hz, 2H), 5.42 (t, J = 2.5 Hz, 2H), 4.71 (s, 4H), 3.84 (m, 2H), 3.59 (m, 2H), 2.39 (s, 6H), 1.89 (m, 
2H), 1.76 (m, 4H), 1.67 (m, 2H), 1.54 (m, 4H) ppm. 13C NMR (CDCl3, 125 MHz): δ 151.80, 
138.95, 137.85, 131.46, 131.30, 131.28, 129.22, 129.09, 129.00, 127.93, 126.28, 116.12, 96.89, 
72.44, 61.76, 30.35, 25.34, 20.70, 18.54 ppm. 
Bis(3-(2-hydroxy-5-methylphenyl)benzyl)ether (C). Compound B (0.90 g, 1.56 mmol) and 
oxalic acid (0.35 g, 3.89 mmol) were dissolved in 10 mL of THF/MeOH (1:1). The mixture was 
stirred at ~50 °C for 2 h and then evaporated to dryness. Dichloromethane (10 mL) was added 
and the mixture was washed with water (3 x 10 mL). The organic layer was dried over Na2SO4, 
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filtered, and the solvent was removed in vacuo to give an off-white solid. The solid was washed 
with hot hexanes to remove a colored impurity and the final product was isolated by filtration 
(0.46 g, 73%). 1H NMR (CDCl3, 500 MHz): δ 7.54 (s, 2H), 7.48 (d, J = 7.5 Hz, 2H), 7.43 (m, 
4H), 7.09 (m, 4H), 6.87 (d, J = 8.0 Hz, 2H), 5.43 (s, 2H), 4.67 (s, 4H), 2.35 (s, 6H) ppm. 13C 
NMR (CDCl3, 125 MHz): δ 151.00, 139.68, 138.43, 131.54, 130.70, 130.33, 129.93, 129.38, 
129.21, 128.50, 127.86, 116.56, 73.02, 21.26 ppm. ESI-MS(–) = 409.1 [M–H]– (Calcd = 409.2 
[M–H]–). Mp = 128-130 °C.  
Bis(3-(2-hydroxy-5-methylphenyl-3-carbaldehyde)benzyl)ether (D). All reagents and 
solvents should be rigorously dried before use in this reaction. Compound C (2.44 g, 5.95 
mmol), anhydrous magnesium chloride (2.26 g, 23.8 mmol), paraformaldehyde (2.68 g, 89.2 
mmol), and triethylamine (5 mL, 35.7 mmol) were combined in 200 mL of dry acetonitrile and 
refluxed for 3 d. The reaction completeness was determined by the disappearance of starting 
material as monitored by silica gel thin layer chromatography. The mixture was evaporated to 
dryness and the residue was dissolved in dichloromethane. The organic phase was washed with 
aqueous HCl, dried over Na2SO4, filtered, and evaporated to dryness, giving a pale yellow oil. 
After purification by silica gel column chromatography (10:90 ethyl acetate/hexanes), the desired 
product was obtained an a light yellow oil (1.7 g, 61%). 1H NMR (CDCl3, 500 MHz): δ 11.37 (s, 
2H, CHO), 9.91 (s, 2H, OH), 7.62 (s, 2H), 7.56 (d, J = 7.5 Hz, 2H), 7.48-7.41 (m, 6H), 7.35 (d, J 
= 1.5 Hz, 2H), 4.69 (s, 4H), 2.39 (s, 6H) ppm. 13C NMR (CDCl3, 125 MHz): δ 197.06, 157.84, 
139.13, 138.55, 136.01, 133.25, 130.25, 129.39, 128.89, 128.88, 128.60, 127.31, 120.03, 72.38, 
20.55 ppm. ESI-MS(–) = 465.3 [M–H]– (Calcd = 465.2 [M–H]–).  
H2PIM. Compound D (1.70 g, 3.65 mmol) was dissolved in 10 mL of dichloromethane and 
combined with 3,3ʹ -diaminodiphenylsulfone (0.90 g, 3.65 mmol) in 700 mL of dry acetonitrile. 
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About 1 mL of trifluoroacetic acid was added and the mixture was refluxed for 6 h. Over the 
course of ~1 h, a large amount of bright yellow-orange material formed. The solid was isolated 
by filtration and washed with diethyl ether to afford analytically pure product (1.80 g, 72%). 1H 
NMR (CDCl3, 500 MHz): δ 13.16 (s, 2H), 8.63 (s, 2H), 7.89 (d, J = 9.5 Hz, 2H), 7.80 (m, 2H), 
7.73 (s, 2H), 7.67 (t, J = 8.0 Hz, 2H), 7.44 (m, 4H), 7.39 (m, 4H), 7.28 (m, 2H), 7.21 (s, 2H), 
4.69 (s, 4H), 2.36 (s, 6H) ppm. 13C NMR (CDCl3, 125 MHz): δ 164.78, 156.69, 149.82, 143.08, 
138.09, 137.72, 136.08, 132.20, 130.72, 130.32, 129.57, 128.69, 128.51, 128.30, 127.06, 125.30, 
123.73, 123.59, 118.85, 73.03, 20.61 ppm. IR (KBr): v 2852, 1620, 1579, 1472, 1454, 1427, 
1326, 1302, 1211, 1148, 1092, 886, 783, 700, 689, 620, 524 cm-1. DART-MS(–) = 677.2121 
(Calc = 677.2116 [M–H]–). Mp = 313-315 °C. 
[57Fe2(Mes)4]. A small-scale synthesis of 57-iron enriched [Fe4(Mes)4] was undertaken using a 
procedure adapted from the literature.28,33,34 57-Iron metal (200 mg, 3.51 mmol, 95% enriched) 
was suspended in 4.0 mL of concentrated aqueous hydrochloric acid. The mixture was heated to 
90 °C for ~4 h without using a stir bar, leading to dissolution of the iron metal and eventual 
formation of a clear brown solution. The reaction is not complete if the solution is yellow; 
further air oxidation must occur to convert iron(II) chloride to iron(III) chloride. Once the 
reaction is complete, aqueous HCl was removed in vacuo (without heating) to give a pale yellow 
solid. The solid was transferred to a 10 mL Schlenk flask under a nitrogen atmosphere and 
treated with 3 mL of freshly distilled thionyl chloride to dehydrate the iron(III) chloride. The 
mixture was heated at 80 °C for 30 min until the solid turned black. Excess thionyl chloride was 
removed by pumping on the black solid under vacuum for 3 h. About 10 mL of dry 
chlorobenzene was added to the reaction flask and the slurry was refluxed for 30 min to give a 
brown suspension, which indicates conversion of anhydrous iron(III) chloride to iron(II) 
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chloride. The septum-sealed reaction flask was brought inside an anaerobic glovebox for 
subsequent manipulations. The tan-colored solid was isolated by filtration and washed with 
toluene. This material was re-suspended in 3 mL of dry THF and stirred for 30 min until the 
brown solution became a beige color. An off-white solid was isolated by filtration as the desired 
57FeCl2(THF)1.5 precursor (571 mg, 53%).34  
 Inside an anaerobic drybox, a mesitylene Grignard reagent was prepared by combining 2-
bromomesitylene (1.02 g, 5.12 mmol) and magnesium metal (123 mg, 5.12 mmol) in 2 mL of 
dry THF. After ~ 5 h, most of the magnesium had dissolved and the solution became a pale light 
brown color. The Grignard reagent was placed inside a -30 °C freezer and allowed to cool. In a 
separate vial, solid 57FeCl2(THF)1.5 (571 mg, 2.14 mmol) was suspended in 3 mL of 
tetrahydrofuran /1,4-dioxane (1:1) that has been cooled to -30 °C. The cold Grignard reagent was 
added over a 5 min period to the iron solution. The reaction mixture was stirred and allowed to 
warm slowly to RT. As the reaction progressed, the light brown slurry became a red color. After 
2 h, a solid precipitate was removed by filtration and the filtrate was evaporated to dryness. The 
dried residue was extracted into diethyl ether, filtered, and placed inside a -30 °C freezer to 
crystallize over the course of ~14 h. A large amount of red crystalline material was isolated by 
filtration and dried to give [57Fe2(Mes)4] as a red powder (430 mg, 60%). The spectroscopic 
characteristics of this compound are identical to those reported for [Fe2(Mes)4].28 This product 
was stored at -30 °C inside the glovebox to prevent oxidation and thermal degradation. 
[Fe2(PIM)(Ph3CCO2)2] (1). In an anaerobic drybox, solid H2PIM (100 mg, 147 µmol) and 
triphenylacetic acid (85 mg, 295 µmol) were dissolved in 2.0 mL of tetrahydrofuran. A 1.0 mL 
solution of tetrahydrofuran containing [Fe2(Mes)4] (86 mg, 147 µmol) was added to the reaction 
vessel and the mixture was stirred for 1 h. The dark red solution was evaporated to dryness and 
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the residue was redissolved in benzene. The solution was filtered through a glass wool plug and 
layered with pentane. After ~12 h, a large amount of red crystals had formed that were suitable 
for X-ray diffraction analysis. The solid material was isolated by filtration and washed with 
pentane to give the desired diiron complex (171 mg, 86%). 1H NMR (C6D6, 500 MHz): δ 78.37, 
74.97, 48.27, 22.78, 8.20-1.19, -5.32, -6.20, -10.37, -13.49, -21.13 ppm. IR (KBr): v 3056, 3031, 
2918, 2850, 1578, 1545, 1490, 1444, 1418, 1378, 1322, 1304, 1284, 1200, 1175, 1152, 1097, 
1085, 1036, 985, 790, 745, 699, 673, 547 cm-1. UV-vis (CH2Cl2): λmax = 290 (36,300  
M-1cm-1), and 410 (16,000 M-1cm-1) nm. Anal. Calcd. for Fe2C82H62N2O9S·(C4H8O) (1·THF): C, 
71.97; H, 4.92; N, 1.95; Found: C, 71.80; H, 4.94; N, 2.22. Mp (decomp) = 302 °C. Mössbauer 
(polycrystalline, apiezon M grease): δ1 = 1.18(2) mm/s, ΔEQ1 = 2.33(2) mm/s, Γ(1, L/R) = 0.38(2) 
mm/s, Site 1 Area = 53%; δ2 = 0.97(2) mm/s, ΔEQ2 = 2.25(2) mm/s, Γ(2, L/R) = 0.35(2) mm/s, Site 
2 Area = 47%.  
[Fe2(PIM)(ArTolCO2)2] (2). The synthesis of [Fe2(PIM)(ArTolCO2)2] was performed as described 
for [Fe2(PIM)(Ph3CCO2)2] (1), except that ArTolCO2H was used instead of Ph3CCO2H. The 
product crystallized upon slow diffusion of pentane into a solution of the complex in 
dichloromethane and was isolated as a red powder when dried (152 mg, 74%). X-ray diffraction 
quality crystals were readily obtained by slow diffusion of pentane into a dichloromethane 
solution of the complex. 1H NMR (CD2Cl2, 500 MHz): δ 76.92, 73.82, 49.00, 24.68, 7.86, 7.31, 
6.22, 2.41, 1.37, 0.96, -0.41, -1.81, -5.72, -9.04, -19.60 ppm. IR (KBr): v 3052, 3024, 2912, 
2851, 1614, 1577, 1533, 1445, 1413, 1381, 1302, 1286, 1202, 1149, 1073, 819, 791, 712, 695, 
542 cm-1. UV-vis (CH2Cl2): λmax = 290 (36,700 M-1cm-1), and 418 (14,000 M-1cm-1) nm. Anal. 
Calcd. for Fe2C84H66N2O9S·(C4H8O) (2·THF): C, 72.23; H, 5.10; N, 1.91; Found: C, 71.72; H, 
4.92; N, 2.17. Mp (decomp) = 240 °C. Mössbauer (polycrystalline, apiezon M grease): δ1 = 
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1.10(2) mm/s, ΔEQ1 = 2.04(2) mm/s, Γ(1,L/R) = 0.38(2) mm/s, Site 1 Area = 63%; δ2 = 0.95(2) 
mm/s, ΔEQ2 = 2.02(2) mm/s, Γ(2, L/R) = 0.32(2) mm/s, Site 2 Area = 37%.  
[Fe2(µ-OH)2(ClO4)2(PIM)(ArTolCO2)Ag] (3). In an anaerobic drybox, [Fe2(PIM)(ArTolCO2)2] 
(2) (50 mg, 35 µmol) and silver perchlorate (18 mg, 90 µmol) were combined in 2 mL of 
dichloromethane and stirred for 1 h. The reaction mixture was filtered through a glass wool plug 
to remove a black precipitate. The solution was concentrated to half its volume and layered with 
0.5 mL of pentane. After ~14 h, a dark solid formed on the bottom of the reaction vial. This 
product was isolated by filtration, yielding a dark crystalline solid (31 mg, 61%). Crystals 
suitable for X-ray diffraction studies were obtained by slow diffusion of pentane into a solution 
of the complex in dichloromethane. IR (KBr): v 3432, 2919, 2851, 1579, 1546, 1521, 1472, 
1446, 1382, 1337, 1306, 1285, 1200, 1181, 1152, 1122, 1020, 796, 603, 548, 530 cm-1. UV-vis 
(CH2Cl2): λmax = 290 (32,300 M-1cm-1), 375 (11,100 M-1 cm-1), 479 (sh, 3,300 M-1cm-1), 600 
(2,300 M-1cm-1). Anal. Calcd. for Fe2C63H51AgCl2N2O17S·(CH2Cl2) (3·CH2Cl2): C, 50.72; H, 
3.52; N, 1.85; Cl, 9.36; Found: C, 51.04; H, 3.64; N, 1.77; Cl, 9.23. Mp (decomp) = ~270 °C. 
Mössbauer (THF): δ = 0.49(2) mm/s, ΔEQ = 1.38(2) mm/s, Γ(L/R) = 0.56(2) mm/s. 
[Fe2(µ-OH)(PIM)(Ph3CCO2)3] (4). In an anaerobic drybox, solid [Fe2(PIM)(Ph3CCO2)2] (1) (30 
mg, 22 µmol), triphenylacetic acid (13 mg, 44 µmol), and triethylamine (6.0 µL) were combined 
in 2.0 mL of benzene. The reaction vial was sealed with a septum, brought outside of the 
glovebox, and bubbled with dioxygen for 5 min. When exposed to O2, the clear red solution 
quickly turned dark brown. Upon vapor diffusion of pentane into the benzene solution, several 
large X-ray diffraction quality crystals were obtained. The product was isolated by filtration (8 
mg, 22%). 1H NMR (CDCl3, 500 MHz): δ 51.28, 44.24, 33.02, 29.70, 23.90, 6.60, -4.52, -7.85 
ppm. IR (KBr): v 3438, 3056, 3032, 2919, 1582, 1544, 1491, 1477, 1446, 1405, 1373, 1331, 
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1205, 1150, 1035, 827, 789, 744, 699, 677, 642, 604, 547, 523 cm-1. UV-vis (CH2Cl2): λmax = 
284 (108,000 M-1 cm-1), 372 (38,000 M-1cm-1), and 570 (10,300 M-1cm-1) nm. Anal. Calcd. for 
Fe2C102H78N2O12S·(C6H6)(NC6H15)2 (4·C6H6·(NEt3)2): C, 73.99; H, 5.90; N, 2.88; Found: C, 
74.40; H, 5.66; N, 3.22. Mp = 214-217 °C. Mössbauer (polycrystalline, apiezon M grease): δ = 
0.52(2) mm/s, ΔEQ = 0.95(2) mm/s, Γ(L/R) = 0.38(2) mm/s. 
[Fe4(µ-OH)6(PIM)2(Ph3CCO2)2] (5). In an anaerobic drybox, solid [Fe2(PIM)(Ph3CCO2)2] (1) 
(40 mg, 29 µmol) was combined with 2.0 mL of benzene in a septum-sealed reaction vessel. 
Dioxygen was bubbled through the mixture for 5 min. The solution was concentrated to 
approximately half its volume and then left alone to crystallize over ~1 d by slow evaporation. 
This method resulted in selective crystallization of the desired tetranuclear [Fe4(µ-
OH)6(PIM)2(Ph3CCO2)2] (5) (hexagonal prisms) instead of the dinuclear [Fe2(µ-
OH)(PIM)(Ph3CCO2)3] (4) (rectangular blocks). Crystals obtained from this method were 
suitable for X-ray diffraction studies. The desired product was isolated by filtration (10 mg, 
32%). 1H NMR (CDCl3, 500 MHz): δ 49.97, 43.69, 31.24, 15.60, 8.71, 5.94, 5.31, 4.14, -7.12 
ppm. IR (NaCl): v 3554, 3445, 3064, 2961, 2921, 2850, 1580, 1542, 1381, 1340, 1324, 1260, 
1238, 1204, 1151, 1101, 1080, 1017, 984, 800, 789, 747, 738, 705, 692, 671, 633, 528, 416 cm-1. 
UV-vis (CH2Cl2): λmax = 280 (84,200 M-1cm-1), 370 (25,000 M-1cm-1), and 540 (8,060 M-1cm-1) 
nm. Anal. Calcd. for Fe4C124H100N4O20S2 (5): C, 66.09; H, 4.47; N, 2.49; Found: C, 66.09; H, 
4.50; N, 2.14. Mp (decomp) = >300 °C. Mössbauer (polycrystalline, apiezon grease): δ = 0.51(2) 
mm/s, ΔEQ = 1.06(2) mm/s, Γ(L/R) = 0.40(2) mm/s. 
[Fe2(µ-O)(PIM)(ArTolCO2)2] (6)/ [Fe2(µ-OH)2(PIM)(ArTolCO2)2] (7). In an anaerobic drybox, 
[Fe2(PIM)(ArTolCO2)2] (2) (200 mg, 144 µmol) was dissolved in 2 mL of tetrahydrofuran in a 20 
mL vial. The vial was sealed with a rubber septum and brought outside of the drybox. Dioxygen 
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was bubbled through the reaction vial for 5 min, at which time the red solution became a dark 
brown. The tetrahydrofuran solvent was removed in vacuo and the resulting brown solid (117 
mg, 58%) was isolated and stored inside the drybox to prevent further reaction with ambient 
moisture. Single crystals suitable for X-ray diffraction analysis were obtained by slow diffusion 
of diethyl ether into a solution of the complex in acetonitrile. 1H NMR (CDCl3, 500 MHz): δ 
26.30, 24.44, 21.84, 13.52, 15.92, 14.77, 11.56, 10.08, 9.58, 8.22, 5.44, 4.86, 4.26, 2.16, 1.80, 
1.25, 0.88, -7.11 ppm. IR (KBr): v 3448, 3021, 2918, 2856, 1613, 1582, 1545, 1515, 1473, 1448, 
1383, 1336, 1304, 1286, 1205, 1152, 818, 791, 766, 700, 546, 531 cm-1. UV-vis (CH2Cl2): λmax = 
380 (sh), 473, 600 nm. Anal. Calcd. for Fe2C84H68N2O11S·(CH3CN) (6·CH3CN): C, 70.45; H, 
4.88; N, 2.87. Anal. Calcd. for Fe2C84H66N2O10S·(CH3CN) (7·CH3CN): C, 71.32; H, 4.80; N, 
2.90. Found: C, 69.89; H, 4.76; N, 2.59. As discussed in the text, compounds 6 and 7 exist as a 
mixture in the solid-state. Mp (decomp) = >300 °C. Mössbauer (polycrystalline, apiezon M 
grease): δ1 = 0.47(2) mm/s, ΔEQ1 = 1.52(2) mm/s, Γ(1, L/R) = 0.36(2) mm/s, Site 1 Area = 21%; δ2 
= 0.50(2) mm/s, ΔEQ2 = 0.97(2) mm/s, Γ(2,L/R) = 0.48(2) mm/s, Site 2 Area = 79%; 
[Fe4(µ-OH)6(PIM)2(ArTolCO2)2] (8). Solid [Fe2(PIM)(ArTolCO2)2] (2) (200 mg, 144 µmol) was 
dissolved in 2.0 mL of benzene and stirred under dioxygen for 5 min, giving a dark brown 
solution. About 10 µL of water was then added to the reaction mixture and the solution was 
stirred for an additional 10 min, then filtered through a glass wool plug before the filtrate was 
evaporated to dryness. The remaining solid was isolated as a pale brown material (~120 mg, 
73%). 1H NMR (DMF-d7, 500 MHz): δ 72.80, 45.00, 26.24, 14.48, 13.26, 10.40, 7.30-0.12, -
3.16, -4.65, -11.36 ppm. IR (KBr): v 3432, 3019, 2919, 2857, 1614, 1584, 1543, 1516, 1473, 
1450, 1385, 1324, 1304, 1286, 1206, 1151, 791, 703, 586, 528 cm-1. UV-vis (CH2Cl2): λmax = 
360 (81,700 M-1cm-1), 550 (17,100 M-1cm-1) nm. Anal. Calcd. for Fe4C126H104N4O20S2·(C6H6)2 
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(8·(C6H6)2): C, 67.99; H, 4.80; N, 2.30; Found: C, 67.92; H, 4.80; N, 2.43. Mp (decomp) = >300 
°C. Mössbauer (THF): δ = 0.49(2) mm/s, ΔEQ = 0.97(2) mm/s, Γ(L/R) = 0.44(2) mm/s. 
 
3.3. Results 
 Ligand Design and Synthesis. A feature of our previous syn N-donor ligands, such as 
H2L and H2BIPS (Chart 3.1), is that their metal-binding units can rotate in such a manner as to 
permit spontaneous self-assembly of undesired bis(syn N-donor)diiron(II) complexes following 
treatment with a base and iron(II) salts.26,35 Molecular modeling studies suggested to us that by 
joining the phenyl rings of H2L or H2BIPS with an appropriate linker to form a macrocycle, it 
would not be possible to generate [Fe2(syn N-donor)2] species. To test this hypothesis, we 
designed and synthesized H2PIM (Chart 3.1), using as the linker a three-atom ether moiety.  
 
Scheme 3.2. i. a) NaH, dry THF, b) 3-bromobenzylbromide; ii. a) Aryl zinc reagent: 2-(2-bromo-
4-methylphenoxy)-tetrahydro-2H-pyran, n-butyllithium, ZnCl2, THF, b) Pd(PPh3)4; iii. oxalic 
acid, THF/MeOH (1:1), 50 °C; iv. anhydrous MgCl2, paraformaldehyde, NEt3, CH3CN, reflux; v. 
3,3ʹ -diaminodiphenylsulfone, trifluoroacetic acid, dry CH3CN. 
 
The H2PIM ligand was prepared as indicated in Scheme 3.2. The dibenzyl ether linker A 
was obtained by reaction of 3-bromobenzyl alcohol with sodium hydride, followed by refluxing 
with 3-bromobenzylbromide. To prepare compound B, a palladium catalyzed, Negishi cross-
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coupling procedure was employed. After silica gel column chromatography, B was isolated as a 
colorless oil. Next, the tetrahydropyran protecting group of B was removed by treatment with 
oxalic acid in tetrahydrofuran/methanol to afford C as a white solid. Orthoformylation of C was 
achieved by treatment with anhydrous magnesium chloride, paraformaldehyde, and triethylamine 
to give D as a yellow oil. To prepare H2PIM, D was condensed with 3,3ʹ -
diaminodiphenylsulfone, generating the desired product as a bright yellow-orange solid in good 
yield. The synthetic route for H2PIM is amenable to scale-up, and the final ligand has been 
obtained in multi-gram quantities.  
  Assembly of Diiron(II) Complexes. The phenolate-to-iron charge transfer band is a 
useful spectroscopic probe for quantitating metal–ligand binding.26 A previous study 
demonstrated that the non-macrocyclic syn N-donors L2- and BIPS2-, the doubly deprotonated 
forms of H2L and H2BIPS (Chart 3.1), respectively, react with iron in a 1:1 ratio to form [Fe2(syn 
N-donor)2] species. To test whether PIM2-, the doubly deprotonated form of H2PIM, exhibits 
different metal binding behavior, iron(II) titration experiments were conducted. When H2PIM 
was treated with 2 equiv of sodium hexamethyldisilazide (NaHMDS) in tetrahydrofuran, optical 
bands at 240, 280, and 420 nm appeared, corresponding to formation of PIM2-. Addition of 
iron(II) triflate to the PIM2- solution decreased the intensity of the 240 and 420 nm bands, with 
concomitant absorption increases at 280 and 375 nm (Figure 3.1A). A plot of the absorbance 
changes at 375 nm revealed an Fe-to-PIM2- ratio of 2:1 (Figure 3.1B), consistent with binding of 
two iron atoms by each macrocycle to give [Fe2(PIM)(SO3CF3)2]. To examine further the nature 
of this diiron species, titration experiments were conducted using external carboxylates. Addition 
of sodium triphenylacetate to a solution containing [Fe2(PIM)(SO3CF3)2] generated new 
absorption features at 410 and 600 nm (Figure 3.1C). A plot of the absorbance changes at 410 
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nm indicated that carboxylates readily displace the triflate anions (Figure 3.1D). These results 
suggested that H2PIM is a dinucleating ligand that supports a carboxylate-bridged diiron(II) 
structure.  
 
Figure 3.1. Optical changes upon addition of Fe(SO3CF3)2(CH3CN)2 to a 24 µM solution of 
PIM2- in THF (A). Absorbance change at 375 nm clearly shows a 1:2 macrocycle to iron binding 
stoichiometry (B). Addition of sodium triphenylacetate to a THF solution containing PIM2-/ 2 
Fe(SO3CF3)2(CH3CN)2 led to absorption increases at ~410 and 600 nm (C). The single 
wavelength plot at 410 nm (D). Panel A: black line = Na2PIM, colored lines = spectra after 
addition of up to 2.50 equiv of Fe(II). Panel C: black line = [Fe2(PIM)(SO3CF3)2], colored lines = 
spectra after addition of up to 5.0 equiv of NaO2CCPh3. 
 
 
 Preparative scale reactions were performed to metalate H2PIM by treatment with 
[Fe2(Mes)4] and a sterically-hindered carboxylic acid, triphenylacetic acid or terphenylcarboxylic 
acid. A diiron(II) complex containing triphenylacetate was crystallized by slow diffusion of 
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pentane into a solution of the compound in benzene. X-ray diffraction studies revealed a 
dinuclear complex having the molecular formula [Fe2(PIM)(Ph3CCO2)2] (1, Figure 3.2, Table 
3.1). The structure indicates that the PIM2- ligand coordinates to two iron atoms that are bridged 
by two triphenylacetates, one of which is bound in an η1,η1-1,3 coordination mode and the other 
in an η1,η2-1,3 arrangement. The Fe–O(carboxylate) distances range from 2.00 to 2.25 Å. The 
four- and five-coordinate iron atoms are separated by 3.61 Å, with average Fe–O(phenolate) and 
Fe–N(imine) distances of 1.88 and 2.04 Å, respectively.  
 
Figure 3.2. Ortep thermal ellipsoid (50%) diagram of the X-ray crystal structure of 
[Fe2(PIM)(Ph3CCO2)2] (1, left). An isolated view of the diiron core is shown as a stick figure 
representation on the right. Solvent molecules and hydrogen atoms are omitted for clarity. Color 
scheme: iron, orange; carbon, gray; nitrogen, blue; oxygen, red; sulfur, yellow. Selected bond 
distances (Å) and angles (Deg): Fe(1)–Fe(2) = 3.610; Fe(1)–N(1) = 2.048; Fe(1)–O(2) = 1.877; 
Fe(1)–O(7) = 1.999; Fe(1)–O(8) = 2.016; Fe(2)–N(2) = 2.039; Fe(2)–O(1) = 1.892; Fe(2)–O(7) = 
2.254; Fe(2)–O(6) = 2.153; Fe(2)–O(9) = 2.024; O(2)–Fe(1)–N(1) = 92.5; O(1)–Fe(2)–N(2) = 
92.4; O(7)–Fe(1)–O(8) = 103.7; O(7)–Fe(2)–O(9) = 89.1. 
 
When the terphenylcarboxylate anion ArTolCO2– was employed in an analogous synthetic 
procedure, crystallization by slow diffusion of pentane into a saturated dichloromethane solution 
of the compound yielded [Fe2(PIM)(ArTolCO2)2] (2, Figure 3.3, Table 3.1). The X-ray structure 
of this compound revealed a dinuclear core that closely resembles the one in 1. The iron atoms in 
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2 are bridged by two terphenylcarboxylate ligands, with Fe–O(carboxylate) distances of 2.00 to 
2.34 Å. This diiron unit is supported by the syn N-donor macrocycle, resulting in Fe–
O(phenolate) and Fe–N(imine) distances of 1.89 and 2.04 Å, respectively. The Fe–Fe distance in 
2 is 3.61 Å, the same as in 1. Compounds 1 and 2 have structures with features remarkably close 
to those at the active sites of sMMOHred,18 mimicking the syn arrangement of nitrogen donor 
atoms as well as the asymmetric bridging mode of carboxylates at the diiron(II) center.  
 
Figure 3.3. Ortep thermal ellipsoid (50%) diagram of the X-ray crystal structure of 
[Fe2(PIM)(ArTolCO2)2] (2, left). An isolated view of the diiron core is shown as a stick figure 
representation on the right. Solvent molecules and hydrogen atoms are omitted for clarity. Color 
scheme: iron, orange; carbon, gray; nitrogen, blue; oxygen, red; sulfur, yellow. Selected bond 
distances (Å) and angles (Deg): Fe(1)–Fe(2) = 3.610; Fe(1)–O(1) = 1.888; Fe(1)–N(1) = 2.037; 
Fe(1)–O(6) = 1.998; Fe(1)–O(8) = 2.028; Fe(2)–O(2) = 1.894; Fe(2)–N(2) = 2.045; Fe(2)–O(7) = 
2.048; Fe(2)–O(8) = 2.092; Fe(2)–O(9) = 2.342; O(1)–Fe(1)–N(1) = 93.1; O(2)–Fe(2)–N(2) = 
91.8; O(6)–Fe(1)–O(8) = 102.1; O(7)–Fe(2)–O(8) = 89.5. 
 
 
Compounds 1 and 2 were further characterized by several spectroscopic methods (Table 
3.2). As shown in Figure 3.4, they have strong absorption bands in the UV-visible region, with 
λmax values of approximately 290 and 410 nm. The higher energy band is attributed to a π–π* 
ligand transition, whereas the lower energy band is most likely due to ligand-to-metal charge 
transfer.36,37
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Table 3.1. X-ray Data Collection and Refinement Parameters for 1-3. 
 
 1 2 3 
Empirical formula  [Fe2N2O9SC82H62] (C6H6)3.55(C5H12)0.45 
[Fe2N2O9SC84H66] 
(C5H12)1.39(CH2Cl2)0.45 
[Fe2N2O17SC63H49Cl2Ag] 
 (CH2Cl2)4 
Formula weight 1672.84 1525.91 1768.28 
Temperature (K) 100 100 100 
Wavelength (Å) 0.71073 0.71073 0.71073 
Crystal system Triclinic Triclinic Monoclinic 
Space group P  P  Cc 
Unit cell dimensions 
a = 13.3280(9) Å 
b = 17.0039(12) Å 
c = 20.3398(14) Å 
α = 87.4680(10)° 
β = 74.1330(10)° 
γ = 73.7290(10)° 
a = 15.1504(18) Å 
b = 17.190(2) Å 
c = 17.956(2) Å 
α = 117.070(2)° 
β = 92.599(2)° 
γ = 108.544(2)° 
a = 16.6129(8) Å 
b = 20.5472(9) Å 
c = 21.6770(13) Å 
 
β = 107.3760(10)° 
 
Volume (Å3) 4253.7(5) 3846.5(8) 7061.7(6) 
Z 2 2 4 
Calculated density (g/mm3) 1.306 1.317 1.663 
Absorption coefficient (mm-1) 0.428 0.494 1.158 
F(000) 1752 1598 3576 
Crystal size (mm3) 0.33 x 0.10 x 0.05 0.33 x 0.26 x 0.14 0.12 x 0.08 x 0.07 
Θ range for data collection 1.60 to 24.87° 1.31 to 26.49° 1.62 to 25.03° 
Index ranges -15 ≤ h ≤ 15 -20 ≤ k ≤ 20 
-24 ≤ l ≤ 23 
-19 ≤ h ≤ 18 
-21 ≤ k ≤ 21 
-22 ≤ l ≤ 22 
-19 ≤ h ≤ 19 
-24 ≤ k ≤ 24 
-25 ≤ l ≤ 25 
Reflections collected 67231 68754 57426 
Independent reflections 14670 [R(int) = 0.0743] 
15831 
[R(int) = 0.0365] 
12483 
[R(int) = 0.0325] 
Completeness to Θ (%) 99.5 99.3 100.0 
Absorption correction Empirical Empirical Empirical 
Max. and min. transmission 0.9789 and 0.8822 0.9340 and 0.8538 0.9233 and 0.8735 
Data / restraints / parameters 14670/54/1119 15831/207/1023 12483/45/933 
Goodness-of-fit on F
2 
1.016 1.076 1.067 
Final R indices [I>2σ(I)] R1 = 0.0470 wR2 = 0.0906 
R1 = 0.0982 
wR2 = 0.2493 
R1 = 0.0381 
wR2 = 0.1020 
R indices (all data) R1 = 0.0820 wR2 = 0.1029 
R1 = 0.1152 
wR2 = 0.2622 
R1 = 0.0406 
wR2 = 0.1044 
Largest diff. peak and hole 
(eA3) 0.641 and -0.638 1.726 and -1.776 0.907 and -0.909 
* R1 = Σ ∣∣Fo∣–∣Fo∣∣/Σ∣Fo∣; wR2 = [Σ[w(Fo2– Fc2)2]/Σ[w(Fo2)2]]1/2; GOF = [Σ[w(Fo2– Fc2)2]/(n–p)]1/2, where n is the number 
of reflections and p is the total number of parameters refined. 
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Table 3.2. Spectroscopic Data for 1-8. 
 
 
 Optical
a Mössbauerb X-ray 
 λ, nm  [ε, M-1cm-1] 
δ(Fe1)  
[mm/s] 
ΔEQ(Fe1) 
[mm/s] 
Γ(Fe1) 
[mm/s] 
Area(Fe1) 
[%] 
δ(Fe2)  
[mm/s] 
ΔEQ(Fe2) 
[mm/s] 
Γ(Fe2) 
[mm/s] 
Area(Fe2) 
[%] 
Fe–Fe 
(Å) 
1 290 (36,300) 410 (16,000) 1.18 2.33 0.38 53 0.97 2.25 0.35 47 3.61 
2 290 (36,700) 418 (14,000) 
1.10 
1.23* 
2.04 
2.58* 
0.38 
0.57* 
63 
59* 
0.95 
1.15* 
2.02 
1.75* 
0.32 
0.49* 
37 
41* 3.61 
3 
290 (32,300) 
375(11,100) 
479 (3,300, sh) 
600 (2,300) 
0.49* 1.38* 0.56* 100* — — — — 3.01 
4 
284 (108,000) 
372 (38,000) 
570 (10,300) 
0.52 0.95 0.38 100 — — — — 3.49 
5 370 (25,000) 540 (8,060) 0.51 1.06 0.40 100 — — — — 
3.06 
3.78c 
6/7 
380 (sh) 
473  
600 
0.47 
0.46d 
0.51* 
1.52 
1.59d 
1.24* 
0.36 
0.58d 
0.62* 
21 
85d 
61* 
0.50 
0.48d 
0.49* 
0.97 
1.03d 
0.78* 
0.48 
0.34d 
0.44* 
79 
15d 
36* 
3.44 
8 360 (81,700) 550 (17,100) 0.49
* 0.97* 0.44* 100* — — — — — 
aAbsorption spectra were recorded in dichloromethane. bMössbauer spectra were acquired at 80 K; polycrystalline 
samples were prepared by mixing with Apiezon M grease and solution samples, which are marked with an asterisk 
(*), were prepared in tetrahydrofuran. c This value corresponds to the Fe–Fe distance between two diiron units. 
dThe polycrystalline sample of 6/7 was dried under vacuum at 150 °C for 24 h. 
 
The zero-field Mössbauer spectrum of polycrystalline 1 at 80 K displays two quadrupole 
doublets, with parameters δ1 = 1.18(2) mm/s, ΔEQ1 = 2.33(2) mm/s, δ2 = 0.97(2) mm/s, and ΔEQ2 
= 2.25(2) mm/s (Figure 3.5). Each iron site accounts for ~50% of the total iron content in the 
sample, consistent with the X-ray structure of 1, which shows two geometrically different iron 
atoms. The Mössbauer spectrum of polycrystalline 2 recorded at 80 K contains two quadrupole 
doublets, which were fit with parameters δ1 = 1.10(2) mm/s, ΔEQ1 = 2.04(2) mm/s, δ2 = 0.95(2) 
mm/s, and ΔEQ2 = 2.02(2) mm/s (Table 3.2). The isomer shift values of 1 and 2 (>1.0 mm/s) are 
typical of high-spin iron(II) complexes and the quadruople splitting parameters are as expected 
for iron coordinated by O,N-donors.5,38 A comparison of the Mössbauer parameters of 1 and 2 to 
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those reported for sMMOHred indicates that, qualitatively, the synthetic compounds are 
electronically similar to the protein active sites. Although the X-ray structure of sMMOHred 
revealed a diiron core with two different iron environments, the Mössbauer data could be fit to a 
single quadrupole doublet (δ1 = 1.3 mm/s, ΔEQ1 = 3.0 mm/s).39 The primary difference between 
1 and 2 compared to sMMOHred is the identity of several donor groups, phenolates in place of 
carboxylates and imines in place of imidazoles.  
 
Figure 3.4. Absorption spectra of 1 (blue) and 2 (red) in dichloromethane. Both compounds 
exhibit optical bands at ~ 290 and 410 nm. 
Figure 3.5. Zero-field 57Fe Mössbauer spectrum of a polycrystalline sample of 
[Fe2(PIM)(Ph3CCO2)] (1) at 80 K. The raw data (black hash lines) were fit to two distinct iron 
sites (green trace). The single site fits are shown as blue and red traces using the following 
parameters: δ1 = 1.18(2) mm/s, ΔEQ1 = 2.33(2) mm/s, ΓL/R(1) = 0.38(2) mm/s; δ2 = 0.97(2) mm/s, 
ΔEQ2 = 2.25(2) mm/s, ΓL/R(1) = 0.35(2) mm/s. 
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Figure 3.6. EPR spectrum of a frozen solution of [Fe2(PIM)(Ph3CCO2)] (1) in 2-
methytetrahydrofuran measured at 5 K. The peaks marked with an asterisk are due to 
contaminants from the instrument cavity. The broad feature centered at g = ~15 is attributed to 1, 
whereas the peaks at g = ~1.7 are of unknown origin. Instrument parameters: 9.281 GHz 
microwave frequency; 2.002 mW microwave power; 1.00 x 104 receiver gain; 100.0 kHz 
modulation frequency; 2.00 G modulation amplitude; 2.560 ms time constant. 
 
To evaluate further its electronic structure, an EPR spectrum of 1 in 2-
methyltetrahydrofuran was recorded at 5 K (Figure 3.6). The spectrum exhibits a broad signal 
with g = ~15, similar to that recorded for sMMOHred, in which two S = 2 iron(II) centers are 
ferromagnetically coupled.40 The EPR spectrum of 2 was not measured, but because its UV-
visible and Mössbauer spectra are similar to those of 1, complex 2 most likely has the same 
electronic structure. 
The paramagnetism of 1 and 2 was verified by NMR spectroscopy. 1H NMR spectra of 1 
(Figure 3.7A) and 2 (Figure 3.7B) in dichloromethane-d2 display resonances ranging from 
approximately 80 to -20 ppm. Although these paramagnetically shifted resonances cannot be 
assigned without more detailed studies,41,42 the peaks at 78.37, 74.97, 48.27, 22.78, -5.32, -10.37, 
-21.13 ppm for 1 and at 76.92, 73.82, 49.00, 24.68, -5.72, -9.04, -19.60 ppm for 2 are attributed 
to the PIM2- ligand because their chemical shifts and relative intensities are nearly identical. 
500 1500 2500 3500 4500
d X
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B
Field (G)
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Because dichloromethane is a non-coordinating solvent, the solution structures of 1 and 2 in 
CD2Cl2 are probably similar to those in the solid state. When the 1H NMR spectrum of 2 was 
recorded in acetonitrile-d3 (Figure 3.7C), there were significant shifts in the proton peaks 
compared to the spectrum acquired in dichloromethane-d2. Most notably, new resonances at 
69.33, 55.70, 48.28, 45.03, 42.85, 39.54, 38.55, and 35.55 ppm were observed. Because 
acetonitrile is coordinating, it is possible that solvent molecules bind to the iron centers and/or 
displace the carboxylate ligands. These results suggest that the solution structures of 1 and 2 
depend on the coordinating abilities of the solvent.  
 
 
 
Figure 3.7. 1H NMR spectra (500 MHz) of ~5 mM A) [Fe2(PIM)(Ph3CCO2)2] (1) in 
dichloromethane-d2 and [Fe2(PIM)(ArTolCO2)2] (2) in B) dichloromethane-d2 and C) acetonitrile-
d3 at room temperature. 
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Figure 3.8. Cyclic voltammograms of 1.0 mM solutions of 1 (A and B) and 2 (C and D) in 
dichloromethane. The plots on the left show the full sweep width at a scan rate of 500 mV/s, and 
the plots on the right display the isolated sweep windows at various scan rates. Tetra-n-
butylammonium hexafluorophosphate (0.2 M) was used as the supporting electrolyte. All data 
were obtained using a platinum working electrode and electrochemical potentials are referenced 
externally to the ferrocene/ferrocenium couple. Quasi-reversible redox couples at +16 mV and 
+ 108 mV were measured for 1 and 2, respectively, at a scan rate of 100 mV/s. Panel B: black 
line = 100 mV/s, red line = 300 mV/s, blue line = 500 mV/s. Panel D: black line = 50 mV/s, red 
line = 100 mV/s, blue line = 300 mV/s, green line = 500 mV/s. 
 
 
 Redox Chemistry. A characteristic property of carboxylate-bridged diiron proteins is 
their tendency to undergo single electron transfer reactions.40 For example, treatment of 
sMMOHox, which contains a diiron(III) unit, with sodium dithionite or gamma radiation from a 
Co-60 source led to formation of a mixed-valent diiron(II,III) species (Hmv). Because 1 and 2 are 
accurate small-molecule models of sMMOH in its reduced state, their electrochemical behavior 
is of interest. A cyclic voltammogram (CV) of 1 measured in dichloromethane using a platinum 
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working electrode and (n-Bu4N)PF6 as supporting electrolyte revealed two electrochemical 
events (Figures 3.8A and 3.8B). At a scan rate of 100 mV/s, a quasi-reversible redox couple at 
+16 mV, with a relatively large peak-to-peak separation of +210 mV, and an irreversible 
oxidation at +840 mV were observed. The CV of 2 was recorded under the same conditions 
(Figures 3.8C and 3.8D) and displayed a similar voltammogram, showing a quasi-reversible 
oxidation at +108 mV (ΔEp = + 198 mV) and an irreversible oxidation at +600 mV. The quasi-
reversible waves are tentatively assigned to metal-centered oxidations, probably conversion of 
diiron(II,II) to diiron(II,III). Ligand-centered redox chemistry, observed in some phenolate iron 
complexes,43-45 cannot be ruled out at this time. Unlike that of 1 and 2, the CV of Na2PIM does 
not exhibit any reversible redox events.  
 The redox chemistry of complex 2 was explored further by using chemical oxidants. 
Because the Ag+/Ag0 redox couple has an E1/2 value of +650 mV (vs. ferrocene/ferrocenium) in 
dichloromethane,46 silver(I) reagents were anticipated to be able to oxidize 2 (E1/2 = +108 mV). 
Treatment of 2 with ~1 equiv of AgClO4 in dichloromethane gradually converted the initial dark 
red solution to pale yellow brown. After stirring for about 1 h, a black precipitate formed, 
presumed to be silver metal. This insoluble material was removed by filtration and the absorption 
spectrum of the filtrate revealed that a new product had formed having optical bands at 290, 375, 
479 (sh), and 600 nm (Figure 3.9A). The filtrate was concentrated and pentane was introduced 
by diffusion to afford X-ray diffraction quality crystals. Structural analysis of these crystals 
revealed the product to be [Fe2(µ-OH)2(ClO4)2(PIM)(ArTolCO2)2Ag] (3), containing a di(µ-
hydroxo)diiron(III) unit and a silver(I) ion. Because the synthesis of 3 was performed under 
anhydrous anaerobic conditions, the most likely source of the OH– groups is trace water in the 
reaction mixture.  
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Figure 3.9. Absorption spectra of A) [Fe2(µ-OH)2(ClO4)2(PIM)(µ-ArTolCO2)Ag] (3) and the 
tetranuclear product from the reaction of 2/AgSbF6. The data were recorded in dichloromethane 
at RT. Panel A: λmax = 290, 375, 475 (sh), and 600 nm. Panel B: λmax = 300, 374, and 605 nm. 
 
 
The octahedral iron atoms (Fe–Fe = 3.01 Å) in 3 are bridged by two hydroxide ions (Fe–
Oave = 2.02 Å) and one terphenylcarboxylate ligand (Fe–Oave = 2.04 Å) (Figure 3.10). The 
hydrogen atoms of the hydroxides were not located, but the protonation state could be 
confidently assigned based on the Fe–O bond distances. Whereas bridging hydroxides afford Fe–
O distance of 1.9-2.1 Å, bridging oxides have Fe–O bond lengths in the 1.7-1.8 Å range.47,48 The 
phenolate (Fe–Oave = 1.86 Å) and imine (Fe–Nave = 2.12 Å) donors of PIM2- and a perchlorate 
anion (Fe–Oave = 2.13 Å) make up the rest of the iron coordination sphere. A Ag(I) ion is 
encapsulated within the macrocyclic framework, showing strong interactions with a hydroxide 
ligand (Ag–O(6) = 2.25 Å), the ether oxygen of PIM2- (Ag–O(5) = 2.36 Å), and a C=C π bond of 
the terphenylcarboxylate moiety (Ag–C(60) = 2.49 Å, Ag–C(61) = 2.74 Å). The Ag–C distances 
are within the 2.36 to 2.77 Å limit reported for other silver(I)-aryl species.49-51 A bond valence 
sum (BVS),52,53 an empirical quantity used to determine the oxidation state of metal ions in 
coordination compounds based on crystallographically determined metal-ligand distances, 
returned values of 3.12 and 3.07 for Fe(1) and Fe(2), respectively (Table 3.3), indicating that the 
iron centers in 3 are both in the +3 oxidation state.  
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Table 3.3. Bond Valence Sum Analyses for 3, 6, and 7. 
Complex Bond Bond Length (Å) Bond Valencea Bond Valence Sum (BVS)b 
3 Fe(1)–O(1) 1.848 0.786 3.116 
 Fe(1)–O(6) 2.049 0.457  
 Fe(1)–O(7) 1.997 0.526  
 Fe(1)–O(8) 2.029 0.482  
 Fe(1)–O(13) 2.122 0.375  
 Fe(1)–N(1) 2.119 0.490  
 Fe(2)–O(2) 1.865 0.751 3.068 
 Fe(2)–O(6) 2.045 0.462  
 Fe(2)–O(7) 1.976 0.556  
 Fe(2)–O(9) 2.048 0.458  
 Fe(2)–O(15) 2.137 0.360  
 Fe(2)–N(2) 2.126 0.481  
6 Fe(1)–O(1) 1.880 0.721 3.053 
 Fe(1)–O(6) 1.744 1.041  
 Fe(1)–O(7) 2.084 0.415  
 Fe(1)–O(8) 2.133 0.364  
 Fe(1)–N(1) 2.103 0.512  
 Fe(2)–O(2) 1.898 0.751 3.034 
 Fe(2)–O(6) 1.753 1.011  
 Fe(2)–O(9) 2.113 0.384  
 Fe(2)–O(10) 2.092 0.406  
 Fe(2)–N(2) 2.125 0.482  
7 Fe(1)–O(1) 1.880 0.721 2.808 
 Fe(1)–O(100) 2.110 0.387  
 Fe(1)–O(101) 2.090 0.409  
 Fe(1)–O(7) 2.084 0.415  
 Fe(1)–O(8) 2.133 0.364  
 Fe(1)–N(1) 2.103 0.512  
 Fe(2)–O(2) 1.898 0.751 2.824 
 Fe(2)–O(100) 2.092 0.406  
 Fe(2)–O(101) 2.103 0.395  
 Fe(2)–O(9) 2.113 0.384  
 Fe(2)–O(10) 2.092 0.406  
 Fe(2)–N(2) 2.125 0.482  
a The bond valence (sij), between cation i and anion j, was calculated using the equation: sij = exp [(ro-
r)/B], where ro and B are empirically determined parameters and r is the observed bond distance. The 
following values were used in these calculations: ro(Fe+3–O) = 1.759, ro(Fe+3–N) = 1.855, B = 0.37. b 
The bond valence sum (BVS) = Σ sij.52,53 
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Figure 3.10. Ortep thermal ellipsoid (50%) diagram of the X-ray crystal structure of [Fe2(µ-
OH)2(ClO4)2(PIM)(ArTolCO2)Ag] (3, left). An isolated view of the heterometallic core is shown 
as a stick figure representation on the right. Solvent molecules and hydrogen atoms are omitted 
for clarity. Color scheme: iron, orange; carbon, gray; nitrogen, blue; oxygen, red; sulfur, yellow; 
green, chlorine; purple, silver. Selected bond distances (Å) and angles (Deg): Fe(1)–Fe(2) = 
3.012; Fe(1)–O(1) = 1.848; Fe(1)–N(1) = 2.119; Fe(1)–O(6) = 2.049; Fe(1)–O(7) = 1.997; 
Fe(1)–O(8) = 2.029; Fe(1)–O(13) = 2.122; Fe(2)–O(2) = 1.865; Fe(2)–N(2) = 2.126; Fe(2)–O(6) 
= 2.045; Fe(2)–O(7) = 1.976; Fe(2)–O(9) = 2.048; Fe(2)–O(15) = 2.137; Ag(1)–O(6) = 2.261; 
Ag(1)–O(5) = 2.420; Ag(1)–C(60) = 2.344; Ag(1)–C(61) = 2.588; O(1)–Fe(1)–N(1) = 88.5; 
O(2)–Fe(2)–N(2) = 88.8; Fe(1)–O(6)–Fe(2) = 94.7; Fe(1)–O(7)–Fe(2) = 98.6; O(5)–Ag(1)–O(6) 
= 109.1; O(5)–Ag(1)–C(60) = 100.4; O(6)–Ag(1)–C(61) = 117.7.  
 
To provide further evidence for this assignment, the Mössbauer spectrum of a frozen 
solution of 3 in tetrahydrofuran was recorded at 80 K (Table 3.2). The data could be 
satisfactorily fit to a single quadrupole doublet, with δ = 0.49(2) mm/s and ΔEQ = 1.38(2) mm/s, 
parameters typical of iron(III) complexes having mixed oxygen and nitrogen donor groups. The 
single quadrupole doublet in the Mössbauer spectrum is consistent with the X-ray crystal 
structure of 3, which has two chemically equivalent iron centers.  
 Because chemical oxidation of 2 using AgClO4 led to metal binding by the perchlorate 
anion, the oxidation was repeated using the silver salt of a less coordinating anion, AgSbF6. 
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Reaction of 2 with 1 equiv of AgSbF6 in dichloromethane yielded a heterogeneous dark brown 
solution formed over the course of ~1 h. After removal of a black solid, the UV-vis spectrum of 
the filtrate revealed bands at 300, 374, and 605 nm (Figure 3.9B), suggesting formation of a new 
species. Single crystals of the product were grown by slow diffusion of diethyl ether into an 
acetonitrile solution containing the material. X-ray diffraction studies revealed a tetranuclear 
complex, [Fe4(µ-X)4(µ-Y)2(PIM)2(ArTolCO2)2], where the identity of atoms X and Y is probably 
F–. We have not been able to fully solve this structure owing to unresolved disorder in the 
crystal. Based on its optical spectrum, however, we can rule out [Fe4(µ-OH)6(PIM)2(ArTolCO2)2]  
(8) as a possible product (vide infra). 
 
Figure 3.11. Absorption spectra of 1 + O2 (black, λmax = ~370, 570 nm), 4 (blue, λmax = ~370, 
570 nm), and 5 (red, λmax = ~370, 540 nm) in dichloromethane.  
 
 Reactivity with O2. To determine whether 1 and 2 exhibit the same functional activity as 
the BMM proteins,54 their reactivity with dioxygen was investigated. Exposure of a 
dichloromethane solution of 1 to dioxygen at RT led to an instantaneous color change and the 
appearance of new optical bands at 370 and 570 nm (Figure 3.11, black trace). Facile reactivity 
of 1 with O2 was confirmed by NMR spectroscopy. Injecting O2 into a septum-sealed NMR tube 
containing 1 in dichloromethane-d2 afforded the 1H NMR spectrum shown in Figure 3.12A. The 
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numerous proton resonances in the spectrum, ranging from approximately 80 to -15 ppm, 
suggest the presence of multiple species in the reaction mixture.  
 
Figure 3.12. 1H NMR spectra (500 MHz) of A) [Fe2(PIM)(Ph3CCO2)2] (1) + O2; B) [Fe2(µ-
OH)(PIM)(Ph3CCO2)3] (4); and C) [Fe4(µ-OH)6(PIM)(Ph3CCO2)2] (5). Comparison of spectrum 
A to that of B and C reveals that reaction of 1 with O2 leads to formation of 4 and 5, in addition 
to at least one other product. All spectra were recorded at room temperature with diiron complex 
concentrations of ~5 mM. All spectra were acquired in CDCl3. Relative peak heights are not 
normalized between spectra. Panel A: δ (selected peaks) = 77.39, 65.13, 54.24, 51.17, 50.39, 
45.94, 43.64, 31.77, 30.88, 26.75, 22.33, 19.89 ppm. Panel B: δ (selected peaks) = 51.28, 44.24, 
33.02, 29.70, 23.90 ppm. Panel C: δ (selected peaks) = 49.97, 43.69, 31.20, 15.80 ppm. 
 
 To characterize the reaction product(s), single crystals of the material were grown by 
slow diffusion of pentane into a benzene solution containing the dark red-brown solid. After 
several days, a mixture of dark brown rectangular blocks and dark brown hexagonal prisms were 
obtained in addition to an amorphous solid. X-ray diffraction analysis of the rectangular-shaped 
crystals showed that the compound has a (µ-hydroxo)diiron(III) core and the molecular formula 
[Fe2(µ-OH)(PIM)(Ph3CCO2)3] (4, Figure 3.13, Table 3.4). The distorted-octahedral iron centers 
	   143 
are separated by 3.49 Å, with Fe(1)–O(6) and Fe(2)–O(6) bond lengths of 1.95 and 1.97 Å, 
respectively. The hydrogen atom on O(6), the bridging hydroxide ion, was located from a 
difference Fourier map. The diiron core is supported by the PIM2- ligand, with average Fe–
O(phenoxyl) and Fe–N(imine) distances of 1.31 and 2.12 Å, respectively, and three 
triphenylacetate groups. Two of the carboxylates coordinate to the iron atoms in a terminal 
bidentate mode, giving average Fe–O distances of 2.11 Å, and the remaining carboxylate bridges 
the diiron core, with an average Fe–O distance of 2.02 Å.  
 
Figure 3.13. Ortep thermal ellipsoid (50%) diagram of the X-ray crystal structure of [Fe2(µ-
OH)(PIM)(Ph3CCO2)3] (4, left). An isolated view of the diiron core is shown as a stick figure 
representation on the right. Solvent molecules and hydrogen atoms are omitted for clarity. Color 
scheme: iron, orange; carbon, gray; nitrogen, blue; oxygen, red; sulfur, yellow. Selected bond 
distances (Å) and angles (Deg): Fe(1)–Fe(2) = 3.487; Fe(1)–O(1) = 1.890; Fe(1)–N(1) = 2.115; 
Fe(1)–O(6) = 1.952; Fe(1)–O(10) = 2.063; Fe(1)–O(20) = 2.075; Fe(1)–O(21) = 2.132; Fe(2)–
O(2) = 1.872; Fe(2)–N(2) = 2.136; Fe(2)–O(6) = 1.969; Fe(2)–O(11) = 1.979; Fe(2)–O(30) = 
2.141; Fe(2)–O(31) = 2.093; O(1)–Fe(1)–N(1) = 87.4; O(2)–Fe(2)–N(2) = 87.5; Fe(1)–O(6)–
Fe(2) = 125.6; O(6)–Fe(1)–O(10) = 88.3; O(6)–Fe(2)–O(11) = 88.9.  
 
 X-ray diffraction studies of the hexagonal prisms, isolated from the 1/O2 reaction 
mixture, revealed a tetranuclear [Fe4(µ-OH)6(PIM)2(Ph3CCO2)2] complex (5), in which two di(µ-
hydroxo)(µ-triphenylacetato)diiron(III) units are linked by two bridging hydroxide ions (Figure 
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3.14, Table 3.4). The tetrairon(III) unit is located on a crystallographic inversion center. The 
diiron subunit bound by the PIM2- ligand has an Fe–Fe distance of 3.06 Å and is bridged by two 
hydroxide ligands (Fe–Oave = 2.02 Å). The separation of iron atoms between two Fe2 
macrocyclic monomers is 3.78 Å, and the linkages involve only one hydroxo bridge (Fe–Oave = 
1.98 Å). The average Fe–O(phenoxyl) and Fe–N(imine) bond lengths were observed at approx. 
1.91 and 2.20 Å, respectively. Finally, two bridging carboxylate groups (Fe–Oave = 2.06 Å) cap 
the tetranuclear cluster at opposite ends. 
 
 
Figure 3.14. Ortep thermal ellipsoid (50%) diagram of the asymmetric unit of the X-ray crystal 
structure of [Fe4(µ-OH)6(PIM)(Ph3CCO2)2] (5, left). The center of the complex is located on a 
crystallographic inversion center. An isolated view of the tetrairon core is depicted as a stick 
figure representation on the right. Solvent molecules and hydrogen atoms are omitted for clarity. 
Color scheme: iron, orange; carbon, gray; nitrogen, blue; oxygen, red; sulfur, yellow. Selected 
bond distances (Å) and angles (Deg): Fe(1)–Fe(2) = 3.056; Fe(1)–Fe(2A) = 3.780; Fe(1)–O(1) = 
1.911; Fe(1)–N(1) = 2.172; Fe(1)–O(6) = 2.042; Fe(1)–O(8) = 2.030; Fe(1)–O(9) = 1.997; 
Fe(1)–O(10) = 1.978; Fe(2)–O(2) = 1.910; Fe(2)–N(2) = 2.229; Fe(2)–O(7) = 2.072; Fe(2)–O(8) 
= 2.028; Fe(2)–O(9) = 2.011; N(1)–Fe(1)–O(1) = 83.4; N(2)–Fe(2)–O(2) = 85.4; Fe(1)–O(8)–
Fe(2) = 97.7; Fe(1)–O(9)–Fe(2) = 99.4; Fe(1)–O(10)–Fe(2A) = 146.6. 
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Table 3.4. X-ray Data Collection and Refinement Parameters for 4-7. 
 
 4 5 6/7 
Empirical formula  [Fe2N2O12SC102H78]  (C6H6)3 
[Fe4N4O20S2C124H100] 
 (C6H6)8 
[Fe2N2O10.24SC84H63] 
 (CH3CN)3 
Formula weight  1901.75 2878.46 1531.15 
Temperature (K) 100 100 100 
Wavelength (Å) 0.71073 0.71073 0.71073 
Crystal system  Monoclinic Triclinic Orthorhombic 
Space group  P21/n P
€ 
1 Pbca 
Unit cell dimensions 
a = 15.2273(15) Å 
b = 16.6307(16) Å 
c = 37.426(4) Å 
 
β = 92.975(2)° 
 
a = 14.2464(8) Å 
b = 15.8784(9) Å 
c = 19.3834(11) Å 
α = 66.3850(10)° 
β = 69.7520(10)° 
γ = 64.3010(10)° 
a = 12.2687(10) Å 
b = 25.927(2) Å 
c = 48.485(4) Å 
 
 
 
Volume (Å3) 9464.9(16) 3540.4(3) 15423(2) 
Z 4 1 8 
Calculated density (g/mm3) 1.335 1.350 1.319 
Absorption coefficient (mm-1) 0.396 0.503 0.468 
F(000) 3976 1504 6375 
Crystal size (mm3) 0.40 x 0.35 x 0.21 0.14 x 0.08 x 0.07 0.19 x 0.16 x 0.10 
Θ range for data collection 1.47 to 26.43° 1.17 to 25.03° 1.57 to 24.71° 
Index ranges -19 ≤ h ≤ 19 -20 ≤ k ≤ 20 
-46 ≤ l ≤ 46 
-16 ≤ h ≤ 16 
-18 ≤ k ≤ 18 
-22 ≤ l ≤ 23 
-14 ≤ h ≤ 14 
-30 ≤ k ≤ 30 
-57 ≤ l ≤ 57 
Reflections collected 133480 50303 227221 
Independent reflections 19402 [R(int) = 0.0677] 
12460 
[R(int) = 0.0677] 
13160 
[R(int) = 0.1197] 
Completeness to Θ (%) 99.7 99.8 100.0 
Absorption correction Empirical Empirical Empirical 
Max. and min. transmission 0.9214 and 0.8575 0.9656 and 0.9329 0.9547 and 0.9163 
Data / restraints / parameters 19402/0/1240 12460/49/922 13160/82/998 
Goodness-of-fit on F
2 
1.040 1.084 1.154 
Final R indices [I>2σ(I)] R1 = 0.0472 wR2 = 0.1245 
R1 = 0.0468 
wR2 = 0.1033 
R1 = 0.0969 
wR2 = 0.2015 
R indices (all data) R1 = 0.0609 wR2 = 0.1334 
R1 = 0.0718 
wR2 = 0.1131 
R1 = 0.1218 
wR2 = 0.2135 
Largest diff. peak and hole 
(eA3) 1.287 and -0.559 1.034 and -0.646 1.516 and -1.390 
* R1 = Σ ∣∣Fo∣–∣Fo∣∣/Σ∣Fo∣; wR2 = [Σ[w(Fo2– Fc2)2]/Σ[w(Fo2)2]]1/2; GOF = [Σ[w(Fo2– Fc2)2]/(n–p)]1/2, where n is the number 
of reflections and p is the total number of parameters refined. 
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Figure 3.15. Zero-field Mössbauer spectrum (80 K) of polycrystalline samples of 
[57Fe2(OH)(PIM)(Ph3CCO2)3] (4, left) and [57Fe4(OH)6(PIM)2(Ph3CCO2)2] (5, right). Spectrum A 
gave Mössbauer parameters δ = 0.52(2) mm/s, ΔEQ = 0.95(2) mm/s, and Γ = 0.38(2) mm/s, 
whereas spectrum B returned Mössbauer parameters δ = 0.51(2) mm/s, ΔEQ = 1.06(2) mm/s, and 
Γ = 0.40(2) mm/s. Raw data are shown in black and the spectral fits are shown in green.  
 
 
 Analytically pure samples of 4 and 5 were prepared for spectroscopic characterization. 
The dinuclear compound 4 was synthesized by combining triphenylacetic acid, triethylamine, 
and 1 in benzene, followed by exposure to dioxygen. Vapor diffusion of pentane into the 
benzene reaction solution over the course of ~24 h afforded dark brown crystals. X-ray 
diffraction analysis of these crystals confirmed the desired (µ-hydroxo)diiron(III) species 4. The 
UV-visible spectrum of 4 exhibits absorption bands at 370 and 570 nm (Figure 3.11, blue trace). 
The higher energy band is most likely a ligand π-π* transition, whereas the visible band is most 
likely a hydroxo-to-iron(III) charge transfer.48 The 1H NMR spectrum of 4 was recorded in 
chloroform-d1 (Figure 3.12B). As expected for a paramagnetic compound, the spectrum shows 
several broad resonances, ranging from approximately 70 to -10 ppm. Assignment of the metal 
oxidation states in 4 as iron(III) is supported by zero-field Mössbauer spectroscopic 
measurements. Polycrystalline 57Fe-enriched 4 displays a single quadrupole doublet in the 
Mössbauer spectrum, with parameters δ = 0.52(2) mm/s and ΔEQ = 0.95(2) mm/s (Figure 3.15A, 
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Table 3.2). Although the two iron atoms in 4 are not chemically equivalent, similarities in their 
coordination geometry and donor groups make them indistinguishable by zero-field Mössbauer 
spectroscopy.  
The tetrairon(III) complex 5 was also fully characterized. The compound was isolated as 
brown crystals by slow evaporation of a benzene solution containing 1 and dioxygen under 
ambient conditions. To ensure that the bulk product did not contain 4, several representative 
crystals were analyzed by X-ray crystallography. In all cases, tetranuclear 5 was obtained. The 
absorption spectrum has peaks with λmax at 370 and 540 nm (Figure 3.11, red trace). The visible 
band, which is blue-shifted by approximately 30 nm from the 570 nm absorption feature in 4, is 
most likely a ligand-to-metal transition involving the diiron-hydroxo unit.48 The 1H NMR 
spectrum of 5 in chloroform-d1 exhibits paramagnetically broadened peaks at ~50, 44, 32, 26, 
and -8 ppm (Figure 3.12C). The simpler 1H NMR spectrum of 5, compared to that of 4, is 
consistent with its higher molecular symmetry (pseudo C2h for 5 versus C1 for 4). The zero-field 
Mössbauer spectrum of 57Fe-enriched 5 was fit with parameters that are distinct from those of 4, 
giving δ = 0.51(2) mm/s and ΔEQ = 1.06(2) mm/s (Figure 3.15B, Table 3.2). Because the four 
iron sites in 5 are chemically equivalent, a single quadrupole doublet is observed in the 
Mössbauer spectrum, consistent with its X-ray structure.  
Comparison of the 1H NMR spectrum of 1/O2 (Figure 3.12A) with those of 4 (Figure 
3.12B) and 5 (Figure 3.12C) reveals that not all of the peaks are accounted for, particularly a 
broad resonance at ~76 ppm and other sharper features between 10 to 40 ppm. To evaluate the 
number of iron-containing species generated upon reaction of 1 with dioxygen, the crude 1/O2 
solid was examined by Mössbauer spectroscopy (Figure 3.16). The Mössbauer data display three 
overlapping quadrupole doublets, with the following characteristics: δ1 = 0.50(2) mm/s, ΔEQ1 = 
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0.78(2) mm/s, Area 1 = 24%; δ2 = 0.51(2) mm/s, ΔEQ2 = 1.12(2) mm/s, Area 2 = 37%; δ3 = 
0.52(2) mm/s, ΔEQ3 = 1.59(2) mm/s, Area 3 = 39%. The three sites have nearly identical isomer 
shift values, but differ in their quadrupole splitting parameters. Based on their similarities to the 
Mössbauer parameters of the crystallographically characterized species, sites 1 and 2 are 
ascribed to compounds 4 and 5, respectively. The nature of the third site, which comprises about 
39% of total iron in the 1/O2 sample, has not yet been identified.  
 
Figure 3.16. Zero-field Mössbauer spectrum (80K) of a frozen benzene-d6 solution of 
[57Fe2(PIM)(Ph3CCO2)2] (57Fe-1)/O2 (black lines). The 1H NMR spectrum of this sample is 
shown in Figure 3.12A. Spectral simulations are represented in green and fit residuals in red. 
Both plots show the same data, but are overlaid with different spectral fits for comparing their 
overall goodness of fit. Spectrum A was fit to a two-site model, with δ1 = 0.50(2) mm/s, ΔEQ1 = 
0.95(2) mm/s, Γ1 = 0.39(2) mm/s, Area 1 = 54%, δ2 = 0.52(2) mm/s, ΔEQ2 = 1.52(2) mm/s, Γ2 = 
0.44(2) mm/s, and Area 2 = 46%. Spectrum B was fit to a three-site model, with δ1 = 0.50(2) 
mm/s, ΔEQ1 = 0.78(2) mm/s, Γ1 = 0.30(2) mm/s, Area 1 = 24%, δ2 = 0.51(2) mm/s, ΔEQ2 = 
1.12(2) mm/s, Γ2 = 0.34(2) mm/s, Area 2 = 37%, δ3 = 0.52(2) mm/s, ΔEQ3 = 1.59(2) mm/s, Γ3 = 
0.41(2) mm/s, and Area 3 = 39%. Comparing the fit residuals between A and B clearly 
demonstrate that the three-site model in B is a better representation of the data.  
 
The dioxygen reactivity of the diiron(II) compound 2, which contains sterically 
demanding terphenylcarboxylates rather than triphenylacetates, was also examined. Exposing a 
dichloromethane solution of 2 to O2 led to an immediate color change from bright red to dark 
brown. The absorption spectrum of dioxygen-treated 2 has features at approximately 380, 473, 
and 600 nm (Figure 3.17, blue trace). The 1H NMR spectrum revealed new resonances between 
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26 and -8 ppm (Figure 3.18). Unlike the 1H NMR spectrum of 1/O2 (Figure 3.12A), which shows 
multiple chemical species in solution, the data suggest that reaction of 2 with O2 forms fewer 
products.  
 
Figure 3.17. Absorption spectra of complex 2 + O2 (blue, λmax = 380, 473, 600 nm) and complex 
2 + O2/H2O (red, λmax = 380, 473, 600 nm) in dichloromethane. The blue spectrum arises from a 
mixture of [Fe2(µ-O)(PIM)(ArTolCO2)2] (6) and [Fe2(µ-OH)2(PIM)(ArTolCO2)2] (7) species. The 
red spectrum is assigned to a tetranuclear [Fe4(µ-OH)6(PIM)2(ArTolCO2)2] (8) complex.  
 
 
Figure 3.18. 1H NMR spectrum (CD2Cl2, 500 MHz) of [Fe2(PIM)(ArTolCO2)2] (2) after exposure 
to dioxygen. The spectrum was recorded at room temperature at a diiron complex concentration 
of ~5.0 mM. 
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Figure 3.19. Ortep thermal ellipsoid (35%) diagram of the X-ray crystal structure of [Fe2(µ-
O)(PIM)(ArTolCO2)2] (6) and [Fe2(µ-OH)2(PIM)(ArTolCO2)2] (7)  on the left. The two complexes 
occur in a single crystal and differ only in their (µ-oxo)diiron(III) and di(µ-hydroxo)diiron(III) 
cores, respectively. Stick figure representations of the diiron core of 6 and 7 are shown on the 
right. The ratio of 6:7 was determined to be 76:24. Solvent molecules and hydrogen atoms are 
omitted for clarity. Color scheme: iron, orange; carbon, gray; nitrogen, blue; oxygen, red; sulfur, 
yellow. Selected bond distances (Å) and angles (Deg): Fe(1)–Fe(2) = 3.436; Fe(1)–O(1) = 1.880; 
Fe(1)–N(1) = 2.103; Fe(1)–O(6) = 1.744; Fe(1)–O(7) = 2.084; Fe(1)–O(8) = 2.133; Fe(1)–
O(100) = 2.110; Fe(1)–O(101) = 2.090; Fe(2)–O(2) = 1.898; Fe(2)–N(2) = 2.125; Fe(2)–O(6) = 
1.753; Fe(2)–O(9) = 2.113; Fe(2)–O(10) = 2.092; Fe(2)–O(100) = 2.103; Fe(2)–O(101) = 2.090; 
O(1)–Fe(1) –N(1) = 87.2; O(2)–Fe(2)–N(2) = 88.00; Fe(1)–O(6)–Fe(2) = 158.6; Fe(1)–O(100)–
Fe(2) = 109.1; Fe(1)–O(101)–Fe(2) = 110.8.  
 
Figure 3.20. Hybrid stick and space-filling diagrams of [Fe2(µ-OH)(PIM)(Ph3CCO2)3] (4, A) and 
[Fe2(µ-O)(PIM)(ArTolCO2)2] (6, B). The aromatic rings of the carboxylate ligands are 
representated as spheres (carbon = green, hydrogen = white) to emphasize their shape and 
volume. The location of the carboxylate unit, either Ph3CCO2– or ArTolCO2–, is indicated by a 
white arrow. The PIM2- framework is displayed in stick form (carbon/hydrogen, gray; nitrogen, 
blue; oxygen, red; sulfur, yellow) with the iron atoms shown as orange spheres. 
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 To determine the composition of the 2/O2 product, preparative-scale reactions were 
performed to obtain sufficient material for characterization. Single crystals of oxygenated 2 were 
grown by slow diffusion of diethyl ether into a solution of the complex in acetonitrile. An X-ray 
structural investigation revealed that each single crystal contains a mixture of two species, a (µ-
oxo)diiron(III) [Fe2(µ-O)(PIM)(ArTolCO2)2] (6) compound and a di(µ-hydroxo)diiron(III) 
[Fe2(OH)2(PIM)(ArTolCO2)2] (7) compound (Figure 3.19, Table 3.4). This result was verified by 
analyzing several crystals independently prepared by the same method. The structures of 6 and 7 
are identical except for the nature of their bridging oxygen atoms, which was modeled with 
positional disorder and partial occupancies assigned to atoms O(6) [in 6] and O(100)/O(101) [in 
7]. Data refinement converged with 6 having an occupancy of 76% and 7 of 24%. The iron 
atoms in both structures are separated by 3.44 Å. Complex 6 is designated as a (µ-oxo)diiron(III) 
species because of its short Fe(1)–O(6) and Fe(2)–O(6) distances of 1.74 and 1.75 Å, 
respectively.48 In contrast, 7 is a di(µ-hydroxo)diiron(III) complex with the longer Fe–O(100) 
and Fe–O(101) bond length of 2.10 Å (averaged), more typical of a dinuclear structure with 
bridging hydroxide ligands. The iron atoms of 6 and 7 are coordinated by the PIM2- ligand, with 
average Fe–O(phenoxyl) distances of 1.89 Å and average Fe–N(imine) distances of 2.11 Å. 
Furthermore, each iron site contains a terminal terphenylcarboxylate (Fe–Oave = 2.11 Å). The 
iron atoms in 6 and 7 have bond valence sums of 3.0 and 2.8, respectively (Table 3.3), indicating 
that the iron centers are in the +3 oxidation state. Although three triphenylacetate ligands are 
accommodated by the PIM2- platform in 4 (Figure 3.20A), only two terphenylcarboxylates could 
occupy the same space in 6 (Figure 3.20B). These observations underscore the importance of 
considering both shape and size when selecting an appropriate carboxylate for synthetic 
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modeling studies; a fan-shaped terphenylcarboxylate is preferable over the cone-shaped 
triphenylacetate for producing dinuclear oxygenated products using the PIM2– ligand framework.  
 The presence of both (µ-oxo)diiron(III) and di(µ-hydroxo)diiron(III) species in the 
reaction product of 2 with dioxygen was further supported by zero-field Mössbauer 
measurements. Polycrystalline 2/O2 gave a Mössbauer spectrum that was best fit to two 
quadrupole doublets, δ1 = 0.47(2) mm/s, ΔEQ1 = 1.52(2) mm/s, δ2 = 0.50(2) mm/s, and ΔEQ2 = 
0.97(2) mm/s. Sites 1 and 2 were refined with areas of 21% and 79%, respectively. Because (µ-
oxo)diiron(III) species typically have larger ΔEQ values (>1.0 mm/s) than (µ-hydroxo)diiron(III) 
complexes (<1.0 mm/s), site 1 is attributed to complex 6 and site 2 to complex 7. When the 2/O2 
solid reaction product was further dried under vacuum at 150 °C for 24 h, Mössbauer 
measurements yielded a 6:7 ratio of 85:15 (Table 3.2), which is similar to the 6:7 ratio of 76:24 
determined by X-ray crystallography (Figure 3.19), suggesting that 6 can be obtained from 7 by 
extrusion of H2O. To examine the 6:7 ratio in solution, an 57Fe-enriched sample of the 2/O2 solid 
dissolved in tetrahydrofuran was studied by Mössbauer spectroscopy at 80 K, yielding the 
following parameters: δ1 = 0.51(2) mm/s, ΔEQ1 = 1.24(2) mm/s, δ2 = 0.49(2) mm/s, and ΔEQ2 = 
0.78(2) mm/s, with sites 1 and 2 having occupancies of 61% and 36%, respectively (Figure 
3.21B). Because site 1 has a larger ΔEQ value than site 2, the ratio for 6:7 in tetrahydrofuran is 
61:36. The varying percentages of 6 and 7, as determined from X-ray crystallographic and 
Mössbauer spectroscopic measurements, are probably due to the different amounts of H2O 
present in each 2/O2 sample. Regardless, these Mössbauer results unequivocally show that both 6 
and 7 are produced in the reaction of 2 with dioxygen. So far we have been unable to isolate 
complexes 6 and 7 in pure form. 
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Figure 3.21. Zero field Mössbauer spectra (80 K) of a 22 mM [57Fe2(PIM)(ArTolCO2)2] (2) 
solution in tetrahydrofuran (A) that was frozen after exposure to dioxygen (B) or dioxygen/ 
water (C). Spectrum A was best fit to a two-site model, which is consistent with the two different 
iron environments in 2. The spectrum in B is assigned to two diiron species 6 and 7, whereas the 
spectrum in C is assigned to a tetranuclear complex 8 containing equivalent iron sites. See Table 
3.2 for solution Mössbauer parameters for species 2, 6/7, and 8. Raw data are represented in 
black; spectral fits are shown in green, with unique iron sites displayed as either red or blue lines. 
 
 Because 7 differs from 6 by a single water molecule, we explored whether addition of 
H2O could convert the (µ-oxo)diiron(III) species 6 to the di(µ-hydroxo)diiron(III) complex 7. 
When a 6/7 mixture was treated with 10 µL of H2O, ~15 equiv relative to the diiron complexes, 
in dichloromethane, the brown solution instantly turned pale red. New optical bands at 360 and 
550 nm were observed (Figure 3.17, red trace), which are reminiscent of those displayed by the 
tetrairon complex [Fe4(µ-OH)6(PIM)2(Ph3CCO2)2] (5, Figure 3.11, red trace). To obtain further 
spectroscopic characterization, a sample containing 57Fe-enriched 6/7 and 15 equiv of H2O in 
tetrahydrofuran was studied by Mössbauer spectroscopy at 80 K (Figure 3.21C). The spectrum 
was fit to a single quadrupole doublet, with δ = 0.49(2) mm/s and ΔEQ = 0.97(2) mm/s. These 
parameters are nearly identical to those obtained for 5 (Table 3.2). Although we are unable to 
crystallize this material, the spectroscopic data suggest that the compound has the molecular 
formula [Fe4(µ-OH)6(PIM)2(ArTolCO2)2] (8). 
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3.4. Discussion 
 Macrocyclic Ligands for Constructing Biomimetic Carboxylate-Bridged Diiron 
Models. To obtain more accurate structural mimics of carboxylate-bridged diiron protein active 
sites,5 we designed and synthesized dinucleating ligands that enforce the syn stereochemistry of 
nitrogen donor atoms. Early work with 1,2-bis(3-ethynyl-8-carboxylatequinoline)-4,5-
diethylbenzene ethyl ester (Et2BCQEBEt) led to isolation of a tri(µ-carboxylato)(syn N-
donor)diiron(II) species that resembles the BMM protein active sites,24 but this compound 
produced an intractable mixture when exposed to dioxygen. Other syn N-donor variants 
primarily afforded bis(ligand)diiron complexes formed through interdigitation of two 
dinucleating ligands when complexed with iron(II).26,35 To prevent such interactions the H2PIM 
ligand (Chart 3.1), was designed. By linking two phenoxylimine chelates covalently, H2PIM still 
enforces syn arrangement of the nitrogen donors but has a more pre-organized conformation. 
This compound was synthesized by the procedure outlined in Scheme 3.2 and could be prepared 
in multi-gram quantities. The H2PIM ligand is also amenable to electronic and geometric 
modifications by introduction of various substituents on the aromatic rings.  
 The H2PIM macrocycle facilitated the preparation of new diiron(II) synthetic analogues 
of sMMOHred and related enzyme active sites.55,56 In the presence of sterically demanding 
carboxylic acids, treatment of H2PIM with [Fe2(Mes)4] led to spontaneous self-assembly of di(µ-
carboxylato)(PIM)diiron(II) species (Figure 3.22A). Compounds 1 and 2 reproduce several key 
features of the sMMOHred active site, including: the bridging µ-η1η2 and µ-η1η1 modes of 
carboxylates, syn stereochemistry of nitrogen donors, neutral charge of the complex, S = 2 spin 
state of the irons, and the stoichiometry of the ligands. The main differences are the substitution 
of carboxylate and imidazole groups with related donors. We used phenolate and imine moieties 
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because they provide both synthetic and functional advantages. Phenol is a versatile building 
block. A variety of substituents could be readily appended on the ring, allowing access to 
different molecular architectures. Although the phenolate anion (pKa of phenol = ~12-19 in 
DMSO) is more basic than a carboxylate (pKa of carboxylic acid = ~ 9-13 in DMSO),57,58 more 
electron-rich oxygen donors may stabilize iron in higher oxidation states, such as the diiron(IV) 
unit of intermediate Q.59 Alternatively, the basicity of the phenolate groups could be lowered to 
match better the donor strength of glutamate and aspartate side chains by introducing electron-
withdrawing substituents on the PIM2- ligand. An additional advantage of the phenolate ligand is 
that its iron complexes display visible absorption bands that provide a spectroscopic handle for 
studying otherwise optically silent species. Finally, imine groups are valuable in the H2PIM 
framework because they form through Schiff base condensation reactions that are efficient in 
producing large macrocyclic structures with syn nitrogen donors.60,61 
 
Figure 3.22. Depiction of the X-ray crystal structures of the diiron sites of sMMOHred (top, left) 
and sMMOHox (bottom, left). For structural comparison, synthethic complexes that mimic each 
protein state are shown on its right. Some relevant bond lengths are provided; the distances 
shown for 1 and 2 are averaged over the two complexes. Color scheme: iron, orange; nitrogen, 
blue; oxygen, red; carbon, gray.  
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 Reactivity of Diiron(II) Mimics and Their Biological Implications. Cyclic 
voltammograms of compounds 1 and 2 show quasi-reversible redox couples at +16 and +108 
mV (vs. ferrocene/ferrocenium), respectively (Figure 3.8). These electrochemical events are 
assigned to diiron(II,II) to diiron(II,III) metal-centered oxidation processes. To investigate 
further the redox behavior of compound 2, chemical oxidation with silver perchlorate was 
attempted. This reaction afforded an organometallic di(µ-hydroxo)(µ-
carboxylato)diiron(III)silver(I) (3) species (Scheme 3.3). The bridging hydroxo ions are most 
likely derived from adventitious water in the reaction mixture. When oxidation of 2 was 
performed using silver hexafluoroantimonate, which contains the less-coordinating SbF6– anion 
compared to ClO4–, a tetrairon(III) cluster was isolated. Although the cyclic voltammograms of 1 
and 2 suggest that reversible oxidation of these carboxylate-bridge diiron units might be possible, 
we were unable to isolate the one-electron oxidized forms using chemical methods. One 
difficulty is that the diiron PIM2– compounds have a propensity to be bridged by small 
nucleophiles, such as the OH– ligands in 3, which were not deliberately introduced into the 
reaction mixture. We cannot determine at this time whether our inability to isolate the oxidized 
product of 1 or 2 is due to their inherent instability or to our experimental conditions. The 
structure of 3, however, demonstrates two important features of our model system. Firstly, its 
di(µ-hydroxo)(µ-carboxylato)diiron(III) core indicates that our macrocylic framework could 
support the unusual asymmetric resting state structure of the sMMOHox active site.18 Secondly, 
the oxophilic character of the diiron(II) complexes may facilitate rapid reaction with dioxygen.  
 A summary of the dioxygen reactivity of 1 and 2 is shown in Scheme 3.3. Exposure of 1 
to O2 generates (µ-hydroxo)diiron(III) (4) and hexa(µ-hydroxo)tetrairon(III) (5) complexes 
together with a third iron(III) product. Because an additional triphenylacetate ligand is required 
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to form 4 from 1 and O2, some of the remaining diiron(III) units might dimerize to generate 5. 
Comparison of the spectroscopic data for analytically pure samples of 4 and 5 with those of the 
1/O2 reaction product indicates that these compounds do not account for all of the species 
formed. A Mössbauer spectrum (Figure 3.16) shows that at least one additional iron(III) 
compound is present in the oxygenated product of 1, the identity of which is currently unknown. 
 
 
Scheme 3.3. Summary of reaction products characterized in this study. Full representation of the 
PIM2– ligand is omitted for clarity; only its phenolate oxygen and imine nitrogen atoms are 
depicted. See Chart 3.1 for the structure of H2PIM, the doubly protonated form of PIM2-.  
 
When 2 was treated with dioxygen, a mixture of dinuclear species was generated. X-ray 
crystallographic studies show that the products are close chemical relatives, (µ-oxo)diiron(III) (6) 
and di(µ-hydroxo)diiron(III) (7) complexes (Figure 3.19). Unlike 4, which contains three 
carboxylate ligands per diiron unit, 6 and 7 retain a carboxylate-to-iron ratio of two (Figure 
3.20). These results demonstrate that the shape and size of the carboxylate ligands in the 
diiron(II) complexes are critical for controlling the nature of the oxygenation products. From X-
ray crystallographic and solid/solution Mössbauer spectroscopic investigations, we discovered 
	   158 
that the ratio of 6:7 could vary due to uncontrolled amounts of water present during oxygenation 
of 2. The occurrence of both (µ-oxo)diiron(III) and di(µ-hydroxo)diiron(III) species in a single 
crystal suggests that the energetic barrier for their interconversion is low. Complex 6 probably 
forms directly from reaction of 2 with dioxygen and convert to 7 by subsequent reaction with 
water. Such interconversion between (µ-oxo)dimetallic and di(µ-hydroxo)dimetallic units has 
previously been observed. Mössbauer spectroscopic studies revealed that drying of a [FeIII2(µ-
OH)2] complex resulted in extrusion of water to give a [FeIII2(µ-O)] species.62 More recently, 
crystal-to-crystal conversion of a (µ-oxo)divanadium polyoxometalate cluster to a di(µ-
hydroxo)divandium analogue was discovered following exposure of the starting complex to 
water vapor.63 These synthetic studies suggest that similar processes occur at the cores of 
carboxylate-bridged diiron proteins.  
 The structure of 7 closely mimics that of the oxidized core of sMMOHox,18 which also 
contains a di(µ-hydroxo)diiron(III) unit (Figure 3.22B). We attribute the longer Fe–Fe distance in 
7 compared to sMMOHox, however, to the lack of a bridging carboxylate. Notably, switching of 
a bridging ArTolCO2– in 2 to a terminal position in 7 reproduces the redox dependent carboxylate-
shift observed in the BMM proteins.64  
 Upon exposure to excess H2O, 7 dimerizes to form the tetranuclear species 8 (Scheme 
3.3). The tendency for iron complexes to aggregate in this manner is well-documented in the 
porphryin as well as the synthetic diiron literature.65,66 Unlike the BMMs, which encapsulate 
diiron cofactors within a protein matrix to avoid unwanted side reactions, small-molecule mimics 
do not have such exquisite steric protection. By installing more bulky groups around the PIM2– 
ligand periphery, however, it should be possible to prevent formation of polynuclear species. 
Furthermore, having a bulkier ligand platform may allow assembly of diiron(II) models with less 
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sterically encumbering carboxylate units and facilitate dioxygen binding or improve hydrocarbon 
substrate access to the diiron core.  
 
3.5. Conclusion 
 Using ligand design, we constructed more accurate models of the carboxylate-bridged 
diiron active sites of bacterial multi-component monooxygenases. To do so we developed the 
new macrocylic ligand H2PIM, which could be readily prepared in multi-gram quantities and in 
good yields. In the presence of external carboxylates and [Fe2(Mes)4], H2PIM self-assembles to 
form diiron(II) complexes that reproduce the syn orientation of nitrogen donors as well as the 
bridging modes of carboxylate ligands in the proteins. Electrochemical studies of the diiron(II) 
units suggest that isostructural diiron(II,III) species may be isolable, or at least trappable, for 
characterization. These diiron(II) compounds react rapidly with dioxygen to give a variety of 
iron-containing species, including (µ-hydroxo)diiron(III), (µ-oxo)diiron(III), di(µ-
hydroxo)diiron(III), and hexa(µ-hydroxo)tetrairon(III) complexes. The composition of the 
oxygenation products is determined in part by the nature of the carboxylate ligand and the 
presence of water. Because we can now access both the reduced and oxidized forms of the 
BMMs in a single synthetic platform, detailed studies of the O2 reaction pathway using these 
models should be able to address some remaining questions concerning the chemistry of 
carboxylate-bridged diiron proteins.  
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Chapter 4 
Carboxylate as the Protonation Site in 
 (Peroxo)diiron(III) Model Complexes of Soluble Methane 
 Monooxygenase and Related Diiron Proteins 
 
 
 
 
 
 
 
 
Portions of this chapter have appeared in print: 
Loi H. Do, Takahiro Hayashi, Pierre Moënne-Loccoz, Stephen J. Lippard. “Carboxylate as the 
Protonation Site in (Peroxo)diiron(III) Model Complexes of Soluble Methane Monooxygenase 
and Related Diiron Proteins.” J. Am. Chem. Soc., 2010, 132(4), 1273–1275.  
 166 
4.1. Introduction  
An important subclass of the diiron protein family is the bacterial multi-component 
monooxygenases (BMMs),1 which comprises soluble methane monooxygenase (sMMO),2 
toluene/o-xylene monooxygenase (ToMO),3-5 phenol hydroxylase (PH),6 and alkene 
monooxygenase (AMO),7 among others.8,9 All of these enzymes require multiple proteins for 
efficient chemical catalysis, including a hydroxylase component that contains two identical 
carboxylate-bridge diiron cofactors, a reductase component that delivers electrons from 
nicotinamde adenine dinucleotide (NADH) through a [2Fe–2S] cluster to the hydroxylase, and a 
regulatory component that is postulated to control electron transfer and substrate oxidation. 
Exposing O2 to the diiron(II) form of the hydroxylase leads to formation of (peroxo)diiron(III) 
intermediates that are capable of hydroxylating and epoxidizing hydrocarbons. In the unique case 
of soluble methane monooxygenase hydroxylase (sMMOH), one of two natural biological 
systems known to convert methane to methanol,10 the (peroxo)diiron(III) (Hperoxo) species forms 
a higher-valent diiron(IV) complex (intermediate Q)11 before decaying to the resting state of the 
enzyme (sMMOHox) (Scheme 4.1). Despite many years of research by our group and others on 
the structural and mechanistic details of the BMM proteins,12-14 important aspects of their 
biochemistry are still unknown.  Some remaining questions are: What are the structures of the 
oxygenated intermediates? Does oxygen–atom transfer by (peroxo)diiron(III) species to 
substrates occur through heterolytic or homolytic O–O bond scission? What features allow 
sMMOH to generate a diiron(IV) species that is distinct from that of other BMMs?15-18  
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Scheme 4.1. The proposed catalytic cycle of soluble methane monooxygenase hydroxylase 
(sMMOH). Conversion of P* to Hperoxo and Hperoxo to Q occur more rapidly under low pH 
conditions. Intermediates Hperoxo and Q are both capable of oxidizing organic substrates but 
exhibit different reactivity profiles.19 
 
 
Chart 4.1. The four (peroxo)diiron(III) model complexes that have been structurally 
characterized by X-ray diffraction analysis. They are [Fe2(µ-O2)(N-EtHPTB)(OPPh3)2]3+ (top 
left),20 [Fe2(µ-O2)(Ph-bimp)(PhCO2)]2+ (top right),21 [Fe2(µ-O2)(HB(iPrpz)3)2(PhCH2CO2)2] 
(bottom left),22 and [Fe2(µ-O)(µ-O2)(6Me2-BPP)2] (bottom right). 23 
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 Re-investigation of the dioxygen activation pathway in sMMOH from Methylococcus 
capsulatus (Bath, Mc) revealed that the rates corresponding to P* decay/Hperoxo formation as well 
as Hperoxo decay/Q formation are significantly slower at high pH (Scheme 4.1).24 The pH 
dependence for these events was taken as evidence that protons are required for further activation 
of the (peroxo)diiron(III) units, in P* and Hperoxo. Similar results have also been reported for 
studies of sMMOH obtained from Methylosinus trichosporium OB3b.13,25 Given the complexity 
of the protein environment, indentifying the sites involved in proton translocation and their effect 
on the O2 reduction pathway has been difficult to examine directly in the biological system. To 
shed light on the possible role of protons in the dioxygen activation chemistry at carboxylate-
bridged diiron enzyme active sites, several structurally characterized (peroxo)diiron(III) 
complexes were examined as possible synthetic mimics of P* and Hperoxo (Chart 4.1).20-23 
Although the structure of the (µ-peroxo)(µ-carboxylato)diiron(III) complex [Fe2(µ-O2)(N-
EtHPTB)(µ-PhCO2)]2+ (1a⋅O2) is not known, its spectroscopic features suggest an Fe2O2 core 
similar to that of the crystallographically determined [Fe2(µ-O2)(N-EtHPTB)(OPPh3)2]3+ 
analogue (Chart 4.1, top left).20,26 The dinucleating N-EtHPTB ligand provides kinetic 
stabilization of the Fe2O2 core and the benzoate group serves as a good mimic of the Asp and 
Glu carboxylate side chains in the protein diiron centers. We postulated that addition of an H+ 
donor to 1a⋅O2 would result in either protonation of the bridging carboxylate ([1a⋅O2]H+) or the 
reduced dioxygen moiety ([1a⋅O2H]+) (Scheme 4.2). Through application of several 
spectroscopic methods, we show that the reaction of H+ with 1a⋅O2 results in protonation at the 
carboxylate unit rather than the peroxo ligand and that the process is reversible. This work 
provides experimental support for recent theoretical studies suggesting that (hydroperoxo)-
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diiron(III) species of non-heme diiron enzymes are too reactive to be isolable protein 
intermediates.27  
 
Scheme 4.2. Reaction of 1a with dioxygen leads to formation of a (µ-1,2-peroxo)diiron(III) 
complex, 1a·O2, that is stable at temperatures below -30 °C. Addition of H+ to 1a·O2 was 
postulated to protonate either the carboxylate group, giving [1a·O2]H+, or the peroxo moiety, 
giving [1a·O2H]+. The spectroscopic data suggest that the carboxylate is the preferred 
protonation site. Treatment of [1a·O2]H+ with triethylamine results in conversion back to 1a·O2.  
 
4.2. Experimental  
Materials and Methods: Commercial reagents were used as received without further 
purification. All air-sensitive manipulations were performed using standard Schlenk techniques 
or under a nitrogen atmosphere inside an MBraun drybox. Solvents were saturated with argon 
and purified by passage through two columns of activated alumina. The H-N-EtHPTB ligand,28 
[Fe2(N-EtHPTB)(PhCO2)](BF4)2 complex,26 and [H(OEt2)2][(3,5-(CF3)2C6H3)4B] (H[BArF4])29,30 
compound were synthesized according to literature procedures. The 40% iron-57 enriched 
Fe(OSO2CF3)2⋅2CH3CN salt was prepared from 57Fe/56Fe metal (2:3) and 
trifluoromethanesulfonic acid.31 Benzoic acid 99% enriched with 13C at the carboxylate carbon 
atom was purchased from Cambridge Isotopes Laboratories, Inc.  
General Physical Methods: NMR spectra were recorded on 500 MHz Varian Mercury 
spectrometers. Chemical shifts for 1H NMR spectra were referenced to residual solvent peaks 
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and 19F NMR spectra were referenced externally to trifluoromethylbenzene (δ = -63.72 ppm). 
Electrospray ionization mass spectra were obtained using an Agilent Technologies 1100 Series 
LC-MSD Trap. Absorption spectra were acquired on a Cary 50 spectrophotometer using a 
custom-made quartz cuvette (path length = 1.74 cm) containing a jacketed dewar. An 
acetonitrile/dry ice bath was used to maintain the samples at -30 ºC. Zero field 57Fe Mössbauer 
spectra were recorded at 90 K on an MSI spectrometer (WEB Research Company) with a 57Co 
source in a Rh matrix. The isomer shift (δ) values are reported with respect to metallic iron that 
was used for velocity calibration and the spectra were fit to Lorentzian lines using the WMOSS 
program. Resonance Raman spectra were measured by Dr. Takahiro Hayashi and Prof. Pierre 
Moënne-Loccoz at Oregon Health and Science University and were acquired with a custom-built 
McPherson 2061/207 spectrometer equipped with a Princeton Instrument liquid N2 cooled CCD 
detector. All samples were obtained with 647 nm laser excitation at 110 K. Solid state and 
solution FTIR spectra of air-stable compounds were acquired with a ThermoNicolet Avatar 360 
spectrophotometer using the OMNIC software. Solid samples were prepared as KBr pellets and 
solutions were injected into a Specac OMNI liquid IR cell (CaF2 windows, 0.10 mm spacer). 
Air-sensitive solution IR measurements were collected with a Mettler Toledo ReactIR ic 10 unit 
equipped with a SiComp K4 conduit probe (ATR). Data were recorded using the ic IR software 
(v. 4.0) and baseline corrected using the OMNIC program.  
Synthesis  
[Fe2(N-EtHPTB)(PhCO2)](BPh4)2 [1a⋅(BPh4)2]. Inside a nitrogen drybox, H-N-EtHPTB (300 
mg, 0.417 mmol), benzoic acid (51 mg, 0.417 mmol), sodium tetraphenylborate (571 mg, 1.67 
mmol) and triethylamine (0.13 mL, 0.917 mmol) were combined with 5 mL of CH3CN and 
stirred at RT. Upon addition of FeCl2⋅4H2O (166 mg, 0.833 mmol), the mixture became a light 
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yellow color. The heterogeneous solution was stirred for 2 h at RT and then filtered to remove 
the insoluble material. After removal of CH3CN in vacuo, the resulting solid was extracted into 
CH2Cl2. The remaining solid was removed by filtration and the DCM solution was evaporated to 
dryness and layered with diethyl ether to afford a light yellow powder upon standing at -30 °C 
(532 mg, 80 %). 1H NMR (CD3CN, 500 MHz): 153.71, 107.44, 78.72, 55.11, 34.12, 22.78, 
20.89, 19.21, 14.37, 12.61, 11.46, 8.78, 7.06, 5.57, 4.66, 4.09, 3.10, 0.21, -9.32 ppm. IR (KBr): ν 
3055, 2978, 1593, 1578, 1550 (asym. COO– stretch), 1490, 1480, 1453, 1425, 1401 (sym. COO– 
stretch), 1330, 1294, 1267, 1236, 747, 695 cm-1. UV-vis: λmax (CH3CN) = 335 nm (1210  
cm–1M–1). Mp = 175-179 °C. ESI-MS(+) = 1273.6 [1a+BPh4–]+. Anal. Calc. for 1a⋅(BPh4)2, 
Fe2C98H94B2N10O3: C, 73.88; H, 5.95; N, 8.79. Found: C, 73.74; H, 6.00; N, 8.82.  
[Fe2(N-EtHPTB)(Ph13CO2)](BPh4)2 [1b⋅(BPh4)2]. The same procedure was used as described 
for the synthesis of [1a⋅(BPh4)2], except that carbon-13 enriched PhCO2H was employed instead 
of natural abundance benzoic acid. IR (KBr): ν 3055, 2978, 1578, 1518 (asym. COO– stretch), 
1490, 1485, 1453, 1425, 1375 (sym. COO– stretch), 1330, 1294, 1267, 1236, 747, 695 cm-1. ESI-
MS = 1274.9 [1b + BPh4–]+. 
 [57Fe2(N-EtHPTB)(PhCO2)](OSO2CF3)2 [57Fe-1a⋅(OSO2CF3)2]. Inside a nitrogen drybox, H-
N-EtHPTB (100 mg, 0.139 mmol), benzoic acid (17 mg, 0.139 mmol), 57Fe(OSO2CF3)2⋅2CH3CN 
(121 mg, 0.278 mmol), and triethylamine (0.13 mL, 0.917 mmol) were combined with 3 mL of 
CH3CN and stirred at RT for 1 h. The resulting solid was isolated by filtration and washed with 
diethyl ether to afford a light yellow material (110 mg, 63%). 1H NMR (CD3CN, 500 MHz): 
153.29, 106.58, 78.73, 55.56, 34.58, 22.69, 20.92, 20.60, 13.90, 12.60, 11.42, 8.71, 7.47, 7.36, 
4.61, 4.10, 1.56, 0.11, -8.87 ppm. IR (KBr): ν 2981, 2944, 1597, 1554, 1492, 1454, 1400, 1339, 
1260, 1224, 1156, 1030, 980, 952, 928, 894, 748, 718, 638, 573, 518 cm–1. UV-vis: λmax 
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(CH3CN) = 335 nm (1490 cm–1M–1). Mp = 300 °C (decomp.). ESI-MS(+) = 1103.7 
[1a+OSO2CF3–]+. Anal. Calc. for 1a⋅(OSO2CF3)2, Fe2C52H54F6N10O9S2: C, 49.85; H, 4.34; N, 
11.18. Found: C, 49.22; H, 4.40; N, 11.28.  
[Fe2(N-EtHPTB)(C6F5CO2)](OSO2CF3)2 [2⋅(OSO2CF3)2]. Inside a nitrogen drybox, H-N-
EtHPTB (500 mg, 0.694 mmol), pentafluorobenzoic acid (147 mg, 0.694 mmol), 
Fe(OSO2CF3)2⋅2CH3CN (606 mg, 1.39 mmol), and triethylamine (0.22 mL, 1.53 mmol) were 
combined with 5 mL of CH3CN and stirred at RT for 1 h. The resulting solid was isolated by 
filtration and washed with diethyl ether to afford a light yellow material (690 mg, 74%). 1H 
NMR (CD3CN, 500 MHz): 151.54, 106.10, 80.99, 56.80, 39.30, 20.76, 18.52, 13.41, 12.42, 
11.14, 8.70, 7.75, 7.15, 4.22, 3.86, 2.61, 1.65, 0.16, -6.56 ppm. 19F NMR (CD3CN, 470 MHz): -
77.8 (s, 6F), -113.87 (s, 2F), -135.71 (s, 2F), -148.12 (s, 1F) ppm. IR (KBr): ν 2984, 2942, 1650, 
1607, 1530, 1490, 1455, 1380, 1341, 1276, 1262, 1224, 1162, 1030, 1003, 986, 893, 748, 638, 
574, 517 cm–1. UV-vis: λmax (CH2Cl2) = 315 nm (sh, 1170 cm–1M–1). Mp = 302 °C (decomp). 
ESI-MS(+) = 1193.2 [2+OSO2CF3–]+. Anal. Calc. for 2⋅(OSO2CF3)2, Fe2C52H49F11N10O9S2: C, 
46.51; H, 3.68; N, 10.43. Found: C, 46.49; H, 3.70; N, 10.34.  
[57Fe2(N-EtHPTB)(C6F5CO2)](OSO2CF3)2 [57Fe-2⋅(OSO2CF3)2]. The same procedure was used 
as described for the synthesis of [2⋅(OSO2CF3)2], except that 40% iron-57 enriched 
Fe(OSO2CF3)2⋅2CH3CN was employed instead of the natural abundance iron(II) salt. 
[Fe2(N-EtHPTB)(C6F5CO2)](BPh4)2 [2⋅(BPh4)2]. The same procedure was used as for the 
synthesis of [1a⋅(BPh4)2], except that pentafluorobenzoic acid was used instead of benzoic acid. 
The final product was isolated as a light yellow solid (340 mg, 50%). 1H NMR (CD3CN, 500 
MHz): 151.85, 106.43, 80.57, 56.31, 39.57, 20.70, 10.17, 12.27, 11.00, 8.58, 7.60, 7.28, 7.13, 
6.99, 6.84, 4.27, 3.77, 2.56, 1.69, -0.20, -6.78 ppm. 19F NMR (CD3CN, 282 MHz): -117.26 (s, 
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2F), -140.21 (s, 2F), -148.70 (s, 1F) ppm. IR (KBr): ν 3054, 2983, 1651, 1608, 1580, 1522, 1491, 
1481, 1453, 1427, 1397, 1330, 1294, 1269, 1132, 1110, 997, 891, 746, 706, 612 cm–1. UV-vis: 
λmax (CH2Cl2) = 315 nm (sh, 2070 cm–1M–1). Mp = 185-189 °C. ESI-MS(+) = 1363.6 [2+BPh4–
]+. Anal. Calc. for 2⋅(BPh4)2, Fe2C98H89F5B2N10O3: C, 69.93; H, 5.33; N, 8.32. Found: C, 69.88; 
H, 5.18; N, 8.19.  
Spectroscopic Studies 
UV-Vis Spectroscopy: Addition of H[BArF4] to a CH3CN solution containing either 1a⋅O2(BF4)2 
or 2⋅O2(OSO2CF3)2 at -30 ºC. Inside a nitrogen glovebox, a 6.0 mL aliquot of a 112 µM CH3CN 
solution of 1a⋅(BF4)2 or 2⋅(OSO2CF3)2 was added to a low temperature UV-vis cell, which was 
sealed with a septum. The cell was brought outside of the glovebox and cooled to -30 ºC with an 
acetonitrile/dry ice bath. To generate the (peroxo)diiron(III) species, the septum seal was 
removed and the sample solution was exposed to air and stirred for 15 min. A UV-vis spectrum 
was recorded. Successive aliquots of a 1.78 mM solution of H[BArF4] in CH3CN were added to 
the (peroxo)diiron(III) solution via syringe and the spectral changes were measured. For the 
protonated complex of 1a⋅O2(BF4)2, addition of 2.0 equiv of triethylamine (relative to 1a⋅(BF4)2) 
led to restoration of the 1a⋅O2(BF4)2 spectrum. Spectra were corrected for dilution where 
appropriate. 
57Fe Mössbauer Spectroscopy: Addition of H[BArF4] to a CH3CN solution containing either 
57Fe-1a⋅O2(OSO2CF3)2 or 57Fe-2⋅O2(OSO2CF3)2. A 8.0 mM CH3CN solution of either 57Fe-
1a⋅(OSO2CF3)2 or 57Fe-2⋅(OSO2CF3)2 was prepared anaerobically and cooled to -30 ºC. The 
diiron(II) compound was exposed to air for 15 min and the resulting mixture was divided into 
two portions. One portion was frozen in liquid nitrogen in a Nylon Mössbauer sample cup and 
the other was treated with 1.0 equiv of H[BArF4], relative to 57Fe-1a⋅O2 or 57Fe-2⋅O2, and then 
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frozen in a second sample cup. The Mössbauer spectra of the samples were recorded over a 
period of ~12 h. In all cases, the data were best fit to a single quadrupole doublet. 
Resonance Raman Spectroscopy: Addition of H[BArF4] to a CH3CN solution containing either 
1a⋅O2(BF4)2 or 2⋅O2(OSO2CF3)2. A 5.9 mM CH3CN solution of either 1a⋅(BF4)2 or 
2⋅(OSO2CF3)2 was prepared anaerobically and cooled to -30 ºC. The diiron(II) compound was 
exposed to air for 15 min to generate the (peroxo)diiron(III) complex. A 200 µL aliquot of the 
1a⋅O2 or 2⋅O2 solution was quickly transferred to an NMR tube and frozen in liquid nitrogen. To 
prepare the protonated 1a⋅O2 and 2⋅O2 samples, 500 µL of the starting (peroxo)diiron(III) 
solution was combined with the appropriate volume of a 59.3 mM solution of H[BArF4] and 
diluted with cold CH3CN to give a final diiron concentration of ~5.0 mM. Approx. 200 µL of the 
resulting solutions were added into separate NMR tubes and frozen.  
Solution IR Spectroscopy: Measurement of diiron(II) complexes in CH2Cl2. Inside a nitrogen 
glovebox, a 3.0 mL solution of 1a⋅(BPh4)2, 1b⋅(BPh4)2, or 2⋅(BPh4)2 (15.0 mM) was transferred 
to a ReactIR Schlenk vessel and sealed with a Teflon screwcap. The flask was brought outside of 
the glovebox, opened under a stream of nitrogen, and attached to the ReactIR probe. 
Measurements were made at RT. Solvent peaks were subtracted from all spectral data. 
Addition of H[BArF4] to a CH2Cl2 or CD3CN solution containing either 1a⋅O2(BPh4)2 or 
1b⋅O2(BPh4)2. Inside a nitrogen drybox, a ~55 mM solution of 1a⋅(BPh4)2 or 1b⋅(BPh4)2 was 
sealed in a scintillation vial. The solution was brought outside of the drybox, cooled to -30 °C, 
and stirred in air for 5 min to generate the (peroxo)diiron(III) species. An aliquot of the dark 
blue-green mixture was treated with an appropriate amount of H[BArF4] and stirred for an 
additional 5 min. Approximately 100 µL of each solution was injected into a liquid IR cell that 
has been pre-cooled over dry ice. IR spectra of the cold samples were recorded over a period of 
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~30 sec. Identical measurements using the ReactIR system, which maintains a constant low 
temperature throughout the experiment, gave the same results, demonstrating that the 
(peroxo)diiron(III) species are stable during data acquisition in the liquid IR cell. Spectral data 
were subtracted from a nitrogen background and baseline corrected, but not solvent subtracted.  
1H and 19F NMR Spectroscopy: Addition of H[BArF4] to a solution containing either 
1a⋅O2(BF4)2 or 2⋅O2(OSO2CF3)2. A 8.0 mM solution of 1a⋅(BF4)2 or 2⋅(OSO2CF3)2 was prepared 
anaerobically and cooled to -30 ºC. The sample was exposed to air to form the 
(peroxo)diiron(III) species and divided into two equal portions. One portion was transferred to an 
NMR tube as the 1a⋅O2 or 2⋅O2 sample. To the other solution, 1.0 equiv of H[BArF4] was added 
and then transferred to a second NMR tube. Both the NMR samples and probe were maintained 
at -30 ºC to ensure the stability of the (peroxo)diiron(III) species throughout the experiment.  
 
4.3. Results and Discussion 
  To aid spectral interpretation of results obtained during studies of the parent [Fe2(N-
EtHPTB)(PhCO2)]2+ complex (1a), two related diiron(II) precursors were synthesized. One is 
[Fe2(N-EtHPTB)(Ph13CO2)]2+ (1b), which contains a 13C-enriched carboxylate ligand, and the 
other is [Fe2(N-EtHPTB)(C6F5CO2)]2+ (2), in which the benzoate ring is fully fluorinated. 
  Exposure of 1a to O2 in CH3CN at -30 ºC generated a deep blue-green solution (1a⋅O2) 
with λmax at 590 nm.26 Addition of an acetonitrile solution of [H(OEt2)2][(3,5-(CF3)2C6H3)4B] 
(H[BArF4]) to 1a⋅O2 shifted the peroxo-to-iron(III) charge transfer band to ~600 nm (Figure 
4.1A). This absorption was assigned to the formation of a new [1a⋅O2]H+ species that maximized 
with addition of ~1.5 equiv of H[BArF4]. The spectrum of 1a⋅O2 was restored upon addition of 
2.0 equiv of NEt3 (Figure 4.1B), indicating that protonation does not lead to irreversible 
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decomposition of the 1a⋅O2 unit. Reaction of 2 with O2 afforded [Fe2(µ-O2)(N-
EtHPTB)(C6F5CO2)]2+ (2⋅O2), which exhibits a broad absorption feature centered at ~600 nm. 
When H[BArF4] was titrated into a solution of 2⋅O2, a small bathochromic shift to ~610 nm 
occurred (Figure 4.2). Unlike 1a⋅O2, 2⋅O2 required ~3.0 equiv of H[BArF4] to fully generate the 
protonated species [2⋅O2]H+. Given that pentafluorobenzoate, for which the acid has a pKa of 1.2, 
is more electron deficient than benzoate (acid pKa = 4.6), the greater amount of H+ necessary to 
produce [2⋅O2]H+ from 2⋅O2 compared to [1a⋅O2]H+ from 1a⋅O2 suggested that either the 
carboxylate ligand influences the basicity of the protonation site or that it itself is the proton 
acceptor. 
 
Figure 4.1. UV-vis absorption spectra of A) 1a·O2 (112 µM in CH3CN, -30 °C) before (dotted 
trace) and after (blue trace) addition of 2.0 equiv of H[BArF4] and B) restoration of the initial 
spectrum (orange trace) upon treatment with 2.0 equiv of triethylamine. 
 
 
  To determine whether a (hydroperoxo)diiron(III) species may form upon addition of H+ 
to 1a⋅O2 or 2⋅O2, 57Fe Mössbauer and resonance Raman (RR) spectra were recorded to examine 
possible changes in the Fe2O2 core. In the absence of H+, the Mössbauer spectrum of a frozen 
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Figure 4.2. UV-vis absorption spectra of [Fe2(µ-O2)(N-EtHPTB)(C6F5CO2)](OSO2CF3)2 (112 
µM in CH3CN, -30°C) after addition of up to 4.8 equiv of H[BArF4], relative to the diiron 
complex. The (peroxo)diiron(III) species displays a λmax at ~600 nm, whereas the protonated 
complex shows a shifted absorption band centered at ~610 nm. Black dotted line = compound 
2·O2, solid lines = spectra after addition of up to 4.8 equiv of H[BArF4].  
 
 
solution of 1a⋅O2 in CH3CN was fit to a single iron site, with δ = 0.53(2) mm/s and ΔEQ = 
0.71(2) mm/s (Figure 4.3A, Table 4.1). Addition of H[BArF4]  to 1a⋅O2 gave [1a⋅O2]H+ having 
the same isomer shift (δ = 0.53(2) mm/s) and a slightly larger quadrupole splitting parameter 
(ΔEQ = 0.80(2) mm/s) (Figure 4.3B, Table 4.1). For comparison, the Mössbauer spectra of 2⋅O2 
and [2⋅O2]H+ were also recorded. The (peroxo)diiron(III) complex of 2 has parameters δ = 
0.53(2) mm/s and ΔEQ = 0.77(2) mm/s (Figure 4.3C, Table 4.1), whereas the protonated [2⋅O2]H+ 
form exhibits parameters of δ = 0.54(2) mm/s and ΔEQ = 0.84(2) mm/s (Figure 4.3D). The 
similar isomer shifts obtained for 1a⋅O2, [1a⋅O2]H+, 2⋅O2, and [2⋅O2]H+ are indicative of iron(III) 
centers and the small increase in ΔEQ values for the protonated forms implies that only minor 
changes occur in the coordination environment.  
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Table 4.1. UV-Vis, Mössbauer, RR, and FTIR Data for 1a⋅O2, [1a⋅O2]H+, 2⋅O2, and [2⋅O2]H+. 
 
 
 
 
Figure 4.3. Zero-field 57Fe Mössbauer spectra of frozen CH3CN solutions containing ~8 mM A) 
[57Fe2(µ-O2)(N-EtHPTB)(PhCO2)](OSO2CF3)2 (δ = 0.53(2) mm/s, ΔEQ = 0.71(2) mm/s, Γ = 
0.42(2) mm/s); B) [57Fe2(µ-O2)(N-EtHPTB)(PhCO2)](OSO2CF3)2/ H[BArF4] (1:1) (δ = 0.53(2) 
mm/s, ΔEQ = 0.80(2) mm/s, Γ = 0.43(2) mm/s); C), [57Fe2(µ-O2)(N-EtHPTB)(C6F5CO2)]-
(OSO2CF3)2 (δ = 0.53(2) mm/s, ΔEQ = 0.77(2) mm/s, Γ =0.34(2) mm/s); and D) [57Fe2(µ-O2)(N-
EtHPTB)(C6F5CO2)](OSO2CF3)2/ H[BArF4] (1:1) (δ = 0.54(2) mm/s, ΔEQ = 0.84(2) mm/s, Γ = 
0.36(2) mm/s). The spectra were acquired at 90 K and the raw data (•) were fit to Lorentzian 
 
λmax, nm 
(ε, M-1 cm–1) 
δ , 
mm/s 
ΔEQ, 
mm/s 
ν  (Fe–O), 
cm-1 (Δ18O) 
ν  (O–O), 
cm-1 (Δ18O) 
νas(COO–) 
cm-1 (Δ13C) 
ν s(COO–) 
cm-1 (Δ13C) 
Δνas-s 
cm-1 
1a⋅O2 590 (3100) 0.53(2) 0.71(2) 466/474 (–18) 897 (–50) 
1607/1572  
(>–22) 1358 (–29) >200 
[1a⋅O2]H+ 600 (2360) 0.53(2) 0.80(2) 467/478 (–20) 896 (–53) 1553 (–32) - - 
2⋅O2 600 (3300) 0.53(2) 0.77(2) 466/475 (–18) 897 (–50) - - - 
[2⋅O2]H+ 610 (2700) 0.54(2) 0.84(2) 478 (–19) 897 (–50) - - - 
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least square lineshapes (black trace). The minor peaks in spectra A and B were not included in 
the data fitting and are attributed to unreacted diiron(II) starting material. 
 
 
 
Figure 4.4. Resonance Raman spectra of frozen CH3CN solutions of [Fe2(µ-O2)(N-
EtHPTB)(PhCO2)](BF4)2 (16O2: black; 18O2: red; and 18O2-sample minus 16O2-contaminant: blue) 
with (A, top) and without (B, bottom) addition of 1.0 equiv of H[BArF4], relative to the diiron 
complex. Each spectrum was normalized based on the solvent bands at 392, 400, and 920 cm-1. 
Top spectra: ν = 897 (847), 532/513 (500), 474/466 (452) cm–1. Bottom spectra: ν = 896 (843), 
533/514 (501), 478/467 (458) cm–1.	  
 
Figure 4.5. Resonance Raman spectra of 2·16O2 (black) and 2·18O2 (red) after addition of 0 (A), 
0.5 (B), 1.0 (C), 1.5 (D), and 2.0 (E) equiv of H[BArF4]. Each spectrum was normalized based on 
the solvent CH3CN bands at 392, 400, and 920 cm-1. Before addition of protons: ν = 910/897/886 
(847), 532/513 (500), 475/466 (457/449) cm–1. After addition of protons: ν = 910/897/886 (847), 
532/513 (500), 478/467 (459) cm–1.  
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  To investigate more directly the nature of the peroxo moiety, Fe–O and O–O vibrations 
were measured by resonance Raman (RR) spectroscopy for species generated with both 16O2 and 
18O2. As previously reported,26 1a⋅O2 exhibits Fe–O and O–O stretching vibrations with Fermi 
splitting (hereafter “/”) centered at 470 and 897 cm-1, respectively (Figure 4.4). Also observed are 
weaker bands at 513/532 cm-1 that shifted to 500 cm-1 with 18O2, which we assigned to the 
asymmetric Fe–O stretch of the Fe2O2 core. Addition of H+ to 1a⋅O2 only marginally affects its 
RR spectrum, with small upshift in Fe–O and downshift in O–O vibrations (Figure 4.4, Table 
4.1). These shifts in RR frequencies upon H+ addition may reflect subtle changes in Fe–O–O–Fe 
angles,32 but are too small to support the conclusion that a (µ-1,2-peroxo)diiron(III) unit has been 
converted to a (hydroperoxo)diiron(III) species. The RR spectrum of 2⋅O2 is practically identical 
to that of 1a⋅O2, with symmetric and asymmetric Fe–O modes at 466/475 and 513/532 cm-1, 
respectively, and Fermi-coupled O–O stretches centered at 897 cm-1 (Figure 4.5). Addition of up 
to 2.0 equiv of H[BArF4] to generate [2⋅O2]H+ primarily affects the symmetric Fe–O stretch, 
which upshifts only a few wavenumbers compared to the spectrum of 2⋅O2 (Table 4.1). From the 
RR data and Mössbauer parameters for 1a⋅O2, [1a⋅O2]H+, 2⋅O2, and [2⋅O2]H+, we conclude that 
protonation does not lead to formation of a (hydroperoxo)diiron(III) species.  
  Since the benzimidazole, amine, and propoxyl groups of N-EtHPTB are less accessible 
due to the multidentate nature of the ligand, we assign the carboxylate unit as the site of 
protonation. To test this hypothesis, we examined the carboxylate stretches of 1a and 1b, and 
their peroxo complexes by FTIR spectroscopy. The assignment of frequencies in terms of 
coordination geometry is complicated by mixing of the COO– symmetric stretch with the O–C–O 
bend and C–C stretch.33 Nevertheless, if the asymmetric and symmetric COO– stretches could be 
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Figure 4.6. Infrared spectra of [Fe2(N-EtHPTB)(PhCO2)](BPh4)2 (1a, green) and [Fe2(N-
EtHPTB)(Ph13CO2)](BPh4)2 (1b, orange) in the solid state (KBr pellet, panel A) and in solution 
(CH2Cl2, panel B). Panel A: ν1a = 1330, 1401, 1425, 1453, 1480, 1490, 1550, 1573, 1593 cm–1. 
ν1b = 1330, 1375, 1425, 1453, 1480, 1490, 1518, 1573 cm–1. Panel B: ν1a = 1332, 1389, 1426, 
1457, 1479, 1493, 1555, 1580, 1597 cm–1. ν1b = 1332, 1377, 1426, 1457, 1479, 1493, 1526, 1580 
cm–1. The peaks at 1550 (1555) and 1518 (1526) cm-1 are assigned to asymmetric COO– 
stretches (where values in parentheses are for the solution data), and peaks at 1401 (1389) and 
1375 (1377) cm-1 are attributed to symmetric COO– vibration modes. 
 
 
identified, the binding geometry of the carboxylate ligand could be derived from the difference 
in the two, Δνas-s.34-36 Specifically, Δνas-s should be close to that of the free ionic form for 
carboxylates bridging two metal ions (150 cm-1 for PhCOO–),  larger in unidentate coordination 
geometry, and smaller in bidentate mononuclear complexes. As expected, 1a and 1b exhibited 
Δνas-s values of 149 and 166 cm-1, respectively, consistent with µ-1,3 bridging carboxylate 
groups (Figure 4.6). In CH2Cl2, 1a⋅O2 displayed νas and νs stretches at 1572/1607 and 1358 cm-1, 
respectively, whereas 1b⋅O2 showed peaks at 1550 and 1329 cm-1 (Figure 4.7A). These 
frequencies give Δνas-s > 200 cm-1 and suggest a switch from bridging to unidentate coordination 
for the carboxylate groups in 1a⋅O2 and 1b⋅O2. Shifting of a phosphinate ligand from a bridging 
to a terminal position has been reported for the (peroxo)diiron(III) unit supported by N-
EtHPTB.37 A bridging benzoate, however, has been observed in the X-ray structure of a 
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(peroxo)diiron(III) complex containing a related ligand system.21 Generation of [1a⋅O2]H+ and 
[1b⋅O2]H+ was associated with downshift of the νas modes by at least 20 cm-1, whereas νs modes 
were not observed, possibly shifting below 1300 cm-1 (Figure 4.7B and 4.8D). The FTIR spectra 
in CH2Cl2 are similar to those in CD3CN and do not show evidence for free benzoic acid in the 
H+ treated samples. With the use of the less basic carboxylate C6F5CO2–, present in 2, 
protonation leads to free pentafluorobenzoic acid, but only in the coordinating solvent 
acetonitrile and not in dichloromethane (Figure 4.8). The peaks at 1529, 1654, and 1739 cm–1 are 
diagnostic of uncoordinated pentafluorobenzoic acid.  
 
Figure 4.7. Solution FTIR spectra of 1a⋅O2 (black) and 1b⋅O2 (red) before (A and C) and after 
(B and D) the addition of 1.5 equiv of H[BArF4]. Spectra A and B were acquired in CH2Cl2 
whereas spectra C and D were measured in CD3CN. The samples were recorded at approx. -30 
 183 
°C with a diiron concentration of ~55 mM. The intense peaks at 1354/1356 and 1420 cm-1 are 
due to the [BArF4]– anion and solvent, respectively. Panel A: ν1a = 1358, 1389, 1456, 1481, 1497, 
1572, 1607 cm–1. ν1b = 1329, 1369, 1389, 1456, 1481, 1497, 1550 cm–1. Panel B: ν1a = 1372, 
1456, 1483, 1494, 1553, 1596, 1609 cm–1. ν1b = 1456, 1483, 1494, 1521, 1596, 1609 cm–1. Panel 
C: ν1a = 1356, 1388, 1456, 1481, 1495, 1579, 1616 cm–1. ν1b = 1326, 1372, 1456, 1481, 1495, 
1557, 1579 cm–1. Panel D: ν1a = 1386, 1455, 1481, 1496, 1554, 1597, 1611 cm–1. ν1b = 1386, 
1455, 1481, 1496, 1518, 1597, 1611 cm–1. 
 
 
Figure 4.8. Solution FTIR spectra of 2⋅O2 before (purple) and after (green) the addition of 3.0 
equiv of H[BArF4]. Spectra in A were acquired in CH2Cl2 and spectra in B were obtained in 
CD3CN at -30 °C with a diiron concentration of ~55 mM. For A, the intense peaks at 1356 and 
1420 cm-1 due to the [BArF4]– anion and CH2Cl2, respectively. For B, the resonances at 1529, 
1654, and 1739 (vC=O) are attributed to formation of free pentafluorobenzoic acid. The absence of 
the 1739 cm-1 absorbance in A is taken as evidence that pentafluorobenzoic acid is not liberated 
in CH2Cl2. Panel A: νpurple = 1370, 1454, 1497, 1525, 1610, 1652 cm–1. vgreen = 1370, 1382, 1454, 
1497, 1525, 1610, 1652 cm–1. Panel B: νpurple = 1360, 1456, 1497, 1529, 1635 cm–1. vgreen = 1385, 
1456, 1497, 1529, 1610, 1654, 1739 cm–1. 
 
  A comparison of the 1H NMR spectra of the benzoate and pentafluorobenzoate diiron 
complexes allowed the phenyl ring protons of the former to be identified in 1a⋅O2 as 
paramagnetically broadened peaks at 7.01, 8.74, and 11.40 ppm (Figure 4.9A). Upon addition of 
H[BArF4], these resonances shifted to 7.50, 7.99, and 9.82 ppm (Figure 4.9C), in support of the 
protonation of the benzoate ligand. This conclusion was confirmed by analysis of the 19F NMR 
spectra of 2⋅O2 and [2⋅O2]H+. The parent complex 2 displayed resonances at -113.87, -135.71, 
and -148.12 ppm (Figure 4.10A). Upon oxygenation in dichloromethane, the peaks for 2⋅O2 
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appeared more upfield at -134.34, -154.44, and -159.02 ppm (Figure 4.10D) and shifted to -
111.30, -142.096, and -154.79 ppm when 3 equiv of H[BArF4] was introduced (Fig. 4.10E). The 
paramagnetically broadened resonances in Figure 4.10D and 4.10F, demonstrate that the 
C6F5CO2H ligand is bound to iron in dichloromethane. Once again, only in the coordinating 
solvent acetonitrile are resonances for free pentafluorobenzoic acid at -139.47, -150.29, and -
161.96 ppm observed (Figure 4.10C). 
 
Figure 4.9. 1H NMR spectra (CD3CN, 500 MHz, -30 °C) of A) [Fe2(µ-O2)(N-
EtHPTB)(PhCO2)](BF4)2, B) [Fe2(µ-O2)(N-EtHPTB)(C6F5CO2)](OSO2CF3)2, C) [Fe2(µ-O2)(N-
EtHPTB)(PhCO2)](BF4)2/H[BArF4] (1:1), and D) [Fe2(µ-O2)(N-EtHPTB)(C6F5CO2)]-
(OSO2CF3)2/H[BArF4] (1:1). Spectral comparison between the benzoate and pentafluorobenzoate 
diiron analogs (A vs B and C vs. D) reveals proton peaks arising from the aromatic benzoate 
ring. The peaks at 11.40, 8.74, and 7.01 ppm are assigned to the benzoate protons in [Fe2(µ-
O2)(N-EtHPTB)(PhCO2)](BF4)2. When H[BArF4] was added to the (peroxo)diiron(III) solutions, 
the benzoate protons shifted to 9.82, 7.99, and 7.50 ppm. The aromatic protons of the [BArF4]– 
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anion appear at 7.7 ppm. Spectrum A: δ = 5.41, 5.81, 7.01, 7.39, 8.74, 11.40, 18.08 ppm. 
Spectrum B: δ = 5.52, 5.92, 7.36, 15.68, 16.94 ppm. Spectrum C: δ = 5.65, 6.08, 7.23, 7.50, 7.99, 
9.82, 15.78 ppm. Spectrum D: 5.66, 6.09, 7.11, 15.67 ppm.  
 
 
Figure 4.10. 19F NMR spectra (470 MHz, -30 °C) of A) compound 2 in CD3CN, B) 
[2⋅O2](OSO2CF3)2 in CD3CN, C) [2⋅O2](OSO2CF3)2/H[BArF4] (1:3) in CD3CN, D) 
[2⋅O2](OSO2CF3)2 in CH2Cl2, and E) [2⋅O2](OSO2CF3)2/H[BArF4] (1:3) in CH2Cl2. The signals 
at approx. -77 and -62 ppm are ascribed to the fluorine atoms of the triflate and [BArF4]– anions, 
respectively. The narrow peaks in spectrum C are indicative of free pentafluorobenzoic acid. It is 
uncertain why spectrum E does not display a peak at -77 ppm for the triflate anion. Spectrum A: 
δ = -113.87, -135.71, -148.12 ppm. Spectrum B: δ = -135.16, -154.62, -158.39 ppm. Spectrum C: 
δ = -139.47, -150.29, -161.96 ppm. Spectrum D: δ = -134.34, -154.44, -159.02 ppm. Spectrum E: 
δ = -111.30, -142.96, -154.79 ppm.  
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4.4. Conclusion 
  In conclusion, the spectroscopic evidence (Table 4.1) clearly indicate that the carboxylate 
is preferred over the peroxo ligand as the site of protonation in these (peroxo)diiron(III) model 
complexes, a possible structure for which is depicted in Scheme 4.2. Our results suggest that, 
during the O2 activation steps in the catalytic cycle of sMMO and related enzymes, protons 
might generate and/or transform the (peroxo)diiron(III) core by inducing a carboxylate shift,16,18 
possibly increasing the electrophilicity of the diiron unit and facilitating substrate access to the 
active site. Preliminary studies demonstrate, however, that [1a⋅O2]H + does not display 
significantly enhanced reactivity toward external substrates compared to that of 1a⋅O2 but this 
oxidation chemistry must be examined in more detail before any conclusions could be drawn.  
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Chapter 5 
Characterization of Synthetic (µ-1,2-Peroxo)diiron(III) 
Complexes by Nuclear Resonance Vibrational Spectroscopy 
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5.1. Introduction 
 To understand the molecular mechanism of O2 activation by carboxylate-bridged diiron 
enzymes,1,2 it is necessary to determine the kinetic behavior of the oxygenation process as well 
as the structure of protein intermediates that occur along the reaction pathway. Exposure of 
dioxygen to the FeII2 cores of diiron proteins often generates transient (peroxo)diiron(III) 
intermediates.3-9 Chart 5.1 depicts the possible coordination modes of a bridging O2 ligand at a 
dinuclear center.1,10 Studies of the peroxide units in the R2 subunit of ribonucleotide reductase 
(RNR),11,12 soluble methane monooxygenase hydroxylase (sMMOH),13,14 toluene 4-
monooxygenase hydroxylase (T4MoH),15 and Δ9 desaturase16 have suggested that the reduced O2 
molecule is bound to the diiron core in a µ-1,2 fashion. Recent theoretical investigations of the 
T201S mutant of toluene/o-xylene monooxygenase hydroxylase (ToMOH)17,18 reveal that both 
µ-1,2- and µ-1,1-(peroxo)diiron species form upon reaction with dioxygen; the terminally 
bridged dioxygen adduct is believed to be protonated and further stabilized by hydrogen-bonding 
interaction with a nearby threonine residue.19 Attempts to characterize the ToMOH intermediates 
by either resonance Raman spectroscopy or X-ray crystallography have not yet been successful. 
Although quantum mechanical/ molecular mechanical (QM/MM) studies have provided some 
insight into the nature of these Fe2(O2) units,20-24 new tools are required to study the protein 
intermediates directly. 
 A powerful technique to examine the primary coordination sphere of iron-containing 
materials is nuclear resonance vibrational spectroscopy (NRVS).25-28 In this method, the 
vibrational spectra of Mössbauer-active nuclei are obtained by tuning the incident photon energy 
to excite vibrational states that are coincident with nuclear excitations. NRVS is more selective 
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Chart 5.1. Possible geometries of the (µ-peroxo)diiron unit. 
 
and comprehensive than Raman or infrared spectroscopy because it reveals all vibrations 
involving motion of the probe nucleus. NRVS measurements require synchrotron radiation and 
are limited to nuclei that have favorable properties, such as an excitation energy that is within the 
range of available monochromators, a sufficiently long nuclear excitation lifetime, a sensitive 
nuclear response, and a scattering energy that does not exceed the detection limit of an avalanche 
photodiode detector (APD). NRVS is an invaluable addition to the bioinorganic toolbox.29-31 For 
example, it has been used to assign the vibrational modes of diatomic molecules coordinated to 
synthetic porphyrins27,32,33 and to detect nitrosylated iron-sulfur clusters in proteins.34,35 NRVS 
and density functional theoretical (DFT) studies of mononuclear Fe(III)–OOH36 and 
Fe(IV)=O37,38 compounds have provided insight into their unique chemical properties. 
  To evaluate whether NRVS could be applied to interrogate the binding mode of O2 at the 
diiron centers of oxygenated protein intermediates, synchrotron-based vibrational measurements 
of synthetic (peroxo)diiron(III) compounds were undertaken. Among the various Fe2(O2) 
geometries that are shown in Chart 5.1, only the cis-η1,η1-1,2- and trans-η1,η1-1,2-dioxygen 
adducts of Fe2 units have been crystallographically characterized.39-42 The η2,η2-1,2-,43 η1,η2-1,2-
44 and η1,η1-1,1-dioxygen45-47 bridging motifs have been reported for other dinuclear transition 
metal complexes. In the present NRVS study, the compounds [Fe2(µ-O2)(N-EtHPTB)(PhCO2)]2+ 
(1·O2, where N-EtHPTB = anion of N,N,Nʹ ,Nʹ -tetrakis(2-benzimidazoylmethyl)-2-hydroxy-1,3-
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diaminopropane)39,48 and [Fe2(µ-O2)(HB(iPrpz)3)2(PhCH2CO2)2] (4·O2, where HB(iPrpz)3 = 
tris(3,5-diisopropylpyrazoyl)hydroborate)40,49 were selected as representative examples of cis-
η1,η1-1,2- and trans-η1,η1-1,2-dioxygen bound diiron species, respectively (Figure 5.2). This 
chapter describes the first successful characterization of (peroxo)diiron(III) complexes by NRVS 
and their normal coordinate analysis.  
 
 
Chart 5.2. A depiction of the proposed structure of [Fe2(µ-O2)(N-EtHPTB)(PhCO2)]2+ (1·O2, top 
left). The X-ray structures of [Fe2(µ-O2)(N-EtHPTB)(OPPh3)2]3+ (2·O2, top right),39 [Fe2(µ-
O2)(Ph-bimp)(PhCO2)2]2+ (3·O2,bottom left),41 and [Fe2(µ-O2)(HB(iPrpz)3)2(PhCH2CO2)2] (4·O2, 
bottom right)40 have been determined. The Cartesian coordinates of the Fe2N6O(µ-O2)(µ-PhCO2) 
core of 3·O2 was used for normal mode calculations of 1·O2. 
 
5.2. Experimental 
Materials and Methods: Commercial reagents were used as received without further 
purification. Air-sensitive manipulations were performed using standard Schlenk techniques or 
under a nitrogen atmosphere inside an MBraun drybox. Solvents were saturated with argon and 
purified by passage through two columns of activated alumina. The [57Fe2(N-
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EtHPTB)(PhCO2)](BPh4)2 complex,50 and K[HB(iPrpz)3] ligand51 were synthesized according to 
literature procedures. The 57-iron(II) bromide salt was prepared from 57Fe metal (98%) and 
concentrated hydrobromic acid.52 18-Dioxygen (99%) was obtained from ICON isotopes and 
used as received. 
General Physical Methods: NMR spectra were recorded on 500 MHz Varian Mercury 
spectrometers. Chemical shifts for 1H NMR spectra were referenced to residual solvent peaks. 
Absorption spectra were acquired on a Cary 50 spectrophotometer using a custom-made quartz 
cuvette (path length = 1.74 cm) containing a jacketed dewar. An acetonitrile/dry ice bath was 
used to maintain the samples at -30 ºC. Solid-state FTIR spectra were acquired with a 
ThermoNicolet Avatar 360 spectrophotometer using the OMNIC software. 
Synthesis 
[57Fe(HB(iPrpz)3)Br] (4-Br). The following procedure was slightly modified from that reported 
for unenriched 4-Br.40 Solid 57FeBr2 (400 mg, 794 µmol) and K[HB(iPrpz)3] (172 mg, 794 µmol) 
were dissolved in 3 mL of THF and stirred for 3 h. The solution was evaporated to dryness and 
the product was extracted into CH2Cl2 (3 mL). The solution was filtered through a glass wool 
plug and the filtrate was concentrated to half its volume. The CH2Cl2 solution was transferred to 
a small tube and the tube was placed inside a sealed vial containing a solution of toluene. After 
standing overnight, most of the CH2Cl2 solution had diffused out of the tube, leaving a pink 
crystalline solid. The solid was isolated by filtration and washed with diethyl ether (158 mg, 
33%). The IR spectrum of the product matched that previously reported.40 1H NMR (CD3CN, 
500 MHz, paramagnetically broadened): δ 60.86, 16.19, 3.79, -2.76, -6.25 ppm.  
[57Fe(HB(iPrpz)3)(PhCH2CO2)] (4). The following procedure was modified from that reported 
for unenriched 4.40 Solid [57Fe(HB(iPrpz)3)Br] (158 mg, 263 µmol) was dissolved in 1 mL of 
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CH2Cl2/THF (1:1) and added to a 1 mL solution of thallium triflate (93 mg, 263 µmol) in THF. 
Upon combining the two solutions, the mixture instantaneously became cloudy and a white 
precipitate began to form. After stirring for 2 h, the insoluble TlBr was removed by filtration. 
Sodium phenylacetate (42 mg, 263 µmol) was added to the colorless filtrate and the mixture was 
stirred for 4 h. The slightly murky solution was filtered through a glass wool plug and the solvent 
was removed in vacuo. The product was extracted into pentane, filtered, and the filtrate was 
evaporated to afford a sparkly white solid (155 mg, 90%). The IR spectrum of the product 
matches that previously reported.40 1H NMR (CD3CN, 500 MHz, paramagnetically broadened): δ 
76.60, 60.76, 16.33, 6.38, 6.05, 3.72-1.28, -22.56 ppm. 
Preparation of [57Fe2(O2)(N-EtHPTB)(PhCO2)](BPh4)2 for NRVS. A 50 mM THF solution 
(0.5 mL) of [57Fe2(N-EtHPTB)(PhCO2)](BPh4)2 was prepared inside the glovebox and added to a 
septum-sealed vessel. The flask was brought outside of the glovebox and cooled to -78 °C using 
a dry ice/acetone cooling bath. For the 1·16O2 sample, the diiron(II) solution was injected with 10 
mL of 16O2 using a syringe. For the 1·18O2 sample, 18O2 gas was directly transferred to the 
diiron(II) solution using a high-vacuum manifold.  After stirring for ~10 min, 150 µL of the deep 
blue solution was transferred via syringe, pre-cooled to ensure that the oxygenated solution does 
not warm up above -30 °C, to an NRVS cell and immediately frozen in liquid nitrogen.  
Preparation of [57Fe2(O2)(HB(iPrpz)3)2(PhCH2CO2)2] for NRVS. A 21 mM pentane/diethyl 
ether (1:1) solution (0.5 mL) of the mononuclear [57Fe(HB(iPrpz)3)(PhCH2CO2)] complex was 
prepared inside the glovebox and added to a septum-sealed vessel. The flask was brought outside 
of the glovebox and cooled to -78 °C using a dry ice/acetone cooling bath. To generate 4·16O2 
and 4·18O2, about 5 mL of 16O2 or 18O2, respectively, was injected into the iron(II) solution. After 
stirring for ~10 min, 150 µL of the deep green solution was transferred via syringe (pre-cooled to 
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ensure that the oxygenated solution does not warm up above -30 °C) to an NRVS cell and 
immediately frozen in liquid nitrogen. 
Nuclear Resonance Vibrational Spectroscopy (NRVS) 
Data Acquisition. NRVS measurements were performed in collaboration with Dr. Hongxin 
Wang (UCD), Dr. Christine E. Tinberg (MIT), Dr. Yoshitaka Yoda (SPring-8, Japan), and Prof. 
Stephen P. Cramer (UCD). Samples were loaded into 3 × 7 × 1 mm3 (interior dimensions) Lucite 
cuvettes wrapped with Mylar tape. 57Fe NRVS spectra were recorded using published 
procedures28 at the BL09XU beamline at SPring-8, Japan. Fluxes were on the order of ~2×109 
photons/sec in a 1.2 eV bandpass. During NRVS measurements, samples were maintained at low 
temperatures using a liquid He cryostat (head temperature < 10 K). The real sample temperatures 
were calculated from the ratio of anti-Stokes to Stokes intensity by the expression27 S(-E) = 
S(E)e(-E/kT) and determined to be at ~35-50 K. Nuclear fluorescence and delayed Fe K 
fluorescence were recorded with an APD array. Each scan took about 50 min, and all scans were 
added and normalized to the intensity of the incident beam using the PHOENIX program.53 
Spectra were recorded between 0 and 600 cm-1. The number of scans acquired for each sample 
are as follows: one for 1, five for 1·16O2, three for 1·18O2, two for 4, five for 4·16O2, and three for 
4·18O2.  
Empirical Force Field Normal Mode Analysis. Empirical normal mode calculations were 
performed by Eric Dowty (Shape Software) and conducted using the program VIBRATZ,54,55 
which uses the Urey-Bradley force field. Analysis of 1 utilized only the Cartesian coordinates of 
the Fe2N6O2(µ-PhCO2) core to reduce the complexity of the calculations. Since the Fe–N/O 
modes are “uncoupled” in this virtual model, differences in the calculated peak intensities 
compared to those observed for 1 are not meaningful because they depend on the precise 
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stretching force constants and bond angles of all the atoms involved in the vibration. The normal 
mode calculations for [Fe2(µ-O2)(N-EtHPTB)(PhCO2)]2+ (1·O2) employed the Cartesian 
coordinates of the Fe2N6O(µ-O2)(µ-PhCO2) core from the X-ray structure of [Fe2(µ-O2)(Ph-
bimp)(PhCO2)2]2+ (3·O2, Chart 5.2)41 using a Cs point group. It was necessary to use 3·O2 as an 
approximate model for 1·O2 because the structure of 1·O2 is not available. The calculated results 
are intended to provide a qualitative description of the modes that involve significant motion of 
the Fe2(O2) core, rather than a complete description of the full molecule. Because the simulated 
frequencies do not take into account the complex bonding interactions of the N-EtHPTB ligand 
with the diiron centers, the calculated intensities are not an exact match to those observed in the 
NRVS of 1·O2. Nevertheless, the modes above 350 cm–1 can be assigned unequivocally to the 
Fe2(O2) unit because they are well separated from the main Fe–N/O manifold ranging from 
~150-350 cm–1. 
 
5.3. Results and Discussion 
 NRVS of Diiron N-EtHPTB Complexes. To determine the iron-ligand modes that arise 
from the N-EtHPTB and benzoate groups, the parent diiron(II) [57Fe2(N-EtHPTB)(PhCO2)]2+ 
(1)50 complex was studied by NRVS. As shown in Figure 5.1, polycrystalline 1 exhibits intense 
features ranging from 150 to 350 cm–1. Because of the mixed ligand environment of 1, this large 
envelope consists of several overlapping Fe–N and Fe–O vibrations from the benzimidazole, 
amine, alkoxide, and carboxylate units that are coordinated to the iron atoms. The simulated peak 
intensities are not an exact match to those observed in the NRVS because knowledge of the 
precise force constants and bonding angles of all the atoms involved in a given mode is 
necessary to obtain meaningful simulations of the vibrational intensities.  
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Figure 5.1. 57Fe partial vibrational density of states (PVDOS) for polycrystalline [57Fe2(N-
EtHPTB)(PhCO2)]2+ (1) measured by NRVS at ~10 K. Blue spectrum: selected peaks = 182, 
224, 240, 298, and 321 cm–1. Red spectrum = 192, 146, 195 cm–1. Color scheme: raw data in 
blue, empirical data fit in red, and individual eigenmode frequencies/intensities before 
broadening in black. 
 
 When a solution of 1 in tetrahydrofuran was exposed to dioxygen a deep blue color 
rapidly developed, indicating generation of the (peroxo)diiron(III) complex [57Fe2(µ-O2)(N-
EtHPTB)(PhCO2)]2+ (1·O2).48,50 The NRVS of 1·16O2 and 1·18O2 display intense bands between 
150-300 cm–1 (Figure 5.2A and 5.2B, respectively), assigned to iron-ligand modes based on the 
spectrum of 1. In addition to these features, higher energy frequencies at 338 and 467/480 cm–1 
are observed for 1·16O2, which shift upon 18O-isotopic labeling to 311 and 446/458 cm–1, 
respectively (Figure 5.2C) (the bands separated by “/” are attributed to Fermi splitting). By 
comparison to the un-oxygenated spectrum of 1, it is clear that these higher energy modes in the 
NRVS of 1·O2 are due to motions involving the (peroxo)diiron(III) unit. These data are 
consistent with resonance Raman spectra that were previously reported.48,50 Most notably, the 
RR spectrum of 1·16O2 exhibited bands at 466/474 cm–1 that shifted to a single peak at 452 cm–1 
when 18O2 was substituted for 16O2 (Figure 5.3A). The 300-350 cm–1 region of the RR spectra 
does not show any resonance enhanced vibrations (Figure 5.3B). The fact that NRVS revealed a 
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distinct Fe2(O2) mode not previously observed, at 338 cm–1 for 1·16O2 and 311 cm–1 for 1·18O2, 
illustrates the utility of this new spectroscopic tool. 
 
Figure 5.2. 57Fe partial vibrational density of states (PVDOS) for frozen THF solutions of 
[57Fe2(µ-16O2)(N-EtHPTB)(PhCO2)]2+ (1·16O2, A) and [57Fe2(µ-18O2)(N-EtHPTB)(PhCO2)]2+ 
(1·18O2, B) measured by NRVS at ~10 K. The 1·18O2 minus 1·16O2 difference plots for the raw 
data and the empirical fits are shown in C and D, respectively. Panel A: blue spectrum (selected 
peaks) = 190, 280, 338, 467, 480 cm–1; red spectrum (selected peaks) = 176, 225, 264, 325, 471, 
579 cm–1. Panel B: blue spectrum (selected peaks) = 186, 241, 281, 311, 446, 458 cm–1; red 
spectrum (selected peaks) = 175, 224, 262, 313, 452, 551 cm–1. Color scheme for plots A and B: 
raw data in blue, empirical data fit in red, and individual eigenmode frequencies/intensities 
before broadening in black. 
 
 NRVS of Iron HB(iPrpz)3– Complexes. The NRVS of the mononuclear [Fe(HB(iPrpz3)-
(PhCH2CO2)] (4) complex exhibits several Fe–N(pyrazole) and Fe–O(carboxylate) bands below 
350 cm–1 (Figure 5.4, black). Upon addition of O2 to 4 in pentane/diethyl ether (1:1) a dark green 
color appeared, indicating formation of the corresponding 4·O2 species.40,49 When the NRVS of 
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Figure 5.3. Resonance Raman spectra of [57Fe2(µ-16O2)(N-EtHPTB)(PhCO2)]2+ (1·16O2, black) 
and [57Fe2(µ-18O2)(N-EtHPTB)(PhCO2)]2+ (1·18O2, blue) previously reported.50 In panel A (ν = 
897 (847), 532/513 (500), 474/466 (452) cm–1), the red spectrum represents the 1·18O2 sample 
before a 1·16O2 impurity was subtracted. The lower energy region, in panel B, does not exhibit 
any clear isotopically shifted resonances. 
 
 
4·16O2 was recorded (Figure 5.4, red) the data suggested that the sample contained mostly 
starting material because its spectrum was nearly identical to that of 4 (Figure 5.4, black). 
Furthermore, RR measurements indicate that a new ν(Fe–O) band should be observed at 415 cm–
1 for 4·16O2.40 Fortunately, the reaction of 4 with 18O2 generated 4·18O2 and the product was 
detected by NRVS. As shown in Figure 5.4 (blue), 4·18O2 has several higher energy frequencies 
at 404, 444, and 486 cm–1. Because an NRVS of 4·16O2 is not available for comparison to that of 
4·18O2, it was not possible to identify peaks involving the Fe2(O2) unit. Prior RR studies, 
however, attributed the frequency at 404 cm–1 to the ν(Fe–O) mode of the iron-peroxo group in  
4·18O2.48,50 
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Figure 5.4. 57Fe partial vibrational density of states (PVDOS) for [57Fe(HB(iPrpz3))(PhCH2CO2)] 
(4, polycrystalline, black), [57Fe(HB(iPrpz3))(PhCH2CO2)]/16O2 (4/16O2, pentane/diethyl ether 1:1, 
red), and [57Fe(HB(iPrpz3))(PhCH2CO2)]/18O2 (4/18O2, pentane/diethyl ether 1:1, blue) measured 
by NRVS at ~10 K. The reaction of [57Fe(HB(iPrpz3))(PhCH2CO2)] with 16O2 does not appear to 
have proceeded to completion, as demonstrated by the similarity of its spectrum (red trace) to 
that of the starting iron(II) material (black trace). Black spectrum: ν = 133, 209, 248, 302, 346 
cm–1; red spectrum: v = 141, 209, 298, 313, 338, 357 cm–1; blue spectrum: v = 138, 184, 214, 
253, 316, 353, 404, 444, 486 cm–1. 
 
 
 Empirical Normal Coordinate Analysis. To obtain qualitative descriptions of the 
modes that show significant 16O2/18O2 isotopic shifts in the NRVS, the data for 1·16O2 and 1·18O2 
were subjected to normal coordinate calculations by the program VIBRATZ.54,55 Although a 
more quantitative analysis could be obtained using density functional theoretical (DFT) 
methods,37 empirical data fitting is less computationally intensive and adequately models the 
features of interest. To test the validity of the VIBRATZ analysis, the NRVS of 1 was calculated 
using the Cartesian coordinates of the iron-bound atoms from its X-ray structure.48 As shown by 
the red trace in Figure 5.1, the calculated spectrum reproduces the experimental one (blue) to a 
good first approximation. A rigorous assignment of this spectral region is beyond the scope of 
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this study. Most importantly, the calculated NRVS of 1 does not show any peaks above 350  
cm–1. 
Because the exact structure of 1·O2 is not known, its primary coordination sphere was 
modeled using the Cartesian coordinates from the X-ray structure of [Fe2(µ-O2)(Ph-
bimp)(PhCO2)2]2+ (3·O2, Chart 5.2, bottom left).41 Although the structure of [Fe2(µ-O2)(N-
EtHPTB)(OPPh3)2]3+ (2·O2, Chart 5.2, top right), an analogue of 1·O2, has been determined by 
X-ray crystallography, 39 it has two triphenylphosphine oxide ligands rather than a benzoate 
group. Using the Fe2N6O(µ-O2)(µ-PhCO2) core of 3·O2 as a structural model, the NRVS of 
1·16O2 and 1·18O2 were simulated (Figure 5.2A and 5.2B, respectively, red traces). The difference 
spectrum (1·18O2 minus 1·16O2) shows that 18O2 substitution afforded three main isotopically 
shifted peaks in the 0-600 cm–1 region (Figure 5.2D). A fourth isotope sensitive mode was also 
calculated at 898(-51) cm–1, where the number in parentheses represents the change in 
wavenumbers upon 18O2 substitution, outside of the window that was recorded for the 1·O2 
samples.  
The highest energy calculated feature, 898(-51) cm–1, is primarily a symmetric O–O 
stretching mode (ν1, Figure 5.5). Because ν1 does not involve significant motion of the iron 
atoms, it is not likely to be very intense in the NRVS. The experimentally determined value for 
the symmetric ν(O–O) mode of 1·O2 is 897(-50) cm–1 (Figure 5.3A),50 in good agreement with 
the calculated one. The second highest energy mode falls at 579(-28) cm–1 and is essentially the 
asymmetric O–O stretching/rotation of the peroxo ligand against the iron atoms (ν2, Figure 5.5). 
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Figure 5.5. Normal mode calculations for 1·O2 using the X-ray coordinates of [Fe2(µ-O2)(Ph-
bimp)(PhCO2)2]2+ (3·O2), showing the vibrations that involve the Fe2O2 unit. The black arrows 
indicate the direction and relative degree of motion of the atoms to which they are attached. 
Color scheme: orange, iron; red, oxygen; blue, nitrogen; and gray, carbon. 
 
 
Although the net stretching of the Fe–O(peroxo) bonds is minimal, ν2 is expected to be 
observable by NRVS. The spectra of 1·O2, however, do not show any features in this region. The 
absence of a clear signal at this frequency may be due to the lower resolution of the NRVS 
spectrum at higher wavenumbers. It is possible that the weak features at 532/513 cm–1 in the RR 
of 1·O2 (Figure 5.3A) may correspond to this ν2 mode.50 The calculated value at 471(-19) cm–1 
(v3) is attributed to the symmetric Fe–O–O–Fe stretching motion and the frequency is dependent 
almost entirely on the Fe–OO force constant (Figure 5.5). The theoretical frequency of v3 (471  
cm–1) matches well to those of 1·16O2 observed at 467/480 cm–1 in the NRVS (Figure 5.2A) and 
at 466/474 cm–1 in the RR spectra (Figure 5.3A).50 Lastly, the isotopically shifted peak that 
occurs at lowest energy was at 325(-12) cm–1 (v4, Figure 5.5). In this mode, the O–O group 
moves as a unit parallel to the Fe–Fe vector and perpendicular to the pseudo-mirror plane that 
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bisects the Fe2(O2) atoms. It is possible that the v4 mode is absent in the RR spectrum because is 
it not strongly coupled to the electronic transition induced by the 647 nm excitation wavelength 
employed in the experiment.  
 
5.4. Conclusion 
 The vibrational profiles of two synthetic (peroxo)diiron(III) complexes have been 
revealed by nuclear resonance vibrational spectroscopy. Through 16O2/18O2 isotopic labeling, the 
frequencies that correspond to motions of the Fe2(O2) unit in [Fe2(µ-O2)(N-EtHPTB)(PhCO2)]2+ 
have been definitively assigned. Most notably, a lower energy mode at ~338 cm–1 involving 
parallel motion between the Fe–Fe and O–O groups has been detected by NRVS, a feature that 
was not previously observed by resonance Raman spectroscopy. The NRVS of [Fe2(µ-
18O2)(HB(iPrpz)3)2(PhCH2CO2)2] displays several distinct modes above 350 cm–1 but these 
frequencies have not been assigned. A more comprehensive study is needed to correlate the 
vibrational characteristics of a (peroxo)diiron unit to its O2 coordination geometry. Nevertheless, 
these results demonstrate that synchrotron-based NRVS is a useful tool to investigate the 
structural and chemical nature of oxygenated diiron protein intermediates and may help to clarify 
many remaining questions regarding the mechanism of O2 activation in non-heme diiron 
enzymes. 
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Appendix A 
Evaluating the Identity of an Electron-Rich Bis(tris(pyridyl-2-
methyl)amine)diiron(III) Complex and Its Involvement  
in the Hydrolysis of Acetonitrile 
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AI. Introduction 
 Because of their importance in the chemistry of non-heme diiron enzymes,1,2 
understanding the chemical and physical characteristics of synthetic diiron(IV) units is of 
significant interest.3-5 Among the various constructs employed to access such species, one 
convenient platform is based on a tripodal tris(pyridyl-2-methyl)amine (TPA) ligand. Stable 
dinuclear species can be readily prepared by linking two monomeric [Fe(TPA)] complexes 
through oxo-, hydroxo-, or carboxylato bridges.6-8 A notable achievement in diiron modeling 
chemistry is the crystallographic characterization of a mixed-valent di(µ-oxo)diiron(III,IV) unit, 
[Fe2(µ-O)2(5-Et3-TPA)2](ClO4)3 (where 5-Et3-TPA = tris((5-ethylpyridyl)-2-methyl)amine) (A, 
Chart A.1).9,10 Complex A contains the quadrilateral Fe2O2 core believed to be present in the 
diiron(IV) intermediate Q of soluble methane monooxygenase hydroxylase (sMMOH).11,12  
 
 
Chart A.1. The [Fe2(µ-O)2(5-Et-TPA)2]3+ (A) complex was the first di(µ-oxo)diiron(III,IV) 
species structurally characterized by X-ray crystallography. The [Fe2(µ-
O)(OH)(H2O)(R3TPA)2]3+ (B) compound was reported to be a versatile starting material for 
generating diiron(III,IV) and diiron(IV,IV) species. 
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Scheme A.1. Reactions of a putative [FeIII2(µ-O)(OH)(H2O)(R3TPA)2]3+ species (B) leading to 
formation of high-valent diiron units. See references for more details.13-15 
 
The electronic and steric properties of the diiron TPA complexes can be tuned by 
appending various substituents around the pyridine rings. Recently, studies using an electron-rich 
tris((3,5-dimethyl-4-methoxy)pyridyl-2-methyl)amine (R3TPA) derivative have enabled high-
valent diiron units to be prepared.13-15 It was reported that, upon treatment with hydrogen 
peroxide, the diiron(III) precursor [Fe2(µ-O)(OH)(H2O)(R3TPA)2](ClO4)3 (B, Chart A.1) 
converts to a di(µ-oxo)diiron(III,IV) [Fe2(µ-O)2(R3TPA)2](ClO4)3 (F) species.15 When F was 
subjected to controlled bulk electrolysis at an applied potential of +900 mV (vs. 
ferrocene/ferrocenium) in acetonitrile at -40 °C, a diiron(IV) [Fe2(µ-O)2(R3TPA)2]4+ (G) species 
was obtained quantitatively (Scheme A.1). Compound G could also be accessed via chemical 
methods.14 Reaction of B with hydrogen peroxide and protons rapidly leads to formation of G, 
through the transient generation of (µ-hydroperoxo)diiron(III,III) (C) and (µ-
oxo)(hydroxo)(oxo)diiron(IV) (D) intermediates (Scheme A.1). Compound G, however, exhibits 
poor H-atom abstraction ability. When the valence-delocalized diiron(III,IV) F was treated with 
tetrabutylammonium hydroxide or the diiron(IV) unit D was reduced by ferrocene, a valence-
localized species E was obtained.13 Compound E was determined to be a high-spin species, 
 214 
unlike the low-spin units previously characterized, and displayed a million-fold rate 
enhancement in H-atom abstraction compared to G.  
To obtain spectroscopic standards for the di(µ-oxo)diiron(IV) unit, efforts were made to 
prepare compound G as described in the literature. During the course of these studies, several 
inconsistent results were obtained that prompted more detailed investigations. This report 
clarifies the identity of the diiron(III) staring material and describes its ability to hydrolyze 
acetonitrile to acetate. Attempts were not made to evaluate the validity of Scheme A.1 in light of 
these new findings, but a more thorough investigation is necessary to address the concerns 
enumerated in this report. 
 
A.2. Experimental 
Materials and Methods. Reagents obtained from commercial suppliers were used as received. 
The tris((3,5-dimethyl-4-methoxypyridyl)-2-methyl)amine (R3TPA) ligand that is deuterated at 
the benzylic positions was prepared as previously described.15 All manipulations were performed 
in air using standard laboratory techniques. Solvents were used as received from the commercial 
suppliers without further purification.  
General Physical Methods. NMR spectra were recorded on 500 MHz Varian Mercury 
spectrometers and chemical shifts for 1H and 13C spectra were referenced to residual solvent. 1H 
NMR spectral data of paramagnetic compounds were obtained by widening the sweep window 
(+100 to -30 ppm) and collecting for longer acquisition times (~1024 scans). IR spectra were 
recorded on a ThermoNicolet Avatar 360 spectrophotometer with the OMNIC software. 
Absorption spectra were recorded on a Cary 50 spectrophotometer using 6Q Spectrosil quartz 
cuvettes (Starna) with 1 cm path lengths. For low temperature UV-vis measurements, a custom-
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made quartz cuvette (path length = 1.74 cm) containing a jacketed dewar was employed. An 
acetonitrile/dry ice bath was used to maintain the samples at -30 ºC. Mössbauer spectra were 
recorded on an MSI spectrometer (WEB Research Company) with a 57Co source in a Rh matrix 
maintained at room temperature. Solid samples were prepared by suspension of the complex 
(~40 mg) in Apiezon M grease and placement in a nylon sample holder. Samples were measured 
over the course of ~5 d at 80 K. Isomer shift (δ) values are reported with respect to metallic iron 
that was used for velocity calibration at room temperature. Spectra were fit to Lorentzian lines 
using the WMOSS plot and fit program.  
X-ray Data Collection and Refinement. Single crystals were mounted in Paratone oil using 30 
µm aperture MiTeGen MicroMounts (Ithaca, NY) and frozen under a 100 K KRYO-FLEX 
nitrogen cold stream. Data were collected on a Bruker SMART APEX CCD X-ray 
diffractometer with Mo Kα radiation (λ = 0.71073 Å) controlled by the APEX 2 (v. 2010.1-2) 
software package. Data reduction was performed using SAINT and empirical absorption 
corrections were applied using SADABS.16 The structures were solved by direct methods with 
refinement by full-matrix least squares based on F2 using the SHELXTL-97 software package17 
and checked for higher symmetry by the PLATON software.18 All non-hydrogen atoms were 
located and refined anisotropically. Hydrogen atoms were fixed to idealized positions unless 
otherwise noted and given thermal parameters equal to either 1.5 (methyl hydrogen atoms) or 1.2 
(non-methyl hydrogen atoms) times the thermal parameters of the atoms to which they are 
attached. 
 Complex 1 occurs on an inversion center; thus, only half of the molecule is present in the 
asymmetric unit, along with 1.5 perchlorate anions and two acetonitrile molecules. Both 
perchlorate groups exhibit positional disorder and were modeled accordingly. One of the ClO4– 
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anions are located on a special position and was refined with 50% occupancy by suppressing 
generation of special position constraints. Due to charge considerations, the Fe2O2 core of 1 is 
best described as a (µ-oxo)(µ-hydroxo)diiron(III) unit, the overall complex having the empirical 
formula [Fe2(µ-O)(µ-OH)(R3TPA)2](ClO4)3. Thus, the observed Fe–O distances must result from 
a disorder imposed by the symmetry of the unit cell averaged over the Fe–O(oxo) and Fe–
O(hydroxo) bond lengths. Although the core structures of 4A and 4B are identical, both 
containing the cationic [Fe2(µ-O)(µ-CH3CO2)(R3TPA)2]3+ unit, they differ in the number of 
solvent molecules in their crystal lattices as well as their unit cell dimensions. The asymmetric 
unit of 4A contains a single [Fe2(µ-O)(µ-CH3CO2)(R3TPA)2]3+ ion, together with three 
perchlorate anions and three acetonitrile moieties. Two of the ClO4– groups were modeled with 
positional disorder using appropriate similarity restraints and equal anisotropic displacement 
parameters. In contrast to that in 4A, the asymmetric unit of 4B has two independent molecules 
of [Fe2(µ-O)(µ-CH3CO2)(R3TPA)2](ClO4)3, five acetonitrile molecules and one diethyl ether. The 
diethyl ether unit is severely disordered, as evident by the large anisotropic displacement 
parameters of its component atoms. Attempts to model this disorder did not give a stable 
refinement; thus, no attempt was made to do so in the final structure. 
Kinetic Measurements. The rate of hydrolysis of acetonitrile by 1 was determined by UV-vis 
spectroscopic measurements. The data were recorded by scanning at 5 min intervals for 900 min. 
The absorption changes at 550 nm were fit to an ABC reaction sequence (Eq. 1), with rate 
constants k1 and k2, respectively. The constants εA, εB, and εC are the molar absorptivities of 
species A, B, and C, respectively and [A]o is the initial concentration of A. 
Absλ(t) = [A]o
€ 
e-k1 t (εA-εC) + 
€ 
k1
k2 - k1
[A]o(
€ 
e-k1 t - e-k2 t)(εB-εC) + [A]oεC                     (1) 
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Synthesis 
[Fe2(µ-O)(µ-OH)(R3TPA)2](ClO4)3 (1). This compound was prepared exactly as described for 
the purported synthesis of [Fe2(µ-O)(OH)(H2O)(R3TPA)2](ClO4)3 (B),15 except that the final 
material was extracted into dichloromethane and filtered to removed an insoluble impurity. The 
organic filtrate was evaporated to dryness to afford a red powder (114 mg, 42%). Red crystals for 
X-ray crystallographic analysis were obtained by vapor diffusion of diethyl ether into a solution 
of the compound in acetonitrile. Crystals obtained from dichloromethane/diethyl ether were 
smaller than those grown from acetonitrile/diethyl ether. Note that hydrolysis of coordinated 
acetonitrile could occur to give [Fe2(µ-O)(µ-CH3CO2)(R3TPA)2](ClO4)3; crystals of the acetate 
bound diiron complex are yellow rather than red. 1H NMR (CD2Cl2, 500 MHz): δ 4.70, 4.00, 
3.89, 3.60, 3.42, 2.79, 2.24, 1.63 ppm. UV-vis (CH2Cl2): λmax =  370, 550 nm. FT-IR (KBr): v = 
2950, 2863, 1599, 1575, 1478, 1456, 1402, 1385, 1292, 1267, 1095, 1080, 997, 875, 800, 623 
cm-1. 57Fe Mössbauer (80 K, apiezon grease): δ = 0.44(2) mm/s; ΔEQ = 1.46(2) mm/s; ΓL/R = 
0.47(2) mm/s. Mp =190 °C.  
[Fe2(µ-O)(µ-CH3CO2)(R3TPA)2](ClO4)3 (4B). Solid R3TPA (200 mg, 426 µmol), Fe(ClO4)3·10 
H2O (230 mg, 426 µmol), sodium acetate (17 mg, 213 µmol), and triethylamine (59 µL, 426 
µmol) were dissolved in 2.0 mL of CH3OH and stirred at RT for 3 h. A solid precipitate was 
isolated by filtration and washed with MeOH to afford a pale yellow material (198 mg, 66%). 
Single crystals suitable for X-ray diffraction analysis were obtained from slow diffusion of 
diethyl ether into a solution of the compound in either acetonitrile or dichloromethane. 1H NMR 
(CD2Cl2, 500 MHz): δ 3.91, 3.77, 3.67, 3.28, 2.92, 2.71, 2.44 ppm. UV-vis (CH2Cl2): λmax = 332 
(14,500 M-1cm-1), 374 (9,850 M-1cm-1), 454 (1,460 M-1cm-1), 504 (1,390 M-1cm-1), 700 (294 M-
1cm-1) nm. FT-IR (KBr): v = 2960, 1599, 1532, 1478, 1402, 1264, 1092, 994, 875, 801, 764, 623 
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cm-1. 57Fe Mössbauer (80 K, apiezon grease): δ = 0.44(2) mm/s; ΔEQ = 1.49(2) mm/s; ΓL/R = 
0.38(2) mm/s. Anal. Calcd. for Fe2C56H75N8O21Cl3·(CH3OH): C, 47.33; H, 5.51; N, 7.75; Found: 
C, 47.06; H, 5.32; N, 7.78. Mp (decomp) = 195 °C. 
 
A.3. Results and Discussion 
 Characterization of Diiron(III) Complexes. Preparation of [Fe2(µ-O)(OH)(H2O)-
(R3TPA)2](ClO4)3 (B) was attempted according to the literature procedure.15 Reaction of iron(III) 
perchlorate decahydrate, R3TPA, and sodium hydroxide in methanol and water afforded a red 
powder as described, which was reported to be pure B. This bulk material, however, was 
determined to be a heterogeneous mixture. Initially, this conclusion was derived from simple 
solubility tests, in which only some of the red solid could be extracted into common organic 
solvents, such dichloromethane or acetonitrile. The fact that this crude compound was red, rather 
than green like other [Fe2(µ-O)(OH)(H2O)(L)2]3+ (where L = a polynitrogen ligand) compounds 
reported in the literature,7,19,20 was also unexpected. Because the only characterization data 
reported for “B” was an elemental analysis and its synthetic yield was not given,15 further studies 
of this material were undertaken. 
 The zero-field 57Fe Mössbauer spectrum of the crude red powder was best fit to three 
quadrupole doublets (Figure A.1A), giving parameters δ1 = 0.44 mm/s, ΔEQ1 = 1.16 mm/s, Area 
1 = 36%; δ2 = 0.44 mm/s, ΔEQ2 = 1.66 mm/s, Area 2 = 28%; and δ3 = 0.44 mm/s, ΔEQ3 = 0.71 
mm/s, Area 3 = 36% (Table A.1). If the material contained pure B, a maximum of two 
quadrupole doublets would be expected if both of its iron atoms had distinct coordination 
environments. A three-site model suggests that at least two different iron-containing species are 
present in the sample, perhaps accounting for the organic soluble and organic insoluble fractions. 
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When the crude powder was extracted into dichloromethane, filtered, and evaporated to dryness, 
a slightly lighter red solid was obtained, hereafter referred to as compound 1. As shown in Figure 
A.1B, this product exhibits a single quadruople doublet, having values of δ = 0.44 mm/s and ΔEQ 
= 1.46 mm/s (Table A.1). The Mössbauer parameters of 1 are most similar to those of either site 
1 or 2 in the crude material, suggesting that the dichloromethane extraction and filtration steps 
were necessary purification procedures. 
 
Figure A.1. Zero-field Mössbauer spectra (80 K) of A) the crude material from reaction of 
R3TPA and iron(III) perchlorate, B) compound 1, C) compound 4A, and D) compound 4B. 
Spectrum A was best fit to three quadrupole doublets, whereas those of B, C, and D were 
adequately fit to single site models. Raw data are in black, simulated fits are in green, and 
individual sites are in blue, yellow, and red. Mössbauer parameters are given in Table A.1. 
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Table A.1. Summary of Spectroscopic Data. 
 
 Crude Solid 1 4A 4B 
Mössbauera Site 1 Site 2 Site 3 Site 1 Site 1 Site 1 
δ (mm/s) 0.44 0.44 0.44 0.44 0.44 0.44 
ΔEQ (mm/s) 1.16 1.66 0.71 1.46 1.47 1.49 
Γ (mm/s) 0.35 0.32 0.40 0.47 0.38 0.38 
 36% 28% 36%    
UV-visibleb 
λmax (nm) 
* heterogeneous solution 370, 550 452, 492, 504, 700 452, 492, 504, 700 
Infraredc  
v (cm–1) 
2945 
1600 
1575 
 
1478 
1456 
1401 
1384 
1293 
1267 
1077 
1096 
995 
874 
 
768(w) 
660 
623 
2947 
1599 
1575 
 
1478 
1455 
1402 
1384 
1292 
1268 
1076 
 
995 
874 
800 (w) 
763(w) 
657(w) 
624 
2927 
1598 
1576 
1540 
1478 
1450 
1402 
1384 
1292 
1267 
1091 
 
994 
875 
 
765 
 
623 
2960 
1599 
1570 
1532 
1478 
1450 
1402 
 
1291 
1264 
1092 
 
995 
875 
800 
764 
 
623 
1H NMRd 
δ (ppm) * heterogeneous solution 
4.70, 4.00, 3.89, 3.60, 
3.42, 2.79, 2.24, 1.63 
3.92, 3.68, 3.28, 2.94, 
2.45 
3.91, 3.67, 3.28, 2.93, 
2.44 
aPolycrystalline samples recorded at 80 K. bRecorded in dichloromethane at RT. cMeasured as KBr pellets; IR peaks designated with a “w” 
indicate weak intensity. dRecorded in chloroform-d1.  
 
 For further comparison of the properties of the unpurified material versus compound 1, 
IR spectroscopy was employed. The IR spectra of the crude solid and 1 are shown in Figure 
A.2A (black and red traces, respectively). As expected, both solids display intense bands at 
~1100 cm–1, indicative of the perchlorate anion. The spectral envelope ranging from 500 to 1700 
cm–1 is essentially identical for the two samples (Table A.1), with some slight variations in the 
weak baseline features.  These data suggest that the insoluble fraction either has few IR active 
features or has a composition similar to that of 1.  
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Figure A.2. Panel A shows plots of the FTIR spectra (KBr pellets) of the crude material from 
reaction of R3TPA with iron(III) perchlorate (black), compound 1 (red), compound 4A (yellow), 
and compound 4B (blue). The difference spectra of 1/4A (panel B) and 4A/4B (panel C) are 
depicted to the right. The spectrum of 4A, compared to that of 1, displays two new peaks at 763 
and 1540 cm–1. No significant differences were observed in the spectrum of 4A compared to that 
of 4B. The spectral region from 1000-1200 cm–1 exhibits strong absorption from the perchlorate 
anion and has been omitted for clarity. 
 
 Crystallization of 1 was attempted by slow diffusion of diethyl ether into a solution of the 
complex in acetonitrile. After several days, two different types of crystals were obtained, some 
red and others yellow. X-ray diffraction analysis of the red crystals revealed a diiron structure 
with an Fe2O2 core (Figure A.3, Table A.2). The iron atoms are separated by 2.79 Å and have a 
pseudo-octahedral coordination environment (Table A.3). Each metal center is bound by the 
tetradentate R3TPA ligand, with Fe–N(amine) and Fe–N(pyridyl)ave distances of 2.18 and 2.14 Å, 
respectively. Two oxygen atoms bridge the iron centers, with Fe–O bond lengths of 1.88 and 
1.93 Å. Because each diiron unit is associated with three perchlorate anions, charge balance 
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considerations dictate that the oxygen atom bridges are best described as oxo and hydroxo 
ligands, giving the molecular formula [Fe2(µ-O)(µ-OH)(R3TPA)2](ClO4)3. Because the molecule 
is located on an inversion center, the Fe–O distances are an average of the iron-oxo and iron 
hydroxo bond lengths. The structural parameters of [Fe2(µ-O)(µ-OH)(R3TPA)2](ClO4)3 fall 
within the ranges exhibited by two isostructural diiron TPA complexes that differ only in their 
oxygen protonation states, [Fe2(µ-O)(µ-OH)(6-Me3TPA)2](ClO4)321 and [Fe2(µ-O)2(6-
Me3TPA)2](ClO4)222  (where 6-Me3TPA = tris((6-methylpyridyl)-2-methyl)amine) (Table A.3). 
Based on the similar spectroscopic characteristics of the red crystals compared to those of the red 
powder before crystallization, 1 is assigned as a (µ-oxo)(µ-hydroxo)diiron(III) complex, [Fe2(µ-
O)(µ-OH)(R3TPA)2](ClO4)3 (vide infra). 
 
Figure A.3. The thermal ellipsoid (50%) diagram of the X-ray structure of [Fe2(µ-O)(µ-
OH)(R3TPA)2](ClO4)3·(CH3CN)4 (1). Hydrogen atoms, solvent molecules, and perchlorate 
anions are omitted for clarity. Color scheme: iron, orange; oxygen, red; nitrogen, blue; carbon, 
black. See Table A.2 and Table A.3 for refinement and structural parameters of 1, respectively.  
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Table A.2. X-ray Data Collection and Refinement Parameters for 1, 4A, and 4B. 
 
 1 4A 4B 
Empirical formula  [Fe2N8O8C54H72](ClO4)3 ·(CH3CN)4 
[Fe2N8O9C56H75](ClO4)3 
·(CH3CN)3 
[Fe2N8O9C56H75](ClO4)3 
·(CH3CN)2.5(C4H10O)0.5 
Formula weight  1535.46 1537.45 1548.94 
Temperature (K) 100 100 100 
Wavelength (Å) 0.71073 0.71073 0.71073 
Crystal system  Monoclinic Triclinic Triclinic 
Space group  C2/c P  P  
Unit cell dimensions 
a = 28.2258(19) Å 
b = 11.7652(8) Å 
c = 22.4938(15) Å 
 
β = 106.6850(10)° 
 
a = 13.6256(9) Å 
b = 14.0402(9) Å 
c = 20.2928(13) Å 
α = 81.2320(10)° 
β = 72.8600(10)° 
γ = 71.0910(10)° 
a = 13.6723(12) Å 
b = 22.640(2) Å 
c = 24.640(2) Å 
α = 99.8960(10)° 
β = 98.875(2)° 
          γ = 102.9360(10)° 
Volume (Å3) 7155.3(8) 3503.6(4) 7135.5(11) 
Z 2 2 2 
Calculated density (g/mm3) 1.425 1.458 1.442 
Absorption coefficient (mm-1) 0.596 0.610 0.600 
F(000) 3212 1600 3236 
Crystal size (mm3) 0.32 x 0.17 x 0.13 0.20 x 0.10 x 0.07 0.20 x 0.16 x 0.12 
Θ range for data collection 1.51 to 26.73° 1.54 to 26.41° 1.14 to 26.77° 
Index ranges 
-35 ≤ h ≤ 35 
-14 ≤ k ≤ 14 
-20 ≤ l ≤ 20 
-16 ≤ h ≤ 17 
-17 ≤ k ≤ 17 
-25 ≤ l ≤ 25 
-17 ≤ h ≤ 17 
-28 ≤ k ≤ 28 
-30 ≤ l ≤ 30 
Reflections collected 63728 61129 123942 
Independent reflections 7549 [R(int) = 0.0340] 
14283 
[R(int) = 0.0532] 
30171 
[R(int) = 0.0564] 
Completeness to Θ (%) 99.3 99.4 99.1 
Absorption correction Empirical Empirical Empirical 
Max. and min. transmission 0.9265 and 0.8321 0.9586 and 0.8878 0.9315 and 0.8895 
Data / restraints / parameters 7549/85/473 14283/0/952 30171/4/1808 
Goodness-of-fit on F
2 
1.077 1.016 1.030 
Final R indices [I>2σ(I)] R1 = 0.0652 wR2 = 0.1759 
R1 = 0.0552 
wR2 = 0.1259 
R1 = 0.0673 
wR2 = 0.1747 
R indices (all data) R1 = 0.0722 wR2 = 0.1815 
R1 = 0.0810 
wR2 = 0.1381 
R1 = 0.0967 
wR2 = 0.1937 
Largest diff. peak and hole 
(eA3) 1.828 and -0.693 1.429 and -1.188 2.467 and -1.199 
* R1 = Σ ∣∣Fo∣–∣Fo∣∣/Σ∣Fo∣; wR2 = [Σ[w(Fo2– Fc2)2]/Σ[w(Fo2)2]]1/2; GOF = [Σ[w(Fo2– Fc2)2]/(n–p)]1/2, where n is 
the number of reflections and p is the total number of parameters refined. 
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Table A.3. Selected Structural Parameters of [Fe2(µ-O)(µ-OH)(R3TPA)2](ClO4)3 (1), [Fe2(µ-
O)(µ-OH)(6-Me3TPA)2](ClO4)3,21 and [Fe2(µ-O)2(6-Me3TPA)2](ClO4)2.22 
 
 
 
 
 1 [Fe2(µ-O)(µ-OH)(6-Me3TPA)2](ClO4)3b [Fe2(µ-O)2(6-Me3TPA)2](ClO4)2c 
Bond Distances (Å)a    
Fe(1)–Fe(1A) 2.7920(9) 2.95(1), 2.94(1) 2.716(2) 
Fe(1)–O(4) 1.883(3) 1.906(8), 1.91(1) 1.844(3) 
Fe(1)–O(4A) 1.934(2) 1.981(8), 1.960(9) 1.916(4) 
Fe(1)–N(1) 2.183(3) 2.174(9), 2.18(1) 2.194(4) 
Fe(1)–N(2) 2.147(3) 2.239(9), 2.28(1) 2.255(4) 
Fe(1)–N(3) 2.151(3) 2.194(9), 2.196(9) 2.279(4) 
Fe(1)–N(4) 2.134(3) 2.188(9), 2.18(1) 2.244(4) 
Bond Angles (deg)a    
Fe(1)–O(4)–Fe(1A) 94.01(11) 98.7(4), 98.7(6) 92.5(2) 
O(4)–Fe(1)–O(1A) 85.99(11) 81.3(4), 81.3(6) 87.5(2) 
N(1)–Fe(1)–N(2) 76.24(10) 77.2(3), 76.0(5) 75.7(1) 
N(1)–Fe(1)–N(3) 76.24(10) 81.2(4), 81.5(4) 74.7(2) 
N(1)–Fe(1)–N(4) 79.74(10) 75.1(3), 75.6(4) 79.0(2) 
N(1)–Fe(1)–O(4) 176.66(10) 170.6(4), 168.7(4) 175.1(2) 
N(1)–Fe(1)–O(4A) 96.12(10) 89.4(4), 88.0(5) 87.8(2) 
aA generalized numbering scheme, depicted in the above cartoon representation, is used. These atom labels do not necessarily 
correspond to those assigned in their respective X-ray structures. bPreviously reported; see ref. 21. Each asymmetric unit 
contains two independent diiron units. cPreviously reported; see ref. 22. 
 
 The yellow crystals obtained from crystallization of 1 in acetonitrile/diethyl ether were 
also evaluated by X-ray crystallography (Figure A.4, Table A.4). The compound has a dinuclear 
structure with an Fe–Fe distance of 3.25 Å. Each pseudo-octahedral iron atom is capped by a 
R3TPA group, with Fe–N(amine)ave = 2.20 Å and Fe–N(pyridyl)ave = 2.15 Å, and is linked by 
two bridging ligands. One of the bridges is an oxo atom, indicated by short Fe–O bond lengths of 
~1.80 Å. The difference electron density map reveals that the second bridging ligand contains 
four non-hydrogen atoms arranged in a trigonal planar geometry. Assigning this group to an 
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acetate moiety allowed the structure to refine to convergence, the Fe–O distances being 2.04 and 
1.96 Å. The presence of an acetate moiety in this structure is surprising because no CH3CO2– was 
used during the preparation of 1 or in the crystallization procedure. Because each diiron unit is 
associated with three perchlorate anions, the molecular formula of this compound is assigned as 
[Fe2(µ-O)(µ-CH3CO2)(R3TPA)3](ClO4)3 (4A).  
 
Figure A.4. The thermal ellipsoid (50%) diagram of the cation observed in the X-ray structure of 
[Fe2(µ-O)(µ-CH3CO2)(R3TPA)2](ClO4)3·(CH3CN)3 (4A). Hydrogen atoms are omitted for 
clarity. Color scheme: iron, orange; oxygen, red; nitrogen, blue; carbon, black. See Table A.2 
and Table A.4 for refinement and structural parameters of 4A, respectively. 
 
As expected, compounds 1 and 4A display distinct optical profiles (Figure A.5). The 
absorption spectrum of 1 has λmax values at 370 and 550 nm, which are characteristic of (µ-
oxo)(µ-hydroxo)diiron(III) rather than di(µ-oxo)diiron(III) species.8 The visible band at 550 nm 
has been attributed to an oxo-to-iron(III) charge transfer. In contrast, 4A exhibits optical bands at 
332, 454, 492, and 700 nm. These features are nearly identical to those reported for other (µ-
oxo)(µ-carboxylato)diiron(III) TPA species.6  
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Table A.4. Selected Structural Parameters of 4A and 4B. 
 
N(7)N(2)
N(3)
N(1)
N(4)
N(6)
N(8)
N(5)
Fe(1) Fe(2)
O(3)
O(1) O(2)
 
 
 4A 4Bb 
Bond Distances (Å)a   
Fe(1)–Fe(4) 3.252(3) 3.250(3), 3.250(3) 
Fe(1)–O(1) 2.044(2) 2.042(3), 2.038(3) 
Fe(1)–O(3) 1.783(2) 1.794(3), 1.788(3) 
Fe(1)–N(1) 2.212(3) 2.216(3), 2.221(3) 
Fe(1)–N(2) 2.114(3) 2.137(3), 2.119(3) 
Fe(1)–N(3) 2.128(3) 2.135(2), 2.131(3) 
Fe(1)–N(4) 2.146(3) 2.138(3), 2.151(3) 
Fe(2)–O(2) 1.962(2) 1.984(3), 1.966(3) 
Fe(2)–O(3) 1.801(2) 1.808(3), 1.803(3) 
Fe(2)–N(5) 2.182(3) 2.191(3), 2.191(3) 
Fe(2)–N(6) 2.138(3) 2.121(3), 2.134(3) 
Fe(2)–N(7) 2.228(3) 2.228(3), 2.233(3) 
Fe(2)–N(8) 2.128(3) 2.131(3), 2.136(3) 
Bond Angles (deg)a   
Fe(1)–O(3)–Fe(2) 130.15(13) 128.98(15), 129.62(15) 
O(3)–Fe(1)–O(1) 98.47(10) 99.63(12), 99.39(12) 
O(3)–Fe(2)–O(2) 102.39(10) 102.14(12), 101.70(12) 
N(1)–Fe(1)–N(2) 77.70(10) 75.81(12), 76.58(12) 
N(1)–Fe(1)–N(3) 79.20(10) 79.01(13), 78.95(13) 
N(1)–Fe(1)–N(4) 75.07(10) 76.18(12), 75.59(12) 
N(5)–Fe(2)–N(6) 76.09(10) 78.52(12), 77.11(13) 
N(5)–Fe(2)–N(7) 77.98(10) 76.93(12), 77.49(12) 
N(5)–Fe(2)–N(8) 76.69(10) 75.89(12), 76.98(12) 
aA generalized numbering scheme, depicted in the above cartoon representation, is used. These atom labels do not necessarily 
correspond to those assigned in their respective X-ray structures. bThere are two independent diiron units of 4B in the asymmetric 
cell; parameters for both cations are provided. 
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Figure A.5. UV-vis spectra of complexes 1 (red), 4A (yellow), and 4B (blue) recorded in 
dichloromethane at RT. Red spectrum: λmax = 370, 550 nm; yellow spectrum: λmax = 332, 454, 
492 nm; blue spectrum: λmax = 332, 454, 492 nm. 
 
 The IR spectra of the red and yellow crystals of 1 and 4A, respectively, were recorded 
(Figure A.2A). Because of similarities in their molecular composition, 1 and 4A share several 
prominent features in the spectral range between 500-1700 cm–1. In addition to the vibrational 
modes present in the spectrum of 1, however, compound 4A displays peaks at 763 and 1540 cm–1 
(Figure A.2B). The former is ascribed to an asymmetric stretching mode of the Fe–O–Fe unit 
and the latter to an asymmetric C–O–O– vibration of the bridging acetate. Based on 
comprehensive analyses of synthetic oxo-bridged diiron(III) compounds,23,24 it has been 
established that the Fe–O stretching frequency of an {Fe2O}4+ unit is strongly correlated with its 
Fe–O–Fe angle. Because the Fe–O–Fe angle in 1 (94°) is significantly smaller than that of 4A 
(130°), the vFe–O stretching frequencies of 1 are expected to occur at higher energies than those in 
4A. 18O isotopic labeling experiments are required to definitively assign the vFe–O modes. 
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Nevertheless, the IR data are fully consistent with the formulation of 1 as [Fe2(µ-O)(µ-
OH)(R3TPA)2](ClO4)3 and 4A as [Fe2(µ-O)(µ-CH3CO2)(R3TPA)2](ClO4)3.  
 
Figure A.6. 1H NMR spectra (CD2Cl2, 500 MHz) of A) complex 1, B) complex 4A, and C) 
complex 4B recorded at RT at concentrations of approx. 5 mM. Spectrum A: δ = 1.63, 2.24, 
2.79, 3.42, 3.60, 3.89, 4.00, 4.70 ppm; spectrum B: δ = 2.45, 2.94, 3.28, 3.68, 3.92 ppm; 
spectrum C: δ = 2.44, 2.93, 3.28, 3.67, 3.91 ppm. Peaks attributed to solvent: δ 
(dichloromethane) = 5.2 ppm; δ (water) = 1.6 ppm; δ (diethyl ether) = 1.2, 2.0 ppm. 
 
 The 1H NMR spectra of 1 and 4A are indicative of paramagnetic species at room 
temperature. The spectrum of 1 shows several significantly broadened peaks at 4.70, 4.00, 3.89, 
3.60, 3.42, 2.79, 2.24, and 1.63 ppm (Figure A.6A), whereas those for 4A appear at 3.92, 3.68, 
3.28, 2.94, and 2.45 ppm (Figure A.6B). Previous studies of iron TPA complexes have indicated 
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that the β protons of its pyridine rings are highly sensitive to the electronic properties of the iron 
centers; no attempts were made to examine this property in the present study.8 
 
Figure A.7. The thermal ellipsoid (50%) diagram of the X-ray structure of [Fe2(µ-O)(µ-
CH3CO2)(R3TPA)2](ClO4)3·(CH3CN)2.5(Et2O)0.5 (4B). Two independent molecules of 4B occur 
in the asymmetric unit; only one of them is shown in the diagram. Hydrogen atoms, solvent 
molecules, and perchlorate anions are omitted for clarity. Color scheme: iron, orange; oxygen, 
red; nitrogen, blue; carbon, black. See Table A.2 and Table A.4 for refinement and structural 
parameters of 4B, respectively. 
 
 To confirm the identity of complex 4A, particularly the assignment of acetate as its 
bridging ligand, efforts were made to prepare [Fe2(µ-O)(µ-CH3CO2)(R3TPA)2](ClO4)3 
independently. Reaction of solid R3TPA, iron(III) perchlorate decahydrate, sodium acetate, and 
triethylamine in a 2:2:1:2 ratio in a methanol solution afforded a yellow precipitate that was 
readily isolated by filtration. Single crystals of the compound were obtained by slow diffusion of 
diethyl ether into an acetonitrile solution. X-ray diffraction analysis of these yellow blocks 
showed two molecules of [Fe2(µ-O)(µ-CH3CO2)(R3TPA)2]3+ in the asymmetric unit (Figure A.7), 
along with six perchlorate anions, five acetonitrile molecules, and one diethyl ether. For 
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comparison purposes, the [Fe2(µ-O)(µ-CH3CO2)(R3TPA)2](ClO4)3 compound obtained from this 
preparation will hereafter be referred to as 4B. Table A.4 lists the metrical parameters of the 
structures of 4A and 4B. The two structures have essentially identical bond distances and angles, 
with deviations that are no greater than ~0.01 Å or ~1 deg., respectively. The small structural 
differences between 4A and 4B can be accounted for by crystal packing, for the two unit cells 
have different dimensions as a result of having different numbers of solvent molecules in their 
lattices (Table A.2).  
 To obtain further confirmation that 4A and 4B are indeed the same compound, 57Fe 
Mössbauer spectra were recorded. The spectra of 4A and 4B both display a single quadrupole 
doublet. The data for 4A were fit with δ = 0.44 mm/s and ΔEQ = 1.47 mm/s, whereas those for 
4B were fit with δ = 0.44 mm/s and ΔEQ = 1.49 mm/s (Table A.1). Although the two iron atoms 
in [Fe2(µ-O)(µ-CH3CO2)(R3TPA)2](ClO4)3 are not related by molecular symmetry, the similarity 
in their coordination environments make them indistinguishable by zero-field Mössbauer 
spectroscopy. These Mössbauer parameters are typical for iron in the +3 oxidation state and 
compare favorably with those of other (µ-oxo)(µ-carboxylato)diiron(III) TPA compounds.6  
Finally, the UV-vis (Figure A.5, blue) and 1H NMR spectra of 4B (A.6C) are identical to 
those of 4A (Figure A.5, yellow and Figure A.6B, respectively), unequivocally showing that the 
four-atom bridging ligand in 4A is acetate. 
 Effect of Solvent, Water, and Temperature on the Stability of 1. To examine the 
stability of the (µ-oxo)(µ-hydroxo)diiron(III) core in solution, the absorption spectrum of 1 was 
recorded in different solvents at room temperature (Figure A.8). The oxo-to-iron(III) charge 
transfer band at 550 nm is present when 1 was dissolved in either neat dichloromethane or 
acetonitrile. Dissolution of 1 in an equal mixture of dichloromethane and methanol, however, led 
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to complete loss of this optical feature. The disappearance of the 550 nm band indicates that 
there is a change in the diiron core, perhaps resulting from a loss of one of the bridging ligands, 
conversion of the hydroxide to a methoxide bridge, or dissociation into mononuclear iron 
species. Because this behavior was observed when methanol was introduced into 
dichloromethane, other protic solvents may also affect the structural integrity of 1.  
 
Figure A.8. UV-vis spectra of complex 1 recorded in different solvents. The 370 and 550 nm 
bands are observed in dichloromethane (green) and acetonitrile (blue) but not in a 
dichloromethane/methanol (1:1) mixture (red).  
 
The (µ-oxo)(µ-hydroxo)diiron(III) core can convert to a (µ-oxo)(hydroxo)(aqua)-
diiron(III) unit through temperature-dependent aquation.8,20 When a solution of 1 in acetonitrile 
was cooled to -30 °C under ambient conditions, the prominent band at 550 nm decreased in 
intensity (Figure A.9, red trace) and completely diminished upon treatment with ~8000 equiv of 
H2O (green trace). Upon warming the solution to room temperature, the 550 nm band of 1 was 
partially restored (blue trace). When 1 is cooled to -30 °C, partial aquation may occur to afford 
[Fe2(µ-O)(OH)(H2O)(R3TPA)2](ClO4)3 (B), resulting in an absorption decrease at 550 nm 
(Scheme A.2). When water was deliberately added to the solution at -30 °C, all of 1 was 
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converted to B. This equilibrium shifted back predominantly toward 1 when the solution was 
warmed to room temperature. 
 
Figure A.9. Plot showing the effect of temperature and water on the UV-vis spectra of a 0.7 mM 
acetonitrile solution of complex 1. At RT, 1 exhibits a prominent band at 550 nm (black dashed 
line). When cooled to -30°C, this absorption decreases (red) and is completely diminished upon 
addition of ~8000 equiv of water (green), relative to the diiron complex. The band at 550 nm was 
partially restored upon warming the solution back to RT (blue).  
 
 
Scheme A.2. Proposed pathway for the complete hydrolysis of acetonitrile to acetate mediated 
by the [Fe2(µ-O)(µ-OH)(R3TPA)2]3+ (1) complex. 
 
 Hydrolysis of Acetonitrile to Acetate. The yellow crystals of 4A isolated from 
crystallization of 1 in acetonitrile could result either from a contaminant or through a chemical 
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process that converts 1 to 4A under the conditions employed. Because no sources of acetate were 
used during the preparation of 1 and the results were verified by multiple independent 
experiments, the latter hypothesis is more likely. Dimetallic complexes can promote the 
hydrolysis of organonitriles in the presence of water.25-27 As depicted in Scheme A.2, we propose 
that trace amounts of water in the solvent reacts with 1 to give B. A possible mechanism would 
be for the coordinated water in B to be displaced by an acetonitrile molecule to generate 2. In the 
first irreversible step, the hydroxide ligand bound to the other iron atom in 2 attacks the 
electrophilic nitrile group, affording a (µ-oxo)(µ-acetamido)diiron(III) species 3. For most 
nitrogen-rich diiron compounds, the hydrolysis of CH3CN does not proceed beyond the 
carboxamide.7,19 Because 4A, rather than 3, was isolated from the crystallization of 1, hydrolysis 
of the acetamide in 3 must occur to afford the acetate. 
To obtain evidence for the complete hydrolysis of CH3CN, the absorption spectrum of 
compound 1 in acetonitrile was recorded over the course of ~900 min. The reaction was 
performed with wet solvent in air to reproduce the conditions under which 4A was crystallized. 
Although the reaction is slow, spectral changes were observed between 340-380 nm as well as at 
550 nm (Figure A.10A). A kinetic analysis of the data at 553 nm were fit satisfactorily to a two 
consecutive unimolecular reaction model, yielding rate constants of k1 = 2.04 ± 0.16 x 10–2 min–1 
and k2 = 1.98 ± 0.06 x 10–3 min–1 (Figure A.10B). These processes are tentatively attributed to 
conversion of 1 to 3 and of 3 to 4A. A (µ-oxo)(µ-acetamido)diiron(III) complex 3 has not been 
isolated from the reaction mixture, but is a logical precursor to 4A. 
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Figure A.10. Decay of 1 in acetonitrile (283 µM) (solvent-grade, not pre-dried) at RT followed 
by UV-vis absorption spectroscopy. The complete optical profile is shown in panel A. The 
absorption changes at 553 nm are shown in panel B as black dots. The data were fit to an 
ABC kinetic model (red trace), yielding the parameters: k1 = 2.04 ± 0.16 x 10–2 min–1, k2 = 
1.98 ± 0.06 x 10–3 min–1, εA = 610.9 ± 0.5 M–1cm–1, εB = 578.5 ± 1.4 M–1cm–1, εC = 488.8 ± 1.0 
M–1cm–1, Χ2 = 1.72 x 10–6, and R = 0.99977. See Eq. 1 in the experimental section for the 
mathematical expression used. 
 
   Validity of the Reported Results. The present study indicates that a more thorough 
investigation is required to evaluate the reaction scheme proposed in Scheme A.1. Firstly, it is 
important to determine whether the reaction of hydrogen peroxide with [Fe2(µ-
O)2(R3TPA)2](ClO4)3 (1) proceeds in a manner similar to that with [Fe2(µ-
O)(OH)(H2O)(R3TPA)2](ClO4)3 (4A). To enable such studies, the conditions that favor either 1 
or 4A in solution have been delineated. Secondly, diiron(III) R3TPA reactivity studies should be 
conducted in non-nitrile containing solvents, such as tetrahydrofuran or methanol. Although the 
hydrolysis of CH3CN is slow in the presence of 1 and trace amounts of water, it is possible that 
additives such as hydrogen peroxide or acids would enhance the rate of this reaction. If so, there 
would be an additional competing reaction pathway that may complicate interpretation of the 
experimental data. It is noteworthy in this context that the reported Mössbauer spectra for the 
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high-valent diiron R3TPA compounds showed significant amounts (30-48%) of “iron(III)” that 
were subtracted from the raw data. It is unclear whether these contributions come from the 
starting material, the decayed product, or another species generated during the reaction. Because 
of the complicated nature of the reactions that produce these high-valent species, the Mössbauer 
data required 15 parameters to be fit during ~1000 simulations.28-30 Perhaps by altering the 
experimental conditions under which the diiron(IV) units are generated, more homogeneous 
samples could be obtained to provide cleaner spectra for data analysis. 
 
A.4. Conclusion 
 The putative diiron(III) starting material, [Fe2(µ-O)(OH)(H2O)(R3TPA)2](ClO4)3, is 
formed only in solution in the presence of excess amounts of water and at low temperature. The 
reported synthetic procedure affords the organic solvent soluble [Fe2(µ-O)(µ-
OH)(R3TPA)2](ClO4)3 compound as well as an intractable iron(III) material. The (µ-oxo)(µ-
hydroxo)diiron(III) core opens up in the presence of water to enable binding of acetonitrile. The 
bound CH3CN group is fully hydrolyzed to the CH3COO– anion. Further studies are necessary to 
clarify the hydrogen peroxide reactivity of the diiron(III) complexes characterized in this report.  
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